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Abstract
Screening plays an essential role in reducing colorectal cancer (CRC) incidence and
mortality rates, yet CRC screening use remains low in Maryland and lower in some age
and racial/ethnic groups with limited resources to participate in CRC screening programs.
The purpose of this quantitative, cross-sectional study is to investigate whether age
group, sex, race/ethnicity, education level, income level, health insurance coverage, and
access to health care professional can predict an individual, 50–75 years of age, in
Maryland to take action to fully meet the United States Preventive Services Task Force
CRC screening test recommendation within the recommended time interval. The health
belief model and the fundamental cause theory provided the framework for this study.
Secondary data of 2014, 2016, and 2018, from 3134 respondents in the Behavioral Risk
Factor Surveillance Systems database, were analyzed using the Pearson chi-square test of
independence and multiple logistic regression techniques. Stratified random sampling
was used to select cases. The results revealed statistically significant (p < .05) association
between age, race/ethnicity, education level, access to health care professional, and CRC
screening use. However, non-significant (p >.05) association was found between income
level, health insurance plan, and CRC screening use. Age group and race/ethnicity were
confounders on the association, but sex had no effect on the odds ratios. By identifying
the predictors of CRC screening use, findings from this research could have positive
social change and guide policy decisions by informing public health practitioners on the
design and implementation of tailored CRC screening programs with modalities that
target groups with lower CRC screening use.

Predictors of colorectal cancer screening among Maryland adults, aged 50–75 years
by
Pamela M. Asangong

MS, Thomas Jefferson University, 2003
BS, Thomas Jefferson University, 2001

Dissertation Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Philosophy
PUBLIC HEALTH – EPIDEMIOLOGY

Walden University
August 2020

Dedication
This dissertation project is dedicated to my late mother Mama Miriam Muyang
Asangong, who passed on to glory in 1979 and did not have the least opportunity to see
me grow nor enjoy the fruits of her labor. A special dedication goes to my father Pa Peter
Asangong who had always believed I was his doctor and wished to officially address me
“Doctor”. He passed away on July 19th, 2017 while I was already in the Ph.D. program;
hence could not physically attend my third graduation of what he had termed “People’s
Highest Degree”. My father lived a very humble life while working tirelessly to single
handedly raise 7 children of whom I am the lucky 6th. With not much academic
education, because his parents could not afford it, my father’s emphasis on the
importance of education to his children was something to admire, and that gave me the
zeal to embark on this academic journey. I could not have done this without the
inspiration from my parents. Your memory will continue to remain in my heart.

Acknowledgments
I thank the entire Walden dissertation team for their support to my success in this
work. My profound gratitude goes to my method expert and committee chair Dr. WenHung Kuo, my content expert Dr. Richard Palmer, and my URR Dr. Sumner Davis for
their mentorship, positive criticisms, and unwavering support to my dissertation.
A huge thank you goes to my husband and the entire Morfaw family for their
patience, and encouragement during this journey. You never complained about my
absence from family activities; instead, the four of you stepped up and picked on my
household responsibilities just so I can study without any worries. My husband John
Morfaw, my children Collins, Nkeng and Muyang I thank you for your untiring support
towards my academic achievements, and this degree.
Special thanks go to my sisters Margaret and Elizabeth Asangong for laying a
solid foundation on my life by being a mother to me in the painful absence of our mother.
My brothers Pius, Sam, and Constantine Asangong you are the solid rock I need upon
that foundation. I would not have reached this level of my education without your endless
support.
To my friends, thanks for your understanding and prayers as I could not be there
in some of your big moments. While I thank everyone, who contributed to my success in
one way or another; I hope to make up for the lost time stolen from you during my
studies.

Table of Contents
List of Tables .................................................................................................................... vii
List of Figures .................................................................................................................. viii
Chapter 1: Introduction to the Study....................................................................................1
Introduction ....................................................................................................................1
Background/Context ......................................................................................................3
Problem Statement .........................................................................................................7
Purpose of the Study ......................................................................................................8
Research Questions and Hypotheses .............................................................................9
Theoretical Foundation and Conceptual Framework for the Study .............................10
Theoretical Foundation of the Health Belief Model ............................................. 10
Conceptual Framework of the Health Belief Model ............................................. 10
Theoretical Foundation of the Fundamental Cause Theory.................................. 11
Conceptual Framework of the Fundamental Cause Theory ................................. 12
Nature of the Study ......................................................................................................13
Definition of the Operational Variables .......................................................................13
Assumptions.................................................................................................................15
Scope and Delimitations ..............................................................................................16
Limitations ...................................................................................................................17
Significance of the Study .............................................................................................18
Contribution to Public Health Knowledge ............................................................ 18
Contribution to Public Health Practice ................................................................. 18
i

Contribution to Public Health Policy .................................................................... 19
Social Change Implication ...........................................................................................20
Summary ......................................................................................................................21
Chapter 2: Literature Review .............................................................................................22
Introduction ..................................................................................................................22
Synopsis of the Current Literature on CRC Screening ......................................... 22
Major Sections of the Chapter .............................................................................. 23
Literature Search Strategy............................................................................................24
Key Search Terms ................................................................................................. 24
Scope of the Literature Search .............................................................................. 24
Theoretical Foundation and Conceptual Framework ...................................................25
Origin of the Health Belief Model ........................................................................ 26
Major Propositions of the Health Belief Model .................................................... 26
Application of the Health Belief Model in Previous Studies ................................ 28
Limitations of the Health Belief Model ................................................................ 30
Origin of the Fundamental Cause Theory............................................................. 30
Major Propositions of the Fundamental Cause Theory ........................................ 31
Application of the Fundamental Cause Theory in Previous Studies .................... 33
Limitations of the Fundamental Cause Theory ..................................................... 36
Rationale for the Health Belief Model and the Fundamental Cause Theory ........ 36
Colorectal Cancer Overview ........................................................................................38
Colorectal Cancer Epidemiology .......................................................................... 39
ii

Colorectal Cancer Epidemiology in the United States ......................................... 40
Risk Factors of Colorectal Cancer ........................................................................ 42
Colorectal Cancer Screening................................................................................. 43
Effectiveness of Colorectal Cancer Screening ...................................................... 45
Colorectal Cancer Screening in the United States ............................................... 46
Cancer in Maryland......................................................................................................47
Colorectal Cancer in Maryland ....................................................................................49
Colorectal Cancer Control and Prevention Strategies in Maryland ...................... 51
Maryland’s Contexts of the Colorectal Cancer Screening Problem ..................... 52
Literature Review Related to Study Variables .............................................................53
How Other Researchers Approached the Problem of Low CRC Screening ......... 53
Age and Colorectal Cancer Screening Use ........................................................... 56
Sex and Colorectal Cancer Screening Use............................................................ 57
Race/Ethnicity and Colorectal Cancer Screening Use .......................................... 58
Education Level and Colorectal Cancer Screening Use ....................................... 60
Household Income Level and Colorectal Cancer Screening Use ......................... 62
Access to Healthcare Professional and Colorectal Cancer Screening Use ........... 63
Health Insurance Coverage and Colorectal Cancer Screening Use ...................... 65
Literature Review Related to Research Design and Methodology ..............................67
Summary ......................................................................................................................68
Conclusion ...................................................................................................................69
Chapter 3: Research Method ..............................................................................................70
iii

Introduction ..................................................................................................................70
Research Design and Rationale ...................................................................................70
Methodology ................................................................................................................74
Target Population .................................................................................................. 75
Sampling Method and Sampling Procedures ........................................................ 75
Sample Size........................................................................................................... 75
Effect Size and Power Analysis ............................................................................ 76
Procedure for Data Collection .....................................................................................77
Centers for Disease Control and Prevention Behavioral Risk Factor
Surveillance System .................................................................................. 77
Maryland Behavioral Risk Factor Surveillance System ....................................... 78
Procedure for Data Access and Collection Process .............................................. 79
Instrumentation and Operationalization of Constructs ................................................80
Instruments and Materials ..................................................................................... 80
Validity and Reliability of the Behavioral Risk Factor Surveillance System
Data ........................................................................................................... 81
Study Operational Variables ........................................................................................83
Independent Variables .......................................................................................... 83
Dependent Variables ............................................................................................. 84
Covariates ............................................................................................................. 84
Data Analysis Plan .......................................................................................................85
Statistical Analysis Plan ........................................................................................ 85
iv

Analytical Techniques to Answer the Research Questions .................................. 88
Rational for Using Specific Statistics ................................................................... 97
Threats to Validity .......................................................................................................98
Threats to External Validity .................................................................................. 98
Threats to Internal Validity ................................................................................... 99
Ethical Procedures .....................................................................................................100
Potential Risks to Participants and Protection of Participants ...................................100
Summary ....................................................................................................................101
Chapter 4: Results ............................................................................................................103
Introduction ................................................................................................................103
Research Questions and Hypotheses .........................................................................104
Data Collection ..........................................................................................................105
Discrepancies in Data Collection ...............................................................................105
Data Analysis .............................................................................................................106
Data Cleaning...................................................................................................... 106
Data Coding ........................................................................................................ 107
Descriptive and Demographic Characteristics of the Sample............................. 108
Results of Statistical Analysis ....................................................................................111
Research Question 1 – Socioeconomic Status and Colorectal Cancer
Screening Use ......................................................................................... 113
Research Question 2 – Access to Preventive Health Care Services and
Colorectal Cancer Screening Use ........................................................... 121
v

Summary ....................................................................................................................127
Chapter 5: Discussion, Conclusions, and Recommendations ..........................................128
Introduction ................................................................................................................128
Interpretation of the Findings.....................................................................................129
Research Question 1 – Socioeconomic Status and Colorectal Cancer
Srceening Use ......................................................................................... 129
Research Question 2 – Access to Preventive Healthcare Service and
Colorectal Cancer Srceening Use ........................................................... 133
Limitations of the Study.............................................................................................139
Recommendations ......................................................................................................140
Implication for Positive Social Change .....................................................................142
Conclusions ................................................................................................................144
References ........................................................................................................................146
Appendix A: CRC Screening Guidelines for Average-risk Individuals ..........................184
Appendix B: Maryland CRC Screening Guidelines ........................................................185

vi

List of Tables

Table 1. Frequency Distribution of Variables................................................................. 110
Table 2. Cross Tabulation: Pearson Chi-Square Test of Independence...........................112
Table 3. Binary Logistic Regression for Education level, Income Level, and
Colorectal Cancer Screening Use ........................................................................115
Table 4. Binary Logistic Regression for Education Level, Income Level, Age, and
Colorectal Cancer Screening Use ........................................................................117
Table 5. Binary Logistic Regression for Education Level, Income Level, Sex, and
Colorectal Cancer Screening Use ........................................................................... 119
Table 6. Binary Logistic Regression for Education level, Income Level,
Race/Ethnicity, and Colorectal Cancer Screening Use ........................................120
Table 7. Binary Logistic Regression for Health Insurance Coverage, Access to
Health care Professional, and Colorectal Cancer Screening Use ........................123
Table 8. Binary Logistic Regression for Health Insurance Coverage, Access to
Health care Professional, Age, and Colorectal Cancer Screening Use ................125
Table 9. Binary Logistic Regression for Health Insurance Coverage, Access to
Health Care Professional, Race/Ethnicity, and CRCSU ......................................126

vii

List of Figures
Figure 1. The three segments of the colon and the rectum ................................................38
Figure 2. A pedunculated colorectal polyp ........................................................................39

viii

1
Chapter 1: Introduction to the Study
Introduction
The National Cancer Institute (NCI) pointed out that cancer of the colon and the
rectum have similar features (NCI, 2019). Hence the term colorectal cancer (CRC) is
commonly used to describe cancer of the colon and/or the rectum (Bray et al., 2018).
CRC is the third most common cancer diagnosed (Macrae, 2019; Simonson, 2018); and
the second leading cause of cancer-related death among men and women in the United
States (Ansa, Coughlin, Alema-Mensah, & Smith, 2018). According to the American
Cancer Society (ACS), the lifetime risk for developing CRC is about 1 in 22 (4.49%) for
men and 1 in 24 (4.15%) for women, showing a higher risk in men than in women (ACS,
2019). CRC is rare in children and relatively? common among adults, 45 years of age and
older (Cardoso, Niedermaier, Chen, Hoffmeister, & Brenner, 2019); it is considered one
of the most preventable and most treatable forms of cancer if detected early (Sauer,
Siegel, Jemal, & Fedewa, 2019; Zauber et al., 2018). Therefore, increasing screening
rates across all groups could ultimately save lives (Doubeni et al., 2019).
Researchers have determined that sociodemographic factors are predictors and
those of lower socioeconomic status (SES) have lower odds of participating in or
completing CRC screening programs (DeMoor et al., 2018; Miranda et al., 2017; BurnettHartman, Mehta, & Zheng, 2016; Wilder & Wilson, 2016). Given the benefits of
screening and early detection of precancerous polyps, the objective of this study is to
quantitatively determine predictors of CRC screening use, by utilizing sociodemographic
and socioeconomic data derived from the Behavioral Risk Factor Surveillance System
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(BRFSS) database. Although concerted public health efforts to prevent CRC have led to
increases in CRC screening rates, disparities in CRC screening still persist in the United
States (Burnett-Hartman, Mehta, & Zheng, 2016; Liss & Baker, 2014), with access to
preventive health care service, such as health insurance coverage and access to physician
services, at the forefront of barriers to CRC screening uptake among minority populations
(DeGroff et al., 2018; Satsangi & DeGroff, 2016). Also, factors such as income
(Woudstra, Smets, Verdam, & Fransen, 2019; Rodriguez, & Smith, 2016) and education
level (Cross et al., 2019; Lee, Natipagon-Shah, Sangsanoi-Terkchareon, Warda, & Lee,
2019) play a significant role in CRC screening differences across groups.
This study was needed because it addresses an under-researched area of CRC
screening use across different groups in Maryland (Maryland Department of Health
2016-2020 Cancer Report). Also, by identifying predictors of CRC screening through this
study, community based screening programs tailored to specific groups can be
implemented to reduce CRC related death in Maryland. Some researchers have suggested
that organized mass screening could be a better approach to reduce deaths from CRC,
than averting risk factors of CRC (Macrae et al., 2019; Cardoso, Niedermaier, Chen,
Hoffmeister, & Brenner, 2019). In its efforts to reduce the CRC incidence and mortality
rates, the National Colorectal Cancer Roundtable (NCCR) set a goal: to increase CRC
screening rate in the U.S. from 58.6% in 2013 to ≥80% by 2018 (Ransohoff, & Sox,
2016), and pointed out that compliance with screening recommendations could reduce
mortality and improve patients’ health and well-being (Bibbins-Domingo et al., 2016).
This dissertation has the potential for positive social change by providing ways for public

3
health professionals to design effective CRC screening programs that target groups with
lower CRC screening use. By identifying the predictors of CRC screening use, clinicians
could offer opportunistic and appropriate CRC screening modalities when patients visit
the doctor’s office for other reasons. This research could also help Maryland to set new
CRC screening priority strategies based on its current 2019–2021 cancer prevention plan.
The remainder of this chapter covers the following topics: the background
information related to CRC screening as an effective method to reduce CRC incidence,
the problem statement, purpose of the research, the research questions and hypotheses
that identify the study objectives, an outline of the theoretical and conceptual framework
that ground this study, nature of the study, definition of variables, assumptions,
limitations, the scope and delimitations, and significance.
Background/Context
CRC is a serious public health problem in the U.S. (Bray et al., 2018). There is
overwhelming evidence from the literature that screening can prevent CRC through early
detection and removal of colorectal polyps before they become cancerous (Cardoso et al.,
2019; Doubeni et al., 2019; Sauer, Siegel, Jemal, & Fedewa, 2019; Jeol et al., 2018;
Levin et al., 2018; Li et al., 2018; Simonson et al., 2018; Bibbins-Domingo et al., 2016;
Ransohoff, & Sox, 2016; Simon, 2016; Meester et al., 2015). CRC screening has also
been identified as the most effective strategy to reduce economic burden related to CRC
(Sharma, DeGroff, Scott, Shrestha, Melillo, & Sabatino, 2019; Zauber, 2012). Data from
the NCI Surveillance, Epidemiology, and End Results (SEER) report showed an overall
decrease in the CRC death rate (Noone et al., 2018); yet up to 145,600 new cases and
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51,020 deaths from CRC was estimated in 2019 (ACS, 2019; Macrae, 2019). Although
screenings have been credited for the drop in CRC incidence and mortality rates in the
last ten years (Maxon, 2018; Simonson et al., 2018), participation in CRC screening
remains a challenge in the U.S. (Wittich et al., 2019; Gonzales, Qeadan, & Mishra, 2017;
Lin, McKinley, Sripipatana, & Makaroff, 2017; Burnett-Hartman, Mehta, & Zheng,
2016), and a hurdle in Maryland (Watkins et al., 2018; Ahmad, Hayes, Rich, & Stern,
2015; Richardson, King, Dwyer, Parekh, & Lewis, 2015).
There is substantial evidence from epidemiologic and modeling studies that
statistically significant (p < 0.001) relationships exist between sociodemographic factors,
socioeconomic factors, and CRC screening use (Cardoso et al., 2019; Macrae et al., 2019;
O’Leary et al., 2019; Sauer, Siegel, Jemal, & Fedewa, 2019). Observational studies and
systematic reviews have shown that programs that provide public funding for CRC
screening and systematic access to physician counseling have a significant role in
improving CRC screening rates and reduce disparities according to race/ethnicity and
education (Simkin, Ogilvie, Hanley, & Elliott, 2019; DeGroff, et al., 2018; Singh et al.
2015). In a systematic review of CRC screening programs across all jurisdictions in
Canada, 92% of those who did not undergo CRC screening were not counseled by their
health care professional (Wee, McCarthy, & Phillips, 2005).
Results from a 2015 cross-sectional study using multiple logistic regression
analysis revealed a statistically significant (p < 0.001) association between age group,
health insurance coverage, and CRC screening uptake (De Moor et al., 2018). Among the
50–64-year age group, those with employer-sponsored insurance were more likely
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(62.2%) to be screened compared to those with private direct purchase plans (50.9%) and
the uninsured (24.8%); while among the 65–75-year age group, those with Medicare and
private insurance were more likely (76.3%) to be screened, compared to those with
Medicare (68.8%) and no supplemental insurance (De Moor et al., 2018). Furthermore,
another cross-sectional study of screen-eligible adults revealed that, compared to insured
adults, the underinsured and never-insured women were less likely (47%) to receive CRC
screening; while the underinsured and never-insured men were less likely (52%) to
receive CRC screening (Zhao, Okoro, Li, & Town, 2017). Moreover, Rogers et al. (2017)
found that among the Black race group, those with public health insurance were more
likely (90%) to be screened for CRC compared to those without health insurance.
Consistent with observational studies, researchers conducting retrospective and
prospective studies have revealed a strong association between variables such as age, sex,
race/ethnicity, income, education level completed, and CRC screening uptake (Ran et al.,
2019; Liang & Dominitz, 2019; Molina-Barceló et al., 2018; Arana-Arri, et al., 2017;
Holme et al., 2017; Kang & Son 2017; Lin, McKinley, Sripipatana, & Makaroff, 2017;
Burnett-Hartman, Mehta, & Zheng, 2016; Mehta, Jensen, & Quinn, 2016). Likewise,
factors such as lack of awareness, access to routine clinic visits (O’Leary et al., 2019;
DeGroff, et al., 2018; Jackson, Goel, Kho, & Keswani, 2016; Wilder & Wilson, 2016),
and inadequate access to a health care professional, have been associated with low
prevalence of CRC screening among adults, 50–75 years of age (Simkin, Ogilvie,
Hanley, & Elliott, 2019; Wong, 2015; Holden et al., 2010).
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The United States Preventive Services Task Force (USPSTF) has recommended
several tests for CRC screening, including stool-based and endoscopic methods known to
be effective for CRC screening in average risk individuals, 50–75 years of age (USPSTF,
2018; Wolf et al., 2018). However, results from the 2015 National Health Interview
Survey (NHIS) indicated that only 62.4% of individuals, age 50–75, received CRC
screening according to the USPSTF recommendations (White et al., 2017). According to
the National Institutes of Health, CRC screening is underused, and disparities in
screening rates are apparent (Verma, Sarfaty, Brooks, & Wender, 2015). Despite increase
access to health insurance with no cost-sharing for most health plans, many eligible
adults in the U.S. (White et al., 2017; Wools, Dapper, & de Leeuw, 2016) and in
Maryland (Watkins et al., 2018; MDH 2018 Cancer Report) are not screening according
to USPSTF guidelines. In 2016, only 67.3% of age-appropriate individuals in the U.S.
were up to date with CRC screening (CDC BRFSS, 2017). It is estimated that achieving
the NCCR ≥80% CRC screening goal would result in 19% fewer CRC deaths (Simon,
2016), prevent 280,000 new CRC cases, and save 200,000 lives in the U.S. by 2030
(Meester et al., 2015). Nevertheless, Maryland is yet to meet its ≥80% CRC screening
target (MDH 2016-2020, cancer report). Strategic efforts to increase CRC screening use
and reduce differences in screening rates across groups are important to improve overall
population health. The goal of this research is to obtain valid evidence regarding the
hypothesis that there is a statistically significant relationship between socioeconomic
factors, access to preventive health care services, and CRC screening use in Maryland.
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Maryland is a state of diverse racial/ethnic subgroups, and a growing adult
population. This study will fill a gap in knowledge and improve understanding in CRC
screening practices across groups, by identifying the variables that predict CRC screening
among men and women age 50–75 years. This study is unique, because it examines
predictors of CRC screening use and provides evidence of the differences in CRC
screening use across groups in the State. Results from this research will highlight the
importance of early detection, and help public health professionals to gauge a careful
plan, and design appropriate CRC screening programs with strategies to improve
screening rates for specific groups. By identifying the predictors of CRC screening use
through this research, public health policies could be initiated to support targeted,
screening programs that are necessary to reduce the disease burden for the State.
Problem Statement
Despite evidence that screening and early detection were the clear reason for a
drop in CRC-related incidence and mortality rates in Maryland between 2004–2014
(Richardson, King, Dwyer, Parekh, & Lewis, 2015), current literature reveals that, as of
2018, the overall CRC screening rate for Maryland was lower (68.6%) than state target of
≥80% and even lowest among Asians (53.6%) living in Maryland (Platz, 2018). Although
previous studies on the predictors of CRC screening use illuminate significant findings,
to the best of my knowledge, no prior research exists that quantitatively examines the
sociodemographic and socioeconomic variables that predict CRC screening in the State
of Maryland. The problem is that little information is available on factors that contribute
to CRC screening use in Maryland (MDH, 2016–2020 cancer report). Given this fact,
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further research is justified to investigate the documented problem of low CRC screening
use in Maryland (Brun & Kanarek, 2018; MDH, 2016–2020 cancer report; Platz, 2018;
Watkins et al., 2018).
Purpose of the Study
The purpose of this study was to identify factors that can predict CRC screening
use to improve understanding of CRC screening practices in Maryland. To address this
gap, I employed a quantitative approach with a cross-sectional design using secondary
data from the CDC BRFSS to determine whether the independent variables of age, sex,
race/ethnicity, education level, household income, health insurance coverage, and access
to healthcare professionals are associated with the dependent variable: CRC screening
use in Maryland. In addition, age, sex, and race/ethnicity were used as covariates in the
multiple logistic regression analysis to estimate associations and effect modification.
These variables were important because previous studies, including systematic reviews,
have shown statistically significant (p < 0.001) relationships between them and adherence
to CRC screening (Cardoso et al., 2019; Macrae, 2019; O’Leary et al., 2019). Hence, it
was essential to investigate their role in CRC screening use in Maryland.
Research Questions and Hypotheses
The research questions and hypotheses used in this study are as follows:
Research Question 1: Is there any association between socioeconomic status
measured by education level, household income, and colorectal cancer screening use
among adults age 50–75 years in Maryland, after adjusting the effects of age, sex, and
race/ethnicity?
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H01: There is no statistically significant association between socioeconomic status
measured by education level, household income, and colorectal cancer
screening use among adults age 50–75 years in Maryland, after adjusting
the effects of age, sex, and race/ethnicity.
Ha1: There is a statistically significant association between socioeconomic status
measured by education level, household income, and colorectal cancer
screening use among adults age 50–75 years in Maryland, after adjusting
the effects of age, sex, and race/ethnicity.
Research Question 2: Is there any association between access to preventive health
care service measured by health insurance coverage, access to health care professional,
and colorectal cancer screening use among adults age 50–75 years in Maryland, after
adjusting the effects of age, sex, and race/ethnicity?
H02: There is no statistically significant association between access to preventive
health care service measured by health insurance coverage, access to health
care professional, and colorectal cancer screening use among adults age 50–75
years in Maryland, after adjusting the effects of age, sex, and race/ethnicity.
Ha2: There is a statistically significant association between access to preventive
health care service measured by health insurance coverage, access to health
care professional, and colorectal cancer screening use among adults age 50–75
years in Maryland, after adjusting the effects of age, sex, and race/ethnicity.
All variables were measured as categorical variables and coded during analyses
for simplicity. Details of how these variables were measured and coded are described in
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chapter three of this dissertation; and the results, interpretation and discussion are
provided in chapters four and chapter five respectively.
Theoretical Foundation and Conceptual Framework for the Study
The theoretical foundation and conceptual framework that guide this study are
grounded in the health belief model (HBM), and the fundamental cause theory (FCT).
Both the HBM and the FCT were best for this Maryland-based study because they have
been successfully used to explore CRC screening predictors across groups (Hurtado et al.,
2015). Additionally, using both the HBM and the FCT provided clues to answer research
questions that could guide whether the state of Maryland would achieve and sustain its
≥80% CRC screening target (MDH, 2016–2020 cancer report).
Theoretical Foundation of the Health Belief Model
The HBM is a sociopsychological framework developed in the early 1950s by
Hochbaum, Rosenstock, and Kegels to explain why only few people participate in
programs to prevent and detect disease (Rosenstock, 1974). The HBM was later updated
with more constructs to emphasize the motivational factors that encourage individuals to
take action towards their health (Rosenstock, Strecher, & Becker, 1988). Key constructs
of the HBM are perceived susceptibility, perceived severity, benefits, barriers, cues to
action, and self-efficacy (Glanz, Rimer, & Viswanath, 2015). Among the six elements of
the HBM, this study focused on the construct of cues to action, used to address research
question of whether age, sex, race/ethnicity, and education level can predict individuals’
action towards CRC screening after recommendation by a healthcare professional.
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Conceptual Framework of the Health Belief Model
The HBM is a theoretical concept of proposed behavior designed to reduce health
risk by identifying factors that can predict the likelihood of a person? to undergo a
preventive action necessary to improve health (Rosenstock, Strecher, & Becker, 1988).
There is extensive research that supports the use of the HBM as an effective conceptual
framework to explain health behaviors across groups (Williams, Wilkerson & Holt, 2018;
Heiniger, Sherman, Shaw, & Costa, 2015; Lee, Stange, & Ahluwalia, 2015; Sohler,
Jerant, & Franks, 2015) and to increase CRC screening compliance across socioeconomic
communities (Abuada et al., 2018; Bernardo et al., 2018; Almadi et al., 2015).
Researchers have successfully used the HBM to determine factors that predict
CRC screening uptake across age, sex, race/ethnicity and socioeconomically deprived
groups (Helander et al., 2018; Heiniger, Sherman, Shaw, & Costa, 2015) and suggested
that components of the HBM can be used individually or in combination to explain health
behaviors (Williams, Wilkerson & Holt, 2018; Heiniger, Sherman, Shaw, & Costa, 2015;
Glanz, Rimer & Viswanath, 2015; Turner, Hunt, Dibrezzo & Jones, 2004). The construct
of cues to action has been used to determine factors related to CRC screening uptake in
the U.S. (Doubeni et al., 2012) and to facilitate understanding of screening behaviors
through a recommended action that lead to positive CRC outcomes (Williams, Wilkerson
& Holt, 2018). In relation to my research, the HBM construct of cues to action align with
the research question of whether there is association between age, sex, race/ethnicity,
education level, access to healthcare professional and CRC screening use.
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Theoretical Foundation of the Fundamental Cause Theory
The FCT was formulated by Link and Phelan in 1995 to explain why the
association between socioeconomic status (SES) and mortality persisted despite
knowledge of risk factors that explain diseases (Link & Phelan, 1995). The major
proposition of the FCT is that SES is a fundamental cause of health inequality (Link &
Phelan, 1995). According to Link and Phelan, SES influences multiple disease outcomes
through its association with multiple risk factors for disease and death (Phelan, & Link,
2005). The authors’ justification is that social states, such as race and SES, contribute to
disease outcomes because they impact available key resources, like knowledge, money,
power, prestige, and beneficial social connections that are needed to combat disease
(Phelan, Link & Tehranifar, 2010; Phelan, Link, Diez-Roux, Kawachi, & Levin, 2004).
In line with the FCT, I sought to explain differences in CRC screening use among age,
sex and race groups, and to identify which variables can predict CRC screening use based
on income level and health insurance coverage as an available resource.
Conceptual Framework of the Fundamental Cause Theory
The FCT has been used to explain the implications of SES and social inequalities
in cancer screening (Vanthomme, & Gadeyne, 2019; Vanthomme, Vandenheede,
Hagedoorn, & Gadeyne, 2018; Hurtado et al., 2015; Goldberg, 2014; Shariff-Marco,
Breen, Stinchcomb, & Klabunde, 2013). Researchers have successfully used it to
investigate the effect of social inequality of factors such as age, sex, race, and
socioeconomic quintile on CRC screening participation among adults aged 45–75 years
(Shariff-Marco, Breen, Stinchcomb, & Klabunde, 2013). In line with the FCT, this study
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posited that those from minority race groups may have limited economic and financial
resources to participate in CRC screening programs that can prevent disease (Araghi et
al., 2019; Cross et al., 2019). Details of how the HBM and the FCT are applied in this
study are explained in Chapter 2.
Nature of the Study
In this study I employed a quantitative methodology with a cross-sectional design
that is descriptive in nature. The focus was on a predictive approach to determine
association between the independent variables (education level, household income, health
insurance coverage, access to healthcare professional), covariates (age, sex,
race/ethnicity), and the dependent variable (CRC screening use). A quantitative approach
was employed because it emphasizes objective and precise measurements of data (Kerry
& Huber, 2018) and because it allowed me to determine differences, relationships and
patterns between groups. Most importantly, the quantitative cross-sectional design
allowed for data manipulation, such as creation of subgroups and coding of variables
(Rudestam & Newton, 2015).
Secondary data were collected from the CDC BRFSS and analyzed using multiple
logistic regression to determine associations between the predictor and the outcome
variables. By using a multiple logistic regression model, this study was in line with other
studies that utilized secondary data analysis on demographic and socioeconomic
variables—such as age, sex, race, education level, health insurance, income, access to
health care professional, marital status, employment and CRC screening test methods—as
predictors of CRC screening uptake in community-based populations (Sharma et al.,
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2019; DeGroff et al., 2018; De Moor et al, 2018; Kang & Son 2017; Lin, McKinley,
Jackson, Goel, Kho, & Keswani, 2016; Mehta, Jensen, & Quinn, 2016).
Definition of the Operational Variables
The following variables were defined to ensure full comprehension of this study:
Age: Corresponds to a categorical variable for adults 50–75 years of age, resident
in Maryland, and participants of the BRFSS survey between 2014–2018. During analysis
three subgroups of the age variable were created and recoded as; 1 = 50–59, 2 = 60–69,
and 3 = 70–75.
Sex: Is a quantifiable statistic of the study population that is necessary to
characterize and identify the variables as either a male or a female. During analysis the
variable was coded as 1 = Male, and 2 = Female.
Race/ethnicity: A nominal categorical variable that corresponds to participant’s
race or ethnicity as categorized in the BRFSS codebook. Four race groups were used in
this study and coded as; 1 = White, 2 = Black, 3 = Asian, 4 = Hispanic, 5 = Other. Native
Hawaiian/Pacific Islander, American Indian/Alaska Native, and multiracial were grouped
as Other race because there was not enough of each race group to warrant a regression.
Education level: Is a measure of individuals’ highest grade of school completed
(BRFSS, 2018). In this study, EDUCA was measured as a categorical variable coded as;
1 = Did not complete high school; 2 = Completed high school; 3 = Some college or
Technical school; and 4 = College graduate.
Household income level: Is a measure of the total annual dollar amount of money
from all sources earned by all members in the household (BRFSS, 2018). Income level
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was measured as a categorical variable and coded as 1 = $0-<$35,000 (Low-income), 2 =
$35,000-<$75,000 (Middle-income), and 3 = $75,000 or more (High-income).
Health insurance coverage (HIC): Is a measure of individuals’ resource
availability as relates to taking care of their health (Miranda et al., 2017). In this study
HIC was used as a socioeconomic resource that facilitates timely participation in CRC
screening. HIC was measured as a categorical variable according to health insurance plan
and recoded as; 0 = Other health insurance plan, 2 = Private plan, 3 = Public plan.
Access to healthcare professional (HCP): Corresponds to timely use of health
care services through access to healthcare professionals to achieve CRC screening goals
for the best possible health outcome (Healthy People 2020, n.d.) The HCP variable was
measured as a categorical variable and coded as; 0 = No health care professional, 1 =
Access to one health care professional; 2 = More than one health care professional.
CRC screening use (CRCSU): This is the dependent variable, and corresponds to
fully meet the USPSTF recommendation by receiving one or more of the CRC screening
test within the recommended time interval (BRFSS, 2018). Measured as a dichotomous
variable (0/1), and coded as: 0 = Did not fully meet the USPSTF CRC recommendation,
and 1 = Fully meet the USPSTF CRC recommendation.
Assumptions
One assumption made in this research was that the BRFSS survey instrument was
reliable and had a strong internal validity for survey response and no interviewer bias at
the time of primary data collection. I also assumed that missing data were not due to the
dependent variable, CRCSU, and hence, missing at random. Considering that
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experimental designs have stronger internal validity compared to non-experimental
designs (Frankfort-Nachmias & Nachmias, 2015), these assumptions were necessary in
the context of this study, because questionnaires used in the BRFSS survey were
validated by state and national standards (Maryland BRFSS, 2018).
Scope and Delimitations
The scope of this study encompassed sociodemographic variables that were
potential predictors of CRC screening use in Maryland. The focus was on seven specific
variables because previous studies have revealed their association with participation in
CRC screening programs (Araghi et al., 2019; Cross et al., 2019; Doubeni et al., 2019;
Witch et al., 2019). The internal validity was addressed by examining the relationship
between the predictors (age, sex, race, Education, income, HIC, HCP) and the outcome
(CRCSU) variable. Threats to internal validity were minimized by controlling for
variables such as age, sex, and race, and by excluding missing or unknown data from the
analysis. For example, data with unknown sex were excluded. This study was limited to
residents of Maryland, aged 50–75 years, who participated in the BRFSS survey between
2014 and 2018.
Although theories such as the social cognitive theory (SCT), theory of planned
behavior (TPB), social-ecological model (SEM), and the social learning theory (SLT)
were reviewed on the basis of cancer screening (Ajzen, 1991; Rosenstock, Strecher, &
Becker, 1988), their relationship to CRC screening use is not well understood (Besharati
et al., 2018; Serra et al., 2017). Hence, to address the issue of external validity, I utilized
the HBM and the FCT, which encompass a more inclusive approach to understand
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whether the identified variables are associated with CRC screening use. Both frameworks
are useful for predicting how specific groups in the study population view the need to
screen for CRC based on available resources. The results from this study maybe
generalized to the Maryland population because I improved the external validity, by
using minimal exclusion criteria, and data collected from all 24 counties of the state.
Limitations
This study was subject to three limitations. The first limitation was access to the
most recent BRFSS survey data for Maryland. Typically, survey data are uploaded to the
website a couple of years after the actual survey was conducted (CDC BRFSS, n.d.).
Since much may have changed from the time the survey was conducted, the reliability
and relevance of the results to current day practice may not be enough to draw
conclusions from the findings. Secondly, by using secondary data from self-reported
questionnaires, there is a potential for recall bias because respondents were reporting on
past events and may not remember, for example, if or when a CRC screening was done.
Thirdly, limitations from confounders not addressed, such as marital status, could affect
the external validity, and the proportion of sample distribution across groups may not be
reflective of the entire population. Limitations of secondary data were addressed during
analysis by treating the data as a homogenous group, creating subgroups, coding
variables, and excluding partial or missing data.
Issues with potential construct validity were limited by employing the Pearson
chi-square goodness-of-fit test to ascertain the reliability and validity of the results
(Frankfort-Nachmias & Nachmias, 2015). Due to the complex nature of preventive health
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behaviors such as CRC screening, and its relation to SES, there was a potential threat to
external, internal and construct validity in this study. However, these threats were
addressed by performing descriptive statistics such as standard deviation and frequency
distribution to ensure reliability of the results (Szklo & Nieto, 2014).
Significance of the Study
Contribution to Advancing Public Health Knowledge on CRC Screening
There is strong evidence from systematic reviews using meta-analysis that
screening helps primary prevention of CRC (Cardoso et al., 2019). This study contributes
to advancing public health knowledge by addressing the gap in an under-researched area
of the documented issues around low CRC screening use in Maryland (MDH 2016-2020
cancer report). In this study, I identified the variables that predict CRC screening use and
examined results for men and women separately. Also, multiple logistic regression model
used provides a useful framework for problems that have a multifactorial structure, such
as CRC screening (Merlo et al., 2018). Findings from this study will advance public
health knowledge, and elucidate where the focus should be to improve CRC screening
rates and to evaluate progress in CRC screening use since the ≥80% goal was set.
Contribution to Advancing Public Health Practice on CRC Screening
Compared to all other cancers, CRC is a good candidate for screening programs,
and yet only 65% of U.S. adults, and less than 50% of some race/ethnicity groups, are
compliant with CRC screening recommendations (Simon, 2016). Prevalence of nonadherence to CRC screening is high (38.7%) among men and women aged 50–75 years
(Seibert, Hanchate, Berz, & Schroy, 2017), making it unclear if the 80% target is
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achievable or sustainable (Bibbins-Domingo et al., 2016). According to the MDH, CRC
screening rates across age groups, gender, race/ethnicity and those without health
insurance coverage were lower (68.0%) than expected for 2017 (Platz, 2018)—a finding
that marks a gap in public health practices on CRC screening programs in the state.
This research is meaningful and significant because identifying groups with low
CRC screening use will provide much-needed insights into the processes needed to
increase participation and adherence to surveillance screening programs. Results from
this study will contribute to public health practice by providing indispensable acuity for
public health officials to design timely, and equitable screening programs that target atrisk groups and encourage more adults to participate in CRC screening outreach efforts.
Through public health efforts, the MDH funds free and low-cost screening programs for
all screen-eligible adults in Maryland (Palmer, Chhabra & Mckinney, 2011).
Contribution to Advancing Public Health Policy for the State
By identifying the predictors of CRC screening use in Maryland, new public
health policies could be initiated, and the structure of existing policies could be reshaped
to provide additional targeted screening programs for specific groups in the state. Insights
from this study will enhance CRC screening policies that emphasize improvements with a
focus on at-risk groups with lower CRC screening use. Through this study, I laid the
groundwork for future research by identifying groups that need intervention to achieve,
sustain, and surpass the state-set ≥80% screening goal. This project would inform policy
makers in Maryland on where the focus should be to increase funding for tailored CRC
screening programs and other cancer prevention efforts.

20
Social Change Implications
CRC screening has been a force for positive social change because it has been
identified as the most efficient and cost-effective way to detect CRC early, when it is
more treatable (Araghi et al., 2019; Cross et al., 2019; Rosenberg, 2019;). This research
has the potential to affect positive social change by advancing knowledge on the factors
surrounding low CRC screening rates among groups (Doubeni, 2019). Findings from this
study can be used by public health officials to determine the best design for effective
social and population-based screening programs. Public health practitioners can
collaborate with volunteer organizations to improve behavioral changes through public
sensitization that promote CRC screening. For example, sensitization can involve a
mission to provide free test kits using mobile vans in low SES neighborhoods or in
densely populated minority areas such as Baltimore City.
Timely, effective, and equitable population-based CRC screening programs are
essential to provide the best possible outcomes on CRC incidence and mortality (Mehta
et al., 2016). To continue on its recorded 30 years’ progress on cancer incidence and
mortality (Brun & Kanarek, 2018), this research will help the MDH to enhance its CRC
priority strategies from its current 2019–2021 cancer prevention plan. A recommendation
is that further studies be conducted to investigate whether other screening modalities will
produce different results in the same target sample used in this study. Regardless of the
factors that may predict CRC screening, public health officials in the Maryland Division
of Cancer Control and Prevention must do more to promote screening programs in the
population.
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Summary
CRC is a deadly disease; but screening and removal of colorectal polyps can
prevent it. It is evident from the literature that, CRC screening rates in the U.S. and in
Maryland are still below the national recommended goal of ≥80%. The literature reveals
statistically significant (p < 0.001) relationships between socioeconomic groups and CRC
screening use. Lowest screening rates were seen among minority groups and those of low
SES, who often lack the resources necessary to participate in preventive healthcare
measures like CRC screening. To improve public health practices and to enhance existing
or inform new policies, it is essential to identify the variables that predict CRC screening
use.
In this study, I employed a quantitative methodology with a cross-sectional design
using multiple logistic regression technique to identify predictors of CRC screening use;
by determining the association between the independent variables (education level,
household income, health insurance coverage, access to healthcare professional),
covariates (age, sex, race/ethnicity), and the dependent variable (CRC screening use) in
Maryland. Details of previous studies and how other researchers have shown the effect of
socioeconomic factors and access to health care resources on CRC screening use are
provided in Chapter two. In chapter three, I described the research methodology that I
used to analyze the secondary data. In chapter four, I provided information on data
collection, data analysis, and the results from the analyses. Finally, the interpretation of
my results, discussions from the findings, social change implications and the conclusions
drawn from this study are provided in chapter five.
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Chapter 2: Literature Review
Introduction
Colorectal cancer (CRC) is the third most common cancer diagnosed in the
United States (Simonson, 2018) and the second leading cause of cancer-related deaths
among men and women (Ansa, Coughlin, Alema-Mensah, & Smith, 2018). In Maryland,
cancer represents the second-leading cause of death following heart disease and CRC
accounts for 9% of all cancer death in the state (Brun & Kanarek, 2018). According to the
Maryland Department of Health (MDH), improvements in screening, early detection, and
removal of precancerous polyps were the main reasons for the drop in the CRC incidence
and death rates in 2004-2014 (Ahmad et al., 2015). Yet screening rates remain
unacceptably lower (68.6%) than the state’s set goal of ≥80% (Ahmad et al., 2018).
Synopsis of Current Literature on Colorectal Cancer Screening
Prevention approaches, such as CRC screening, are necessary for public health
research. Both national and state data suggest an increase in CRC screening rates in the
last 10 years in Maryland (SEER Stat, 2018; Noone et al., 2018; Brun & Kanarek, 2018).
Yet when compared across groups, CRC screening rates are lower in some demographic
and socioeconomic subgroups than others in the state (Ahmad et al., 2018; Richardson et
al., 2015). During the annual Maryland Cancer Collaborative meeting, Dr. Elizabeth Platz
(2018) pointed out that, in Maryland, the CRC screening rate for women (70.2%) was
higher than for men (65.2%) and that rates for Whites (72.5%) were substantially higher
than for Asians (53.6%). Results from multiple logistic regression analyses have shown
that factors that contribute to low CRC screening rates are multifactorial, including age
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group, sex, race/ethnicity (Sava, Dolan, May, & Vargas, 2018; Burnett-Hartman, Mehta,
& Zheng, 2016), education level completed (Lee, Natipagon-Shah, SangsanoiTerkchareon, Warda, & Lee, 2019; Rodriguez, & Smith, 2016); income level (Simkin,
Ogilvie, Hanley, & Elliott, 2019; Satsangi & DeGroff, 2016); health insurance (DeMoor
et al., 2018; Miranda et al., 2017); and access to a health care professional (Sharma et al.,
2019; DeGroff et al., 2018; Jackson, Goel, Kho, & Keswani, 2016).
The overall purpose of this study was to identify factors that predict CRC
screening use in Maryland. The objective was to quantitatively assess the predictor
variables (age, sex, race/ethnicity, education level completed, household income level,
health insurance coverage, and access to healthcare professional), using data derived
from the CDC BRFSS database. This research is expected to improve understanding in
CRC screening practices by identifying the factors that could predict CRC screening
uptake in Maryland.
Major Sections of the Chapter
This chapter covers the following topics: the literature search strategy; an
overview of, and epidemiology of, CRC; a description of the theoretical and conceptual
frameworks on which this study was built; a detailed description of the literature as it
relates to the specific independent and dependent variables, and covariates; the
methodologies used in previous studies, and how previous researchers approached the
CRC screening problem; the summary and conclusion.
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Literature Search Strategy
I conducted an in-depth literature review of the topic to determine predictors of
CRC screening in Maryland. I reviewed a wide range of knowledge on CRC screening
measures, as well as resources on cancer control topics from the MDH, the Maryland
Comprehensive Cancer Control Plan (MCCCP), the Maryland Cancer Collaborative
(MCC), and the Maryland Patient Navigation Network (MPNN). I searched the SEER
websites for relevant statistics. The following databases were used to locate and access
relevant articles: Google, Google Scholar, Science Direct, ProQuest, Medline, CINAHL,
EBSCO Host, and PubMed.
Key Search Terms
According to Creswell & Creswell (2018) using key terms to search the literature
is essential to obtain resources that are more appropriate to answer the research questions.
The keywords that I used for the searches included colorectal cancer screeningprograms, -health insurance, -healthcare professional, -age, -sex, -race, -education, income, and USPSTF recommendation.
Scope of the Literature Search
I found ProQuest, Medline, CINAHL, EBSCO Host, and PubMed databases most
useful to my search, because it produced thousands of peer-reviewed journal articles,
links to other articles related to my topic, and review papers arranged in logical order
based on my search terms. The ProQuest, Medline, CINAHL, EBSCO Host, and PubMed
databases also allowed me to filter my search by peer-reviewed articles, and date ranges.
Although I reviewed and referenced relatively fewer articles older than 5 years; most of
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the materials used for my literature review were from peer-reviewed articles published
between 2015 and 2019. There were few current studies that identified factors that hinder
CRC screening in Maryland; studies done on related topics in Maryland were older than 5
years from the time of this study. To mitigate for the limited number of current peerreviewed journal articles specific to Maryland, recent articles on similar topics in the U.S.
were used. I also included information on a few current seminal presentations,
handbooks, and conference proceedings in Maryland. For example, I used conference
proceedings from the 2018 annual MCC meeting, the 2019-2021 MCCCP workgroups,
and information from the MDH 2016-2020 Cancer Report.
Theoretical Foundation and Conceptual Framework
This study is grounded on two theoretical and conceptual frameworks namely; the
Health Belief Model (HBM), and the Fundamental Cause Theory (FCT). Although
theories such as the social cognitive theory (SCT), theory of planned behavior (TPB),
social-ecological model (SEM), and the social learning theory (SLT) were reviewed on
the bases of cancer screening (Rosenstock, Strecher, & Becker, 1988); their relationship
to CRC screening uptake are not well understood (Besharati et al., 2018; Serra et al.,
2017). Hence the HBM and the FCT were the frameworks that best explained CRC
screening differences across the identified variables in this study. Applying both theories
provide a potential to motivate individuals to take actions towards CRC screening and
will assist the State in designing, targeted, culturally tailored CRC screening programs
and policies for Marylanders.
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Origin of the Health Belief Model
The HBM is a theory of health behavior, formulated by Hochbaum, Rosenstock,
and Kegels in the early 1950s for the United States Public Health Service (Rosenstock,
1974). The HBM was first used to address beliefs essential to yield desirable health
behaviors (Rosenstock, Strecher, & Becker 1988); and later advanced to the current
instantiation of six constructs, to emphasize the motivational factors that mold individuals
to take action towards their health (Rimer & Glanz, 2014). The theory was successfully
used in the 1970s to explain the failure of free tuberculosis screening programs in the US
(Sharma, & Romas, 2011). Since then, the HBM has been the most widely used
theoretical model to guide health promotion and disease prevention programs (Helander,
Heinävaara, Sarkeala, & Malila, 2018; Williams, Wilkerson & Holt, 2018); and to
explain why only few people participate in disease prevention programs (Glanz, Rimer &
Viswanath, 2015; Giorgi et al., 2015).
Major Propositions of the Health Belief Model
The key elements of the HBM are perceived susceptibility, perceived severity,
perceived benefits, perceived barriers, cues to action, and self-efficacy (Glanz, Rimer &
Viswanath, 2015). Experts like Lee, Stange, & Ahluwalia, (2015); Sohler, Jerant, &
Franks, (2015); and Purnell et al., (2010) have described the constructs as follows:
Perceived susceptibility is defined as one’s belief of the ability to develop or be at risk of
developing a disease. Severity refers to the extent of understanding the threat associated
with the seriousness of a disease. Benefit refers to the belief that acting towards a health
recommendation will reduce the seriousness of the disease. Barriers are related to
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sociodemographic barriers which may affect an individual’s inclination towards a
beneficial health behavior. Cues to actions refer to the strategies, forces, or triggers used
to activate one’s readiness towards a behavioral change. Self-efficacy is an individual’s
resource ability, to act towards health behavioral changes.
According to propositions of the HBM, people will comply with any healthrelated action if they assess the disease as preventable when a particular action is taken
(Glanz, Rimer & Viswanath, 2015). Researchers have used components of the HBM to
assess the likelihood of acting towards disease prevention (Abuadas et al., 2018; Sohler,
Jerant, & Franks, 2015); and suggested that constructs of the HBM can be used
individually or in combination to explain health behaviors (Williams, Wilkerson & Holt,
2018; Rimer & Glanz, 2014; Turner, Hunt, Dibrezzo & Jones, 2004). This dissertation is
focused on the construct of barriers and cues to action.
The ability to influence health outcomes through proper actions are essential to
preventive behaviors (Lee, Stange, & Ahluwalia, 2015). Despite demographic barriers,
the HBM construct of cues to action facilitates an understanding of health behaviors
through a recommended action that leads to positive outcomes (Williams, Wilkerson &
Holt, 2018; Heiniger, Sherman, Shaw, & Costa, 2015; Lee, Stange & Ahluwalia, 2015).
The basic idea of the HBM is that, if people know about a serious health threat, feel at
risk of the threat, and think that the benefits of taking an action outweighs the risk
associated with the action, they will do whatever it takes to reduce their risk of the threat
(Glanz, Rimer, & Viswanath, 2015). The construct of cues to action posits that if
individuals are aware of the health benefits of a recommended action, they will
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participate in the beneficial health behavior associated with their action (Glanz, Rimer, &
Viswanath, 2015). The strategy towards cues to action addresses the aspect of healthcare
professional recommendation (HPR) for screening as uncovered by the scope of this
literature. For example, HPR for CRC screening may motivate individuals to participate
in free and low-cost CRC screening outreach programs available in Maryland (Palmer,
Chhabra, & McKinney, 2011; Gilbert & Kanarek, 2005). The HBM would be used in this
study to address the research question of whether individuals act towards CRC screening
after healthcare professional recommendation.
Application of the Health Belief Model in Previous Studies
The HBM is known as the most popular model for analyzing individuals’ decision
making about using any health service (Glanz, Rimer, & Viswanath, 2015; Rimer &
Glanz, 2014); and has been used to promote compliance in screening programs across
several health issues (Abuadas et al., 2018; Bernardo et al., 2018; Almadi et al., 2015).
Prospective studies have revealed that based on the HBM component of cues to action,
factors such as age, race, gender, marital status, income, education level, knowledge
based on perceived susceptibility, severity, and benefits, can contribute to an individual’s
likelihood to act towards CRC screening (Helander, Heinävaara, Sarkeala, & Malila,
2018; Jih et al., 2018; Rat et al., 2017; Rogers et al., 2017; Almadi et al., 2015). Also,
knowledge, cultural perceptions, personal views, beliefs about CRC and socioeconomic
barriers to CRC screening uptake have been associated with the utilization of CRC
screening services and low screening compliance among various groups (Abuadas et al.,
2018; Almadi et al., 2015; Fernández, et al., 2015).

29
To explain gender differences as predictors of CRC screening, the literature
reveals that more women participate in CRC screening because they belief in the benefit
of screening, after being encouraged by a health care professional to take action towards
screening (Abuadas et al., 2018; Helander, Heinävaara, Sarkeala, & Malila, 2018). To
determine the factors associated with willingness to undergo CRC screening Almadi et
al., (2015) used concepts of the HBM in a cross-sectional study in Riyadh, Saudi Arabia
and found that only 6.7% of males 50-55 years of age had undergone CRC screening
compared to 7.5% for females. Using data from the Texas BRFSS to examine perceptions
of CRC and to determine if health literacy is associated with CRC screening use among
Hispanic adults, Fernández et al., (2015) found that 59% of participants, reported never
been screened due to lack of knowledge about CRC screening as a prevention strategy.
The differences in CRC screening rates in Maryland could be described as a
disagreement between barriers and action, which I sought to explain using the HBM. In
realm of the HBM, this research argues that more men will take action towards CRC
screening if they receive recommendation from a healthcare professional. The HBM for
this study also suggest that, those from minority race groups often at the low income level
and without access to a health care professional are less likely to participate in CRC
screening. The HBM is an appropriate model to determine if there is an association
between age, sex, race/ethnicity, education level, income level, health insurance
coverage, access to health care professional, and CRC screening use in Maryland.
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Limitations of the Health Belief Model
Despite the wide use of the HBM in epidemiological studies, some researchers
have argued that health behaviors are influenced by many factors such as socioeconomic
status (SES), marital status and education, and not just by health beliefs (Moore et al.,
2015). The HBM had been described as “reductionistic” because it does not include
emotional, social and other environmental factors such as culture (Dutta, & Basu, 2011;
Abbatangelo-Gray, Cole, & Kennedy, 2007). Others have suggested that the HBM is a
“rational exchange” model where individuals systematically weigh the barriers and
benefits of a behavior, without making decisions based on individual rules of thumb
(Thaler, & Sunstein, 2009). Essentially, it is difficult to design appropriate tests of the
HBM to compare results across studies, since studies can use different research questions
to investigate the same beliefs (Yoo, Kwon, & Pfeiffer, 2013). This study minimized the
impact of these issues by using the FCT to compensate for the gaps in the HBM.
Origin of the Fundamental Cause Theory
The FCT was first proposed in 1995 by two medical sociologists, Link and Phelan
in an article titled, “Social Conditions as Fundamental Causes of Disease” (Link &
Phelan, 1995). The FCT seeks to explain why the association between SES and mortality
persist, despite improvements in the risk factors known to cause morbidity and mortality
in low SES individuals (Goldberg, 2014; Link & Phelan, 1995). Link and Phelan argued
that, low SES is strongly correlated with countless diseases, as the poor are known to live
with the worse health and die younger than the wealthy (Goldberg, 2014; Phelan, Link &
Tehranika, 2010). For example, in the 19th century, adequate sanitation and sewerage
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were key risk factors for disease in the US; however, availability of sanitation during this
period was along a social gradient with lower rates of waterborne disease among the
affluent compared to the less affluent individuals (Goldberg, 2014). Based on the FCT,
the persistence of socioeconomic health disparities is so clear that even the eradication of
diseases, like typhoid fever and tuberculosis did not change health inequalities in most
societies (Phelan, Link & Tehranika, 2010).
Major Propositions of the Fundamental Cause Theory
The broad generality of the FCT is that, there is an ongoing association between
SES and disease outcomes; because social states embody the availability and accessibility
of many resources through multiple mechanisms (Adams & White, 2004; Link & Phelan,
1995). A major proposition of the FCT is that, SES is a fundamental cause of health
inequality; because it demonstrates four essential features of health inequalities; first,
there is evidence that SES influences multiple disease outcomes; secondly SES is tied to
multiple risk factors for disease and death; thirdly, an association exist between SES and
health, because of disparity in deployment of resources; and fourthly that the association
between SES and mortality changes constantly via the emergence of new intervening
mechanisms (Phelan, Link & Tehranika, 2010).
Key resources that lower SES individuals lack include knowledge, money, power,
prestige, and beneficial social connections (Phelan, Link & Tehranika, 2010). The FCT
posit that because resources change constantly, the lack of resources such as health
insurance coverage persists, and at any given SES level, it is the social connections that
serve to protect health, regardless of the resource mechanism used to combat diseases,
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(Phelan, Link & Tehranifar, 2010; Adams, & White, 2004). Despite advances in
technology and improvements in CRC screening techniques, the basic fact is that people
from low SES communities often lack resources to protect and improve their health
(Qasim, 2016; Goldberg, 2014). A real question of whether the SES-health gradient
favors high SES individuals even after the development of new knowledge as relates to
CRC screening is not clearly understood (Doubeni, et al., 2012; Preston, & Wang, 2006).
Therefore, this study was grounded by in the third proposition of the FCT that there is an
association between SES and health, because of disparity in deployment of resources.
Although empirical data supports the proposition that SES is vital to maintaining
good health, it is the utilization of available resources that becomes critical in maintaining
health and prolonging life (Tehranifar et al., 2009). The idea that resources held by higher
SES individuals prevent disease and death leads to the prediction that at any given time,
more resources will produce better health (Horne et al., 2015; Phelan, Link, Diez-Roux,
Kawachi, & Levin, 2004). Consistent with these predictions, researchers have found that
socioeconomic inequalities in death are significantly more evident for highly preventable
causes of death such as lack of CRC screening use (Vanthomme, & Gadeyne, 2019;
Pellat, Deyra, Coriat, & Chaussade, 2018; Horne et al., 2015; Doubeni et al., 2012).
Results from a prospective study using the National Institutes of Health-Diet and Health
survey data showed that SES is associated with the risk of CRC in adults 50-71 years of
age in the US; with a significantly (p < .05) higher overall CRC incidence among those
who lived in low-SES neighborhoods, compared to those of the highest-SES groups, even
after adjusting for other risk factors (Doubeni et al., 2012).
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The FCT can be used to explain why emphasis on intervening factors such as
screening would be ineffective if structural determinants of the disease are left untouched
(Vanthomme, Vandenheede, Hagedoorn, & Gadeyne, 2017). For example, if provision of
sanitation in the 1970s was suboptimal because there was a lack of simultaneous attention
to socioeconomic conditions (Goldberg, 2014; Phelan, & Link, 2005). Therefore, in
relation to my research, recommending CRC screening without concomitant attention to
whether individuals have the resources such as health insurance coverage to go for
screening maybe suboptimal as well. It is not only the availability of health insurance as a
socioeconomic resource, but the simultaneous provision of CRC screening options by a
healthcare professional that determines participation in CRC screening programs. In
realm of the FCT, this study posits that minority race groups, those at lower education
level, lower income level, those without health insurance or access to a health care
professional will be less likely to screen for CRC regardless of age, or sex.
Application of the Fundamental Cause Theory in Previous Studies
The FCT is an essential framework to identify sections of public health programs
that are most likely to improve overall population health and compress health inequalities
(Goldberg, 2014). The FCT has been used to explain the implications of SES and social
inequalities in cancer screening (Vanthomme, & Gadeyne, 2019; Vanthomme,
Vandenheede, Hagedoorn, & Gadeyne, 2018; Pellat, Deyra, Coriat, & Chaussade, 2018);
to determine factors related to CRC screening uptake (Doubeni et al., 2012); and to
investigate the effect of social inequality and individual level factors such as sex,
race/ethnicity, and socioeconomic group on CRC screening participation (Wilder &
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Wilson, 2016; Hurtado et al., 2015). Results of multiple logistic regression models to
estimate CRC screening use based on socioeconomic quintiles, revealed that among
women, the highest (71.5 %) CRC screening use was in the third socioeconomic quintile
and the lowest (65.7 %) was in the first and least disadvantaged socioeconomic quintile
(Hurtado et al., 2015). However, among men, the lowest (60.2%) CRC screening use was
identified in the fifth most disadvantaged socioeconomic quintile (Hurtado et al., 2015).
On the contrary Desantis et al., (2016) argued that, SES does not fully explain
racial/ethnic disparities in CRC screening rates. Using the 2006-2015 data from the NCI,
the National Center for Health Statistics (NCHS) and the North American Central Cancer
Registry, Desantis et al., (2016) found that the overall CRC incidence rate decreased
faster in black men (2.4%) than in white men (1.7%), and black females (2.6%) than in
white females (1.6%). To better understand the race/ethnic differences in CRC screening,
public health administrations must ensure that individuals and families of lower SES have
access to adequate health care resources and high-quality prevention services necessary
to participate in CRC screening (Wilder & Wilson, 2016).
Other studies have revealed a disproportionately higher burden of CRC among
those of the socioeconomically disadvantaged group (Shariff-Marco, Breen, Stinchcomb,
& Klabunde, 2013). Factors such as, lower education, less income, less fruits and
vegetables intake, increased biological susceptibility, and inadequate healthcare resources
contribute to racial disparities in CRC screening uptake (Feng et al., 2017; Tammana &
Laiyemo, 2014). Although adoption of a lifestyle that include routine physical activity
and intake of plant based diet among minority race groups could not be proven to reduce
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susceptibility to CRC in randomized trials (Feng et al., 2017); modification of screening
modalities for specific race/ethnic groups (Levin et al., 2018), and implementation of
organized screening programs that include public health campaigns and patient
navigation may be necessary to improve CRC screening rates across groups (Tammana &
Laiyemo, 2014).
The literature reveals that though a relatively newer health theory, the FCT is
likely to present new mechanisms through which the connections between low SES and
poor health are perpetuated over time (Vanthomme, & Gadeyne, 2019; Vanthomme,
Vandenheede, Hagedoorn, & Gadeyne, 2017). Although no framework has been
developed specifically for SES as mediator of CRC screening uptake, education, income,
and health insurance access as available socioeconomic resources had been used to
mediate the association between sociodemographic factors and CRC screening (Lo,
Waller, Vrinten, Kobayashi & Wagner, 2015; Wagner, Good, Whittaker, & Wardle,
2011). For my dissertation, predictions of CRC screening use based on the FCT were
determined from the effect of age, race/ethnicity, on the association between education
level, income and CRC screening use. To the extent of the FCT, this study hypothesized
that CRC screening use will favor those with high income and access to more than one
health care professional, and more likely for women than men. Findings from this
dissertation will not only guide an agenda for future research on CRC; but will provide a
platform for the MDH to design and implement policies that prioritizes CRC screening
use for those without resources such as health insurance coverage.

36
Limitations of the Fundamental Cause Theory
Despite the evident-based knowledge of the role of resources to disease outcomes,
critics of the FCT argued that it is difficult to test the importance of resources, because it
requires separation of the socioeconomic resources from SES itself (Tehranifar et al.,
2009). Others argued that the FCT is not the best model because, observed tests of the
FCT are not straightforward, as it involves an amalgamation of effects across multiple
processes and conditions (Adams, & White, 2004). It is suggested that prioritizing
downstream determinants of health may have less impact on future population health and
instead expand health inequities (Goldberg, 2014). Therefore, to design public policies to
improve cancer outcomes, there may be competing interest that supersedes health
(Qasim, 2016; Adams, & White, 2004). However, more studies are needed to further
elucidate the role of the FCT on CRC screening use.
Rationale for Using the Health Belief Model and the Fundamental Cause Theory
Given that screening ultimately requires an individuals’ action to go for any of the
United States Preventive Services Task Force (USPSTF) recommended screening test, it
is essential to understand the factors that may impose suboptimal CRC screening use in
Maryland. The HBM and the FCT were selected for this study because they complement
each other and have been applied across a wide range of compliance issues to predict
human behavior in preventive health and promotion strategies (Vanthomme, & Gadeyne,
2019; Helander, et al., 2018; Holme et al., 2018; Vanthomme, Vandenheede, Hagedoorn,
& Gadeyne, 2017; Qasim, 2016; Wilder & Wilson, 2016; Glanz, Rimer, & Viswanath,
2015; Hurtado et al., 2015; Goldberg, 2014; Tammana & Laiyemo, 2014).
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In relation to my dissertation, the HBM will go with the premises that despite a
person’s knowledge of the risk, seriousness, consequences of CRC, nor knowledge of the
benefits of screening, there might still be other socioeconomic factors that may hinder
CRC screening use among individuals. The HBM is an appropriate framework because
my hypothesis that there is a statistically significant association between age, sex, race,
education level, income, health insurance coverage, access to a health care professional,
and CRCSU aligns with the HBM construct of cues to action. The FCT is used in this
research to explain differences in CRC screening use across groups, based on income,
and health insurance coverage, as a resource acquisition. The FCT framework is also
used to guide data analysis; and as a starting point for designing tailored CRC screening
programs and policies in Maryland.
The overarching finding from the literature review is that, constructs from the
HBM and FCT are linked with health behavior and SES. It could be argued that both
conceptual frameworks cannot be used without the other as they both compensate for the
gaps in each other. Given that none of these theoretical models were developed
specifically for CRC screening use, and that CRC screening outcomes have several
predictive factors that are different from other preventive approaches, the observation that
these models account for CRC screening use is essential for understanding how
individuals make decisions to screen for CRC. Findings from this research could provide
an indication of whether the state would achieve and sustain its ≥80% screening target.
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Colorectal Cancer Overview
Colon cancer and rectal cancer have many similar features, hence they are often
grouped together as CRC (NCI, 2019). CRC usually starts as a benign growth and
gradually grows via a multistep process involving molecular, histological, cytological,
morphological, and genetic changes over a period of 10 to 20 years into cancer cells
(Mayo Clinic, 2019; NCI, 2019). CRC pathogenesis have been described as “a
heterogeneous disease with different paradigms” (Li, 2018). The two main types of
polyps are the most common hyperplastic and inflammatory non-cancerous polyps; and
the adenomatous polyps that lead to cancer (ACS, 2018). Up to 96% of CRC are caused
by adenocarcinomas; and the remaining 4% are either carcinoid tumors, gastrointestinal
stromal tumors (GIST), lymphomas or sarcomas (ACS, 2018). Most colorectal tumors
develop over time; making screening an important strategy to prevent the disease through
early detection and removal of precancerous polyps (Simon, 2016). The anatomy of the
colon includes; the ascending, transverse and the descending lobes (Figure 1).

Figure 1. A diagram showing the anatomy of the large intestine including segments of
the colon to the rectum. Adapted from Medical News Today by Chun, C. and Brazier, Y.
Journal of Gastroenterology, p. 22. Copyright (2018) by Mayo Clinic Foundation.
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Pre-cancerous polyps can be identified in the colon during colonoscopy exam (Figure 2).

Figure 2. A diagram showing a large pedunculated colorectal polyp as seen during a
colonoscopy exam. Photos courtesy of Louis M. Wong Kee Song, Mayo Clinic. Adapted
from “Colorectal cancer development and advances in screening” by Simon, K. Journal
of Clinical Interventions in Aging, 11 (11), p. 967. Copyright (2016) by authors.
Colorectal Cancer Epidemiology
According to the International Agency for Research on Cancer (IARC), CRC is
the third most common cancer diagnosed worldwide (Macrae, 2019); and represents
about 10% of annual global cancer incidence (Araghi et al., 2019; Lauby-Secretan,
Vilahur, Bianchini, Guha, & Straif, 2018). CRC is ranked fourth of all cancer-related
deaths, with an estimated increase to 2.2 million new cases and 1.1 million CRC-related
deaths by 2030 (Arnold et al., 2017). The American Institute for Cancer Research (AICR)
pointed out that CRC is one of the most transparent markers of the epidemiological and
nutritional transition of cancer that is easy to interpret (AICR, 2019). Yet global statistics,
show an estimated 1.8 million new CRC cases, and over 880,000 deaths from CRC in
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2018 (IARC, 2019; Macrae, 2019). However, the CRC incidence and mortality rates vary
remarkably across populations with substantially higher (25%) rates in males than in
females; with higher incidence seen among individuals with specific inherited conditions
that predisposes them to the disease (Macrae, 2019); and approximately 20% higher in
African Americans than in Whites (Jemal, Siegel, Xu, & Ward, 2010). Data from some
cancer registries show that CRC incidence is increasing in individuals below 50 years of
age, and decreasing in the older groups (SEER Stat, 2018; Howlader, Noone, & Krapcho,
2016). An estimated 35% of CRC cases in young adults are associated with known
hereditary syndromes from causes that are yet to be understood (Mork et al., 2015; Ahnen
et al., 2014). Studies on the genetic epidemiology revealed an increased risk in firstdegree relatives of patients with inherited CRC syndromes (Yu, & Hemminki, 2019; Li,
2018; Zhu et al., 2017; Folprecht, 2014; Vogelstein et al., 2013).
With a wide distribution of CRC, the global burden of the disease is expected to
increase by 60% to an estimated 2.2 million new cases and 1.1 million deaths by 2030
(Arnold et al., 2017). High CRC incidence rates are expected in countries undergoing
rapid societal and economic changes (Fitmaurice & Allen, 2017); predominantly those
linked to western lifestyles in medium-to-high-income countries (Bray, Ferlay, &
Soerjomataram, 2018; Arnold et al., 2017; Siegel et al., 2017). In 2018 Hungary had the
highest overall CRC incidence rate at 51.2% for both sexes, and South Korea was next at
44.5% (AICR, 2019). Predictions of the future burden of CRC would inform public
health experts and raise awareness of the need for CRC control actions, such as mass
screening programs for at risk groups (Araghi et al., 2019; WHO, 2018).
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Colorectal Cancer Epidemiology in the United States
Despite the availability of prevention methods, early detection, and improvements
in treatment strategies, CRC remains the second leading cause of cancer death in the
United States (Doubeni et al., 2019; Jeon et al., 2019). The overall risk for developing
CRC is 4.49% in men, and 4.15% in women (Siegel, Miller, & Jemal, 2019). It is
estimated that 145,600 new cases and about 51,020 deaths from CRC will be reported in
the US in 2019, with slightly higher rates expected for men than women (ACS, 2019;
Macrae, 2019). The risk for developing CRC is multifactorial. Modifiable behaviors such
as physical inactivity, unhealthy diet, smoking, and obesity are known to account for an
increased risk of CRC (Rosenberg, 2019; Chang et al., 2018). But disparities still exist
when compared across groups (Wittich et al., 2019; Cronin et al., 2018; Burnett-Hartman,
Mehta, & Zheng, 2016; Wilder, & Wilson, 2016; Liss & Baker, 2014). Low SES has
been associated with an increased risk for developing CRC and lower CRC screening rate
(Bernardo, et al., 2018; Mehta, Jensen, & Quinn, 2016; Burnett-Hartman, Mehta, &
Zheng, 2016). Improvements in screening and accessibility to early detection services can
lead to reductions in CRC incidence and mortality rates (ACS, 2019; Araghi et al., 2019;
Wittich et al., 2019).
Age has been associated with sporadic CRC for individuals 40 years of age, and
the incidence increase significantly from 45 to 50 years of age (Mehta, Jensen, & Quinn,
2016). Age-specific CRC incidence rates increase with each succeeding decade after 50
years of age (Macrae, 2019; Jeon et al., 2018). Rising CRC incidence among younger
adults 20 to 39 years of age have also been reported (Macrae, 2019), although the
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absolute incidence in this age group remains much lower than for adults aged 50 or older
(Siegel et al., 2017; Tawadros et al., 2015). Data from the SEER database suggest a
steady increase in CRC incidence for individuals below 50 years of age at a rate of 2%
per year from 1992 through 2013 (SEER Stat, 2016); and decreasing rate in age groups
over 50 years (Meester, Mannalithara, Lansdorp-Vogelaar, & Ladabaum, 2019; Siegel,
Miller, & Jemal, 2019). This may be attributable to increase CRC screening among
individuals over 50 years of age (Atkin et al., 2017).
Although screening for CRC aid physician to identify and remove precursors to
CRC (ACS, 2019); social inequalities in CRC outcomes remain remarkably evident
(Wittich et al., 2019; Cronin et al., 2018; Burnett-Hartman, Mehta, & Zheng, 2016;
Wilder & Wilson, 2016; Verma, Sarfaty, Brooks, & Wender, 2015; Liss & Baker, 2014).
Also, the distribution of economic resources, and knowledge about CRC screening
uptake are unevenly distributed along the social cleavages of age, gender, race, health
insurance coverage and access to healthcare professionals (Wittich et al., 2019; Golboni,
Nadrian & Najafi, 2017; Burnett-Hartman, Mehta, & Zheng, 2016; Wilder & Wilson,
2016; Williams et al., 2016; Fernandez et al., 2015).
Risk Factors of Colorectal Cancer
Although epidemiological findings suggest that some risk factors are more related
to colon than to rectal cancer (Wei, Giovanni & Wu, 2004; Presciuttini, & Strigini, 1996),
for the purpose of this dissertation, both colon and rectal cancer will be considered as the
same entity. Risk factors for CRC include, mutations in inherited genes such as the APC,
KRAS, and p53 (Yu, & Hemminki, 2019; Jeon, 2018; Li et al., 2018; Zhu et al., 2017);
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and chromosomal instability which includes the CIN phenotype found in over 80% of
CRC, the CIMP+ phenotype found in 15 to 20% of CRC; and the MSI+ phenotype found
in 12 to 20% of CRC (Jeon et al., 2018; Folprecht, 2014).
Other risk factors include, personal and family history of CRC and adenomas
(Simon, 2016); history of inflammatory bowel disease (Jeon et al., 2018; NCI, 2015); and
environmental, sedentary and other lifestyle and modifiable risk factors such as diet high
in flavonoid, and red meat intake (Chen et al, 2018); physical inactivity, obesity,
excessive alcohol intake, and cigarette smoking (Chang et al., 2018; He, & Sun, 2016;
Hua et al., 2016). However, the prevalence of modifiable risk factors varies widely by
age, race/ethnicity (Wittich et al., 2019; Fernandez et al., 2015); and by health insurance
access (Wyatt, Pernenkil & Akinyemiju 2017). Early detection through CRC screening,
identification and removal of colorectal polyps have played a crucial role in reducing the
CRC-related incidence and mortality rates across groups (Sauer, Siegel, Jemal, &
Fedewa, 2019; Matsuda, Ono, Kakugawa, Matsumoto, & Saito, 2015). Therefore, the
impact of some high-risk factors to CRC could be minimized through screening.
Colorectal Cancer Screening
The fact that it takes multiple years for normal cells in the colonic mucosa to
grow and become cancerous, provides a great opportunity for successful CRC screening
programs (ACS, 2019). Modeling studies have suggested that improvements in CRC
screening will save lives (Zauber, 2015), and that the disease could be nonexistent in the
US if screening becomes commonplace (Maxon, 2018; Simonson, 2018; Simon, 2016).
The USPSTF is the national policy group that provides guidelines for CRC screening for
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average risk adults, starting at age 50 years and continuing until 75 years (USPSTF,
2019). The current USPSTF guidelines (Appendix A) include CRC screening
recommendations for both stool-based and endoscopic methods for all screen eligible
adults aged 50–75 years of age. However, the guidelines may vary slightly within states
(Rex et al., 2017; Lin, Piper, & Perdue, 2016). For example, in California, screening is
recommended for everyone to begin at age 50 years (Levin et al., 2018); while in
Maryland screening is recommended for average risk individuals 45–75 years of age
(Watkins et al., 2018).
The epidemiology of race and age-related differences in CRC screening had been
evaluated in a population-based retrospective cohort study of asymptomatic average risk
African Americans and Latinos (Williams et al., 2016). Results showed improvements in
CRC screening rates with rates for blacks who had received screening guidelines
increasing from 6.5% in 2000 to 30.6% in 2008 (Williams et al., 2016). However, in a
cross-sectional study, Hispanics in rural areas were less likely to be screened for CRC
and more likely to present with late stage disease than other race or ethnic groups
(Wittich et al., 2019). Studies have shown that consideration of sociodemographic and
economic factors (Rogers et al., 2017; Fernandez et al., 2015); and combinations of
different screening options are viable to investigate CRC screening uptake (Rosenberg,
2019; Wittich et al., 2019; Li, 2018). To increase CRC screening use and to achieve the
optimal screening goal across all groups, health care providers should therefore
emphasize all available information for each test method to the patient during the
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decision-making process to choose appropriate CRC screening modality needed to
accomplish individual goals (Golboni, Nadrian & Najafi, 2017).
Effectiveness of Colorectal Cancer Screening
The preventive effects, benefits and harms of various CRC screening modalities
in average-risk populations have been assessed in randomized controlled trials, and
observational studies (Doubeni, 2019; Doubeni et al., 2018). In terms of performance,
findings from recent studies suggest that CRC detection rates using the fecal occult blood
test (FOBT) every 2 years for five consecutive screening rounds were similar to a single
screening round by any of the endoscopic techniques (Koskenvuo et al., 2019; Emilsson,
Holme, & Bretthauer, 2017; Sali, Mascalchi, & Falchini, 2015). In their randomized
population based study to investigate the effectiveness of CRC screening, Koskenvuo et
al. (2019) found that overall survival rate was higher among those in the screening arm
than those in the control arm; Suggesting that biennial FOBT screening is effective in
improving CRC outcomes in men, but not in women (Koskenvuo et al., 2019).
Stool-based tests are important approaches for CRC screening programs due to its
cost‐effectiveness and non‐invasiveness (Li & Yuan, 2019; Cross et al., 2019; Senore et
al., 2019). By using FOBT, high‐risk individuals can be selected from the general
population, therefore reduce the demand for colonoscopies (Li & Yuan, 2019). Overall,
there is evidence that regardless of the screening modality used, both endoscopic and
stool-based techniques provide enough reliability in detecting cancer early, and in
reducing the risk when current established guidelines are followed (Cardoso et al., 2019;
Li & Yuan, 2019; Doubeni et al., 2019; Salas et al., 2014). The benefits of participating
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in any screening program outweigh the harms associated with any of the recommended
screening test method (Cardoso et al., 2019; Meester et al., 2018; Bibbins-Domingo,
Grossman, & Curry, 2016; Bibbins-Domingo et al., 2016; Meester et al., 2015). The
focus should therefore be on improving various CRC screening strategies and the
efficiency of the modalities used.
Colorectal Cancer Screening in the United States
There is no standard national cancer control plan (Rex et al., 2017). Instead, states
develop and implement specific cancer plans for its residents, based on federal
recommendations, state policies and programs, and recommendations of other
authoritative sources such as the ACS, who are consulted during the development of state
cancer plans (Fowler et al., 2015; Villanueva, Gugel, & Dwyer, 2013). Elements that
determine the Maryland cancer control plan depends on multiple factors, including state
priorities, political climate, stakeholder involvement and partnership (Fowler et al.,
2015). Due to the relative low incidence of CRC in women compared to men, some
researchers have suggested that CRC screening for men should begin five years earlier
than for women, and that women may start screening at age 50–55 years and men at 4550 years of age depending on their risk levels (Arana-Arri et al., 2017; Brenner &
Werner, 2017).
Others have argued that despite the difference in incidence rates, guidelines for
CRC screening programs should start at age 50 years for both men and women of average
risk (Doubeni et al., 2019; Li, 2018). However, Brenner & Werner (2017) pointed out
that regardless of the age at which initial screening is recommended for any public health
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program, the essential factors to consider are the individuals’ risk level, the sensitivity
and specificity of the test, the capacity of the specific target population and availability of
colonoscopy. Although there are improvements in CRC screening trends in the past 10
years (MMWR, 2016), there is evidence of racial/ethnic disparities in screening uptake
across groups (Sauer, Siegel, Jemal, & Fedewa, 2019; Wilder & Wilson, 2016; Liss &
Baker, 2014; Tammana & Laiyemo, 2014). Hispanics and Asian Americans are known to
have low (<50%) CRC screening rates (Jih et al., 2018; Jung et al., 2018); compared to
54.3% for American Indian/Alaska Natives, 61.8% for blacks, and 65.4% for whites
(Rosenberg, 2019). Therefore, States need to review their cancer control plans to
determine where the focus should be to improve CRC screening use across all groups.
Cancer in Maryland
Despite recent decline in CRC incidence and mortality rates in Maryland (Brun &
Kanarek, 2018; Dwyer et al., 2015), the cancer burden for Maryland remains large when
measured by human suffering, loss of life, loss of quality of life, and expenditures for
medical care (Ahmad et al., 2018). More than 27,000 Marylanders are diagnosed with
invasive cancer each year, and many family members, and friends support patients
through their cancer treatment journeys (MDH, 2016-2020 Cancer Report). According to
the MDH, if current trends in incidence and mortality rates continue, cancer will soon
become the leading cause of death in Maryland (Brun & Kanarek, 2018). Although
several prevention-related recommendations are covered under the Affordable Care Act
(ACA) introduced in 2012 (Fox & Shaw, 2015), the Maryland Comprehensive Cancer
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Control Plan (MCCCP) provides prevention strategies which sometimes do not match
federal evidence-based screening recommendations (Fowler et al., 2015).
The Maryland Centers for Cancer Control and Prevention developed a
comprehensive cancer control strategy managed under the Maryland Comprehensive
Cancer Control Plan (MCCCP). The first Maryland cancer control plan was written in
1991 by contributors from hospitals, the academia, nongovernment organizations and
volunteers; and has been updated every five years since then (Fowler et al., 2015). The
MCCCP involves communities and partners working together to maximize the impact of
cancer through coordinated efforts to reduce the risk, detect cancers early, improve
treatment and enhance survivorship (MDH, 2016-2020 cancer report). The most recent
MCCCP is the updated 2016-2020 cancer report which is a coordinated effort of staff
from the MDH, and 83 public and private stakeholders across the state (Ahmad et al.,
2018). The goal of the MCCCP is to encourage collaboration among all stakeholders and
coordinate activities of the Maryland Cancer Collaborative (MCC), and the Maryland
Patient Navigation Network (MPNN) (MDH, 2016-2020 cancer report). Both the MCC
and the MPNN are statewide coalition of individuals and organizations who volunteer to
navigate patients through the Maryland cancer continuum, promote initiatives and
implement priorities set by the MCCCP (MDH, 2016-2020 Cancer Report). A 2014 study
to examine the cancer prevention treatment demonstration (CPTD) screening trial in
Maryland revealed that patient navigation was an effective strategy to increase CRC
screening among older blacks in Baltimore City (Horne et al., 2015).

49
In its efforts to continue a steady progress towards low cancer incidence with zero
disparities (Brun & Kanarek, 2018), the MCC recently met in Annapolis, Maryland for
the 2018 MCC annual meeting, with a main agenda to set priority projects and strategies
on cancer prevention goals for 2019–2021 and a focus to increase CRC screening uptake
across all groups (Platz, 2018). The MCCCP is a useful resource for cancer statistics
needed by professionals and organizations throughout the state to help guide their cancer
control activities and by researchers conducting studies on cancer control topics in
Maryland (Ahmad et al., 2018). According to the MDH, healthcare access and cancer
disparities are two areas that offer opportunities and challenges for patients, public health
professionals, and healthcare providers across the cancer continuum; hence are
emphasized in the 2019–2021 MCCCP (MDH, 2019). This study will provide evidencebased data to inform future priorities for the MCCCP.
Colorectal Cancer in Maryland
CRC is classified as one of seven high burden cancers for Maryland including
breast, cervical, colorectal, lung, oral, prostate, and skin cancer (Ahmad et al., 2018; Brun
& Kanarek, 2018), and accounts for 9.0% of cancer deaths in Maryland (MDH, 20162020 cancer report). The Maryland Cigarette Restitution Fund Prevention, Education,
Screening, and Treatment program (CRF PEST) has targeted the seven high burden
cancers for public health programs (Smith et al., 2019; Richardson et al., 2015). Between
2010-2014, Maryland was the 27th highest in CRC mortality rate among all states in the
US and the District of Columbia (MDH, 2017 cancer report). Data from the Maryland
Cancer Registry (MCR) shows that 2,477 new cases and 955 deaths from CRC were
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reported in Maryland in 2014 (MCR, 2015). The 2014 age-adjusted CRC incidence rate
for Maryland was 37.3 per 100,000 (35.8-38.8, 95% CI); and the mortality rate was 14.4
per 100,000 (13.5-15.4, 95% CI); statistically higher than the national CRC mortality rate
of 14.1 per 100,000 (14.0-14.2, 95% CI) for the same period (SEER Stat, 2015).
Statistically significant (p < 0.05) differences in CRC diagnosis exist between age, sex,
and race groups in Maryland (MDH, 2017 cancer report). Between 2008-2012, more
blacks (22.4%) in Maryland were diagnosed with CRC, than whites (19.5%). Among
those diagnosed at distant stages, black males (25.5%), white males (22.5%); and black
females (20.4%), white females (17.0%) (MDH, 2017 cancer report).
The 2012 Maryland BRFSS data for screen eligible adults, shows that only 65.2%
males and 70.2% females have received at least one surveillance CRC screening by any
of the recommended modality (Brun & Kanarek, 2018). The percentage of adults, 50
years and older, who were up-to-date with CRC screening increased from 64% in 2002 to
70% in 2012 (Platz, 2018; MDH, 2017). However, data from the Baltimore City Health
Department Office of Epidemiologic Services, shows that despite increases in CRC
screening rates, up-to-date screening are not uniform across the State, as differences
within gender, race/ethnicity, and access to health care services persist across all 24
counties in Maryland (MDH, 2017 cancer report). In 2016, 69.2% white, 68.3% blacks
and 53.6% Asians in Maryland were up-to-date with screening (Brun & Kanarek, 2018).
Cross-sectional studies have identified factors such as gender, and race as reasons
for not adhering to CRC screening in Maryland (Dwyer et al., 2015; Villanueva, Gugel,
& Dwyer, 2013). Socioeconomic factors such as low-income, and health insurance, were
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identified as factors that affect CRC screening among African American men and women
50 years and older in Maryland (Palmer, Chhabra & McKinney, 2011). According to the
Maryland Center for Cancer Surveillance and Control, between 2002 to 2012 the
proportion of adults who reported never being screened for CRC was consistently higher
among the uninsured, compared to the insured (MDH, 2017 cancer report). The focus of
statewide public health efforts to address the CRC problem is to reduce disease outcomes
through screening and early detection (Brun & Kanarek, 2018; Richardson et al., 2015).
During the 2018 MCC annual meeting Dr. Elizabeth Platz pointed, efforts to reduce CRC
incidence through screening are essential to meet the State’s target goals (Platz, 2018).
Colorectal Cancer Control and Prevention Strategies in Maryland
Improvements in CRC screening programs remains an important pillar of work by
the MDH, as it strives to bridge the sex and race gaps in CRC screening, and increase the
percentage of screen eligible adults who are up to date with screening schedule (Watkins
et al., 2018). The current public health effort by the state is to increase the number of
adults ages 45 to 75 years who have had a FOBT in the past 1-3 years, a sigmoidoscopy
in the past 5 years and a colonoscopy in the past 10 years (MDH, 2016-2020 cancer
report). Based on the 2018 guidelines, the FOBT combined with fecal immunochemical
test (FIT) is the recommended stool-based modality for CRC screening programs in
Maryland, that serve as a screening test for any of the endoscopic tests (Watkins et al.,
2018). For those enrolled in the Maryland CRF CPEST program, a positive stool test is
directly recommended for colonoscopy, and for a negative test, a colonoscopy or
sigmoidoscopy is encouraged at the next annual FOBT/FIT or during follow-up calls
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(Ahmad et al., 2018; Watkins et al., 2018). The goal of a colonoscopy is to remove all
identified polyps whether sessile or pedunculated, biopsied and sent for pathologic
examination (Watkins, et al., 2018). Under the CRF CPEST program, all cancer
diagnoses are immediately followed with treatment funded by the program (Watkins et
al., 2018).
In Maryland, the public health purpose of CRC screening is to ensure enough
bowel preparation to visualize polyps >5mm through adequate colonoscopy; and that
polyps found during sigmoidoscopy are not removed but referred for colonoscopy for
complete excision or biopsy depending on the size of the lesion (MDH, 2017). The good
news for Marylanders is that new prevention programs as well as promising practices to
reduce cancer disparities in the state are ongoing (Ahmad et al., 2018; Watkins et al.,
2018). Some epidemiologists have recently evaluated the 30 years’ progress in the
implementation of cancer control and prevention programs in Maryland (Brun &
Kanarek, 2018), and provided useful CRC statistics used in designing this dissertation.
Maryland’s Contexts of the Colorectal Cancer Screening Problem
The guidelines for “Minimal Clinical Elements for Colorectal Cancer Detection
and Diagnosis” was generated by the advisory board of the Maryland CRF PEST, to
serve as CRC screening guidelines for diagnostic services in the CRF CPEST program
(Watkins et al., 2018). The updated 2018 guidelines, included elements to promote CRC
screening for Marylanders who are either uninsured or underinsured, aged 50-75 years,
and enrolled in the CRF CPEST program. Under this guideline, in-office FIT or FOBT
are not recommended, each positive FIT or FOBT must be followed with a colonoscopy.

53
Any other procedures or follow-up can be done only after a discussion between the
participant and provider (Watkins et al., 2018). See appendix B for details.
Literature Review Related to Study Variables
Key variables in this study include education level completed, household income
level, health insurance coverage, access to health care professional (independent
variables), age, sex, race/ethnicity (covariates) and CRC screening use (dependent
variable). These variables are of interest because, studies have shown statistically
significant relationships between them and CRC screening across groups in the United
States (Doubeni, 2019; Rosenberg, 2019; Doubeni, Corley, & Quinn, 2018; BurnettHartman, Mehta, & Zheng, 2016; Williams et al., 2016). Findings from this study will
help to improve understanding of CRC screening use in Maryland and demonstrate the
effect of sociodemographic factors on CRC screening rates in the State.
How Other Researchers Have Approached the Problem of low CRC Screening
Although there is a paucity of data on the predictors of CRC screening across
various groups in Maryland; researchers have investigated predictors of CRC screening
use in population-based retrospective and cross-sectional studies using both primary and
secondary data (Abuadas et al., 2018; Helander, Heinävaara, Sarkeala, & Malila, 2018;
Jih et al., 2018; Almadi et al., 2015). Publicly available data from reliable databases such
as the National Health Interview Survey (NHIS), National Health and Nutrition
Examination Survey (NHANES), and the CDC BRFSS, have been used to investigate
risk factors (Cardoso et al., 2019; Sauer, Siegel, Jemal, & Fedewa, 2019); as well as
barriers and trends in CRC screening utilization across demographic and socioeconomic
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characteristics in the US (Ran et al., 2019; Vanthomme, & Gadeyne, 2019; DeMoor, et
al., 2018; Miranda et al., 2017; Kang & Son, 2017; Seibert, Hanchate, Berz, & Schroy,
2017; Lin, McKinley, Sripipatana, & Makaroff, 2017).
Secondary data from the 2014 Health Center Patient Survey was used to
investigate the relationship between age, sex, race/ethnicity, geography, preferred
language, household income, insurance, employment status and patient-provider
communication on CRC screening among patients aged 45–75 years in the U.S. (Lin,
McKinley, Sripipatana, & Makaroff, 2017). Results from multiple logistic regression
analyses showed that patients 65–70 years of age had higher odds (aOR, 2.32; 95% CI,
1.37–3.94) of receiving CRC screening compared to those of the younger age group.
Those who were insured were, 2.5 times more likely to receive CRC screening compared
to the uninsured who were 67% less likely (aOR, 0.33; 95% CI, 0.18–0.61) to receive
CRC screening (Lin, McKinley, Sripipatana, & Makaroff, 2017).
A population-based study was used to identify barriers to CRC by examining the
prevalence of CRC screening adherence among obese adults 50–75 years of age, using
the 2010 data from the NHIS. Results of the multiple logistic regression analysis showed
that obese class III men (BMI ≥40), were 65 % less likely (aOR = 0.35, 95% CI = 0.17,
0.75, p = 0.04) to adhere to screening guidelines compared to non-obese class men
(Seibert, Hanchate, Berz, & Schroy, 2017). A retrospective cohort study using the 2000–
2015 data from the Kaiser Permanente North California members in a community-based
CRC screening program, showed that implementation of a structured CRC screening
program using stool-based test and colonoscopy significantly (p < 0.01) increased CRC
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screening uptake, from 38.9% in 2000 to 82.7% in 2015 (Levin, Corley & Jensen, 2018).
Implementation of organized CRC screening outreach programs have been associated
with rapid increase in screening participation (Cardoso et al., 2019; Doubeni, 2019; Levin
et al., 2018) and decrease in CRC incidence and mortality rates (Li & Yuan, 2019; Pellat,
Deyra, Coriat, & Chaussade, 2018).
Evidence-based approaches, such as patient navigation, have also been used for
promoting CRC screening at population levels (Hunleth, Steinmetz, McQueen, & James,
2016; Enard, Nevarez, & Hernandez, 2015; Gordon & Green, 2015; Verma, Sarfaty,
Brooks, & Wender, 2015; Fernandez et al., 2015). However, disparities in CRC screening
rates across age, sex, and race/ethnic groups persist (Burnett-Hartman, Mehta, & Zheng,
2016; DeSantis et al., 2016; Wilder & Wilson, 2016). As evident in the literature, a
strength in research on CRC screening use is the use of quantitative approaches that
employ multiple logistic regression models to analyze data across groups (Cardoso et al.,
2019; Levin, Corley & Jensen, 2018; Seibert, Hanchate, Berz, & Schroy, 2017; Lin,
McKinley, Sripipatana, & Makaroff, 2017).
The weakness in population-based and cross-sectional designs on CRC screening
is that most of the studies are broad, using national data (Lin, McKinley, Sripipatana, &
Makaroff, 2017; Seibert, Hanchate, Berz, & Schroy, 2017; Verma, Sarfaty, Brooks, &
Wender, 2015). Little information is available on cross-sectional studies on CRC
screening use across groups in Maryland. However, previous researchers have found a
strong association between physician recommendation for CRC screening and adherence
to screening guidelines across some groups in Maryland (Palmer et al., 2011; Gilbert &
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Kanarek, 2005). To meet the state CRC screening target of ≥80%, smaller, culturally
sensitive and tailored studies on predictors of CRC screening use such as is the premise
of this dissertation are necessary.
Age and Colorectal Cancer Screening Use
There is overwhelming evidence from the literature that for people aged 45 years
or older, screening by any of the recommended modalities can detect CRC early and
improve treatment if diagnosed (Doubeni et al., 2019; Zauber et al., 2018). Yet CRC
screening uptake remain low among this age group (De Moor et al., 2018; Kang & Son,
2017). According to Molina-Barceló et al., (2018) men are more likely to participate in
CRC screening only if they are 60 years of age or older. De Moor et al., (2018) used the
2008–2015 NHIS data to examine CRC screening rates among individuals 50–75 years of
age with health insurance coverage. After stratifying the age variable into two subgroups
(50–64 years and 65–75 years), results from multiple logistic regression analysis showed
that adults aged 50–64 had a higher (73.4%) use of CRC screening by any modality
compared to adults aged 65–75 years with lower (71.7%) use (De Moor et al, 2018).
To support this finding, Kang & Son, (2017) used secondary data from a 2012
Community Health Survey to conduct a cross-sectional study to examine the relationship
between age, sex, and CRC screening participation. Results from the multiple logistic
regression analysis showed that younger age was associated to CRC screening in both
men and women. Pooled analysis of randomized trials to determine the effectiveness of
screening in CRC screening program showed that screening reduced CRC incidence in
women <60 years of age (RR 0.71; 95% CI 0.59–0.84), but not significantly (0.90; 95%
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CI 0.80–1.02) in those ≥60 years old (Holme et al., 2017). Increase in public health effort
is needed to promote CRC screening among the younger age group in the U.S. (Maxwell,
Hannon, & Escoffery 2014).
Sex and Colorectal Cancer Screening Use
Screening by any of the recommended modalities can detect CRC early (USPSTF,
2018), yet sex differences in CRC screening uptake exist with men having lower CRC
screening rates compared to women (Brenner & Chen, 2018; Molina-Barceló et al., 2018;
Sava, Dolan, May, & Vargas, 2018; Kang & Son 2017; Mehta, Jensen & Quinn, 2016;
Symonds et al., 2016). In a cross-sectional study using multiple logistic regression
analysis to examine the factors that influence CRC screening, Molina-Barceló et al.,
(2018) found a statistically significant (p < 0.05) relationship between sex and CRC
screening participation. Results showed that women were more likely (OR:1.52; 95% CI:
1.06–2.19) to participate in screening compared to men. However, men were more likely
to participate in screening if they live with a partner (OR: 6.26; 95% CI: 1.82–21.49) or
have family responsibilities (OR: 2.53; 95% CI: 1.39–4.63) (Molina-Barceló et al., 2018).
Contrary to these findings, Almadi et al., (2015) found that, neither gender, income,
marital status, nor knowledge about CRC were associated with participation in screening.
However, understanding that colonoscopy is a screening test was associated with a strong
desire (OR:1.55, 95% CI; 1.04–2.29) to undergo screening (Almadi et al., 2015).
Furthermore, to determine the highest CRC screening rates in sex and age groups
Sava, Dolan, May, & Vargas (2018), found that CRC screening participation was higher
in women (35.81%) aged 50–59 years than in men (25.91%) of same age group.
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Although there is limited current literature on sex specific differences in CRC screening
use, the influence of traditional gender roles where women have greater self-care
compared to men who have a poorer perception of vulnerability could explain the gender
differences in CRC screening participation (Molina-Barceló et al., 2018; Mehta, Jensen &
Quinn, 2016). Moreover, available literature shows that higher rates of positive CRC
screening test for men may be associated with lower CRC screening uptake (Sava, Dolan,
May, & Vargas, 2018; Symonds et al., 2016). Therefore, gender-specific interventions
are needed to encourage CRC screening use for both sexes (Kang & Son, 2017).
Race/Ethnicity and Colorectal Cancer Screening Use
Despite increases in CRC screening rates among adults 50–75 years of age,
significant racial disparities remain across groups (Bernardo et al., 2018; Meester et al.,
2018; Moreno, Fibus, Krupinski, Kim, & Pickhardt, 2018; Seibert, Hanchate, Berz, &
Schroy, 2017; Gonzales, Qeadan, & Mishra, 2017; Burnett-Hartman, Mehta, & Zheng,
2016; Wilder & Wilson, 2016; Liang, Mayer, &Wakefield, 2016; Liss & Baker, 2014).
The relationship between race/ethnicity and CRC screening in the US, had been
investigated in population based studies that revealed Hispanics lag Whites, Blacks, and
other racial groups in being up-to-date with CRC screening (Burnett-Hartman, Mehta, &
Zheng, 2016; Khajuria, 2016; Mehta Jensen & Quinn, 2016). Data from the Morbidity
and Mortality Weekly Report (MMWR, 2016), showed that during the 2000–2015
period, CRC screening rates were higher among non-Hispanic white (65.6%), relative to
non-Hispanic black (60.3%), non-Hispanic Asian (52.1%), and Hispanic (47.4%).

59
Using the 2010 data from the CDC BRFSS database, results from multiple
regression analysis showed that CRC screening rates were highest among whites (62.0%)
compared to, blacks (59.0%), Native Hawaiian/Pacific Islander (54.6%); Englishspeaking Hispanics (52.5%), American Indians/Alaska Natives (49.5%), Asians (47.2%),
and exceptionally low for Hispanic-Spanish groups with 30.6% (Liss & Baker 2014).
Also, Liss & Baker (2014) demonstrated that racial/ethnic disparities persisted even after
adjusting for SES and access to health care professional; Hispanic-Spanish (RR:0.76,
95% CI: 0.69–0.83); Hispanic-English (RR:0.94, 95%CI: 0.91–0.98); and American
Indian/Alaska Native (RR:0.91, 95%CI: 0.85–0.97). In support of these findings a
retrospective cohort study using the 2004–2013 data of the KPNC community-based
integrated healthcare system was conducted to examine the association between
race/ethnicity and CRC screening and timely follow-up after intervention program
(Mehta, Jensen, & Quinn, 2016). Results of the multiple logistic regression analysis
showed that, although screening rates increased across all groups after the intervention
program, rates remained lower in minority race groups compared to whites both before
and after implementation of CRC screening program; whites (rate ratio:1.04, 99 % CI:
1.02–1.05) and blacks (RR = 0.97, 99% CI: 0.96–0.97).
Although an estimated 61% of the U.S. population have shown the inclination to
screen for CRC (Mason, 2018; Ransohoff, & Sox, 2016), compared to other race/ethnic
groups 65% of Vietnamese Americans aged 50 years and older have never taken a CRC
screening test (Heiniger, Sherman, Shaw, & Costa, 2015; Ghai et al., 2015). Data from
the National Center for Health Statistic (NCHS) showed that between 2003 to 2013, CRC
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screening rates increased from 41% to 60% for Whites, 35% to 58% for Blacks, 27% to
50% for Asians, but increased the least for Hispanics from 27% to 41% (NCHS, 2017).
Given that some racial/ethnic groups are less likely to get screened (Khajuria, 2016), and
more likely to present with late stage CRC (Gonzales, Qeadan, & Mishra, 2017; ACS,
2017); It is therefore no secret that the racial/ethnic differences in CRC screening rates
and their association with CRC diagnosis has been a challenge to CRC prevention
programs across many healthcare systems in the United States (Burnett-Hartman, Mehta,
& Zheng, 2016). Enhanced, multilevel efforts and multi-component culturally tailored
programs are important strategies to address CRC screening differences among at risk
race groups such as Hispanics, Blacks and Asians (Wittich et al., 2019; Khajuria, 2016;
Fernandez et al., 2015; Enard, Nevarez, & Hernandez, 2015; Gordon & Green, 2015;
Hunleth, Steinmetz, McQueen, & James, 2016); who often lack the economic resources
such as health insurance that is needed for most screening programs (Sauer, Siegel,
Jemal, & Fedewa, 2019).
Education Level and Colorectal Cancer Screening Use
Extensive studies had been conducted to show that CRC screening rates among
adults age 50-75 is linked to education level and education is a strong predictor to CRC
screening participation. Researchers have studied the relationship between education
level and CRC screening use by examining highest level of education completed on the
ability to read, judge, make informed decision (Lee, Natipagon-Shah, SangsanoiTerkchareon, Warda, & Lee, 2019; Woudstra, Smets, Verdam, & Fransen, 2019;
Woudstra et al., 2018; Rodriguez, & Smith, 2016; Wee, McCarthy, 2005 & Phillips,
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2005) and the effect of health literacy on the ability to understand and apply CRC
screening information for personal relevance (Ojinnaka et al., 2015). Results from a
multivariable logistic regression analysis to investigate the factors that influence CRC
screening uptake among Thais in the United States aged 50–75 years, showed that in
addition to other sociodemographic factors, significant predictors of screening adherence
include having at least some college education (OR 3.74, 95% CI 1.23–11.37), compared
to those no college education (Lee et al., 2019).
To examine the association between education level and CRC screening among
US veterans age 50–75 years using the 2012 BRFSS data, results from multiple logistic
regression analyses showed that while adjusting for sex, income, race/ethnicity, health
insurance coverage, having a primary care provider, employment status, and delay in care
due to medical cost, the probability to obtained CRC screening increases as education
level increases (p < .05); individuals with less than high school (73%), high school
graduates (77%), some college (84%) and college degree or more (87%) compared to
those with lower education levels (Rodriguez, & Smith, 2016). To support these findings,
by adjusting for age, sex, healthcare access, and region of the country, Wee, McCarthy, &
Phillips, (2005) found that respondents at lower education levels were less likely to
undergo CRC screening by FOBT (OR: 0.7 [95% CI: 0.6–0.9]) and colonoscopy (OR:
0.8 [95% CI: 0.7–0.9]) compared to those at higher education levels. According to
Woudstra, Smets, Verdam, & Fransen, (2019) individuals at lower educational levels
have more difficulty understanding health information and making informed decisions
about CRC screening. However, people with less education are more likely to participate
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in CRC screening at the initiative of a health care professional or a screening programme
(Willems, & Bracke, 2018).
Income Level and Colorectal Cancer Screening Use
There is overwhelming evidence from retrospective, prospective and crosssectional studies that income level highly correlates with CRC screening use; with higher
income associated with increased odds of up-to-date CRC screening in both retrospective
and prospective studies (Sharma et al., 2019; Simkin, Ogilvie, Hanley, & Elliott, 2019;
Honein-AbouHaidar et al., 2016; Satsangi & DeGroff, 2016; Singh et al., 2015; Pruitt et
al., 2014; Wheeler et al., 2014). Previous researchers have examined the association
between income and CRC screening, by investigating the effect of cost of screening on
compliance and adherence to USPSTF recommended guidelines in both community and
population based studies (Cross et al., 2019; Honein-AbouHaidar et al., 2016; Ojinnaka et
al., 2015; Davis, & Ballreich, 2014; Pornet et al., 2014; Klabunde et al., 2013). The
association between income level and CRC screening has also been investigated in the
context of other aspects related to socio-economic deprivation, social determinants of
health, rurality, and universal access (Hunleth, Steinmetz, McQueen, & James, 2016;
Calo et al., 2015; Singh et al., 2015; Shariff-Marco et al., 2013).
To estimate the prevalence of up-to-date CRC screening among adults aged 5074 years across income strata by urbanization, Simkin, Ogilvie, Hanley, & Elliott, (2019)
used the 2013/2014 data from the Canadian Community Health Survey and found that
up-to-date CRC screening rates ranged from 47.0% for the lowest income group to 54.0%
for the highest income group. Results from the multiple logistic regression analysis
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revealed high income quintile (OR = 1.49, 95% CI 1.17–1.89) and middle income
quintile (OR = 1.42, 95% CI: 1.02–1.99) were more likely to be up-to-date CRC
screening compared to the lowest income quintile (Simkin, Ogilvie, Hanley, & Elliott,
2019). Low-income and rural populations are less likely to report up-to-date CRC
screening than high-income and urban counterparts, respectively (Simkin, Ogilvie,
Hanley, & Elliott, 2019). It is essential to understand and address inequities in CRC
screening use, particularly among low-income populations.
In the 2015 CDC funded CRC Control Program (CRCCP), researchers analyzed
clinic data using ordinary least square regression analysis to estimate CRC screening
rates across income levels, and found that those who lived in low income counties were
negatively associated with lower (43%) CRC screening rates compared to high income
counties (Satsangi & DeGroff, 2016). Given the disparities in CRC screening rates by
income levels, there is need to examine up-to-date CRC screening use across income
levels in Maryland. The design and implementation of CRC screening programs in
Maryland should be underpinned by evaluation of the current CRC screening program to
help identify vulnerable populations and inform screening priorities across groups.
Health Insurance Coverage and Colorectal Cancer Screening Use
Health insurance coverage has been linked to limited use of preventive health
services such as CRC screening programs (Wyatt, Pernenkil & Akinyemiju 2017; Zhao,
Okoro, Li, & Town, 2017; Wools, Dapper, & de Leeuw, 2016). Although the ACA has
expanded access to health insurance for people who were previously uninsured, and costsharing for most preventive health care plans with USPSTF grade “A” or “B” has been
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eliminated in the Medicare program (Blumenthal & Collins, 2014); many eligible adults
are not screening according to USPSTF recommendations (White et al., 2017). The
literature revealed that individuals without health insurance coverage of any type are less
likely to receive CRC screening (Miranda et al., 2017; Zhao, Okoro, Li, & Town, 2017);
and more likely to present with advanced stages of disease (Amini, Jones, & Yeh, 2016).
In using data from the CDC BRFSS to examine CRC screening participation
among U.S. adults by health insurance status, Zhao, Okoro, Li, & Town, (2017) found
that the underinsured (3%) and never insured (47%) women, as well as the underinsured
(6%) and never insured (52%) men were less likely to receive CRC screening. However,
women and men ≥50 years of age with private plans were less likely to receive CRC
screening, and men with public insurance were more likely to receive CRC screening
(Zhao, Okoro, Li, & Town, 2017). The odds of CRC screening were slightly higher (OR:
1.05, 95% CI: 1.03–1.08) during high resource availability period post-recession/ACA of
2010-2012; and lower (OR: 0.73, 95% CI: 0.72–0.75) during the low resource availability
period of the 2007–2009 recession (Wyatt, Pernenkil & Akinyemiju, 2017).
Contrary to this finding, De Moor et al., (2018) used the 2008–2015 data from the
NHIS and demonstrated that, compared to other health insurance plans like TRICARE
individuals aged 50–75 years with traditional employer-sponsored insurance were 62.2%
more likely to be screened those with traditional private purchase plans (50.9%), and the
uninsured (24.8%). However, screening increased from 51.6% in 2008 to 58.3% in 2010;
then plateaued from 2010 to 2013 but increased again from 58.3% to 61.3% in 2015
during high resource available period (De Moor et al., 2018). It is essential to point that
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CRC screening rates increased from 2013, after the 2012 ACA, when over 40 million
more Americans gained health insurance coverage (Sommers, Gunja, & Finegold, 2015)
and have steadily progressed since the ACA (Zhao, Okoro, Li, & Town, 2017; Wherry, &
Miller, 2016). These findings suggest that more public health efforts are needed to close
the gaps in insurance plans so as to increase the use of preventive healthcare services
among the insured and the uninsured in the U.S (Zhao, Okoro, Li, & Town, 2017). It is
likely that health insurance coverage and support from healthcare professionals will
contribute to improvements in CRC screening use in Maryland, as health insurance
remains a primary focus of CRC screening programs in Maryland (MDH, 2017).
Access to Healthcare Professional and Colorectal Cancer Screening Use
There is evidence from the literature that access to a health care professional is a
strong predictor of CRC screening use. Previous researchers have suggested that access
to a healthcare professional provides an opportunity for individuals to make informed
decision to participate in CRC screening programs, regardless of educational attainment,
poverty, level of urbanization, and other factors that may influence the use of preventive
health care services (Figueroa et al., 2017; Kirkegaard et al., 2016) and increase the
likelihood to participate in CRC screening programs (Willems, & Bracke, 2018). The
relationship between access to healthcare professional and CRC screening use have been
investigated in the realms of the number of health care specialists as a preventive
approach for cancer (Sharma et al., 2019; Simkin, Ogilvie, Hanley, & Elliott, 2019;
DeGroff et al., 2018; Jackson, Goel, Kho, & Keswani, 2016); and the role of physician
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counseling in increasing CRC screening uptake (Willems, & Bracke, 2018; Satsangi &
DeGroff, 2016; Wee, McCarthy, & Phillips, 2005).
To identify factors that contribute to variations in CRC screening rates among
patients who visit four medical centers in Chicago, results from the multiple logistic
regression analysis showed that patients who had regular checkups with health care
professionals in the previous two years were 16 times more likely (OR 16.01, 95% CI:
3.75, 68.75) to have obtained CRC screening for the first time compared to those who did
not visit the clinic regularly (Jackson, Goel, Kho, & Keswani, 2016). Moreover, in their
cross-sectional study to examine the role of primary care clinic to increase CRC
screening rates in medically underserved areas, Sharma et al., (2019) found that those
with access to at least one health care professional had up to 16.4% higher CRC
screening rates compared to those who did not visit the primary care clinic. To support
these findings, Wee, McCarthy, & Phillips, (2005) found that among those who did not
undergo CRC screening in low SES areas, 92% were not counseled by their physician.
Some researchers have suggested that, a strategy to increase CRC screening rates
and reduce SES inequity is by systematic patient counseling about CRC screening
through visit to a health care professional (DeGroff et al., 2018; Satsangi, & DeGroff,
2016). Therefore, it is essential for public health professionals to design and implement
combinations of CRC screening programs that are underpinned by access to a health care
professional, cost, and capacity of specific community need. This study went further to
quantitatively examine if there is any association between access to one or more than one
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health care professional and fully meeting the USPSTF CRC screening recommendation
within the recommended time interval among adults 50–75 years in Maryland.
Literature Review Related to the Research Design and Methodology
Based on the literature gathered so far, it is no secret that removal of precancerous
lesions as well as early detection of CRC through screening reduces CRC-related
incidence and mortality in men and women (Sauer, Siegel, Jemal, & Fedewa, 2019). This
dissertation utilized a quantitative design using secondary data from the CDC BRFSS to
determine associations between the independent variables (age, sex, race/ethnicity, health
insurance coverage, access to health care professional) and the dependent variable (CRC
screening use). The BRFSS is a rich resource for a wide variety of research questions on
CRC screening use. Using data from the BRFSS would allow me to collect and analyze a
large volume of data within a relatively short time (Lakerveld et al., 2017).
The influence of the identified independent variables on CRC screening
participation and adherence to screening programs were also discussed in this chapter.
Data for this study were analyzed using multiple logistic regression approach because the
model allowed for the estimation of the predictive relationship between the predictors and
the dichotomous dependent variable, and useful to identify outliers control of potential
confounding factors (Rogers et al., 2017; McDonald, 2014). Prior studies that only
measure initiation of CRC screening, without follow-up of positive results, may have
overestimated CRC screening participation, and missed potential differences in CRC
screening completion rates across groups (Cross et al., 2019; Wilder & Wilson, 2016;
Wools, Dapper, & de Leeuw, 2016). The underlying hypothesis of this study is that the
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association between the predictor variables and CRC screening use differs across groups
depending on demographic characteristics and resource availability. Thus, findings from
this study are a useful guide for the MCC to design, targeted screening programs within a
variety of community settings in Maryland.
Summary
Epidemiologic studies to evaluate the age to start and stop CRC screening, and the
differences in screening rates based on presumed level of benefit were reviewed.
Researchers have demonstrated that it is essential for adult men and women aged 50–75
years to comply with USPTSF CRC screening recommendation (Cardoso et al., 2019;
Meester et al., 2018); because screening can prevent the disease through detection and
removal of precancerous polyps (Jeon et al., 2018). Adherence to recommended
guidelines play a significant role in reducing CRC outcomes among groups (Jeon et al.,
2019). The reasons for low CRC screening rates are multifactorial, including
sociodemographic and socioeconomic factors that include age, sex, race/ethnicity,
education level, income level, health insurance coverage, and access to health care
professional (Simkin, Ogilvie, Hanley, & Elliott, 2019; DeGroff et al., 2018; De Moor et
al, 2018; Woudstra et al., 2018; Rogers et al., 2017; Jackson, Goel, Kho, & Keswani,
2016). CRC is one of seven high burden cancers for Maryland hence a focus on CRC
screening programs in the last ten years in the State (MDH, 2018).
In embracing the overall literature, CRC screening use is higher among women
than men of the same age and race group (Chen, Hoffmeister, & Brenner, 2019; Brenner
& Chen, 2018; Molina-Barceló et al., 2018; Sava, Dolan, May, & Vargas, 2018; Arana-
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Arri et al., 2017). Also, CRC screening rates are higher among whites than in any other
race/ethnic groups (Mehta, Jensen, & Quinn, 2016; Liss & Baker, 2014). Access to a
health care professional is influential to improving CRC screening up take among groups
(Willems, & Bracke, 2018; Satsangi & DeGroff, 2016). Surveillance screening should
not be limited to those with health insurance coverage, but provided to all individuals in
the community regardless of income level or resource availability (Cross et al., 2019).
This study fills a gap in understanding the documented issues around low CRC screening
rates in Maryland (MDH 2016-2020 cancer report) and elucidate where the focus should
be to increase CRC screening use among various groups. Given the benefits of CRC
screening, targeted screening programs would produce better prognosis from early
diagnosis, and consequently reduce CRC mortality rate (Dubé, 2018).
Conclusions
The evidence around sociodemographic and socioeconomic inequalities in CRC
outcomes remains remarkable (Cross et al., 2019). Some researchers have suggested that
regardless of associations, more targeted and culturally tailored screening programs at
both the national and state levels may improve CRC screening and early diagnosis in both
men and women (Dubé, 2018; Stock, Hoffmeister, & Brenner, 2018; White et al., 2018).
Using a comprehensive culturally sensitive and system-wide approach can be effective
for long-term CRC screening programs in Maryland. Increase in CRC screening rates are
essential to improve overall population health for the state. To increase rates across all
groups in the Maryland population CRC screening can be extended to both the insured
and the uninsured.
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Chapter 3: Research Method
Introduction
The purpose of this study was to improve understanding of CRC screening uptake
in Maryland by identifying factors that predict CRC screening use in the state. Previous
researchers found strong associations between sociodemographic factors, socioeconomic
factors, and CRC screening uptake in both small and large scale communities (Cross et
al., 2019; Simkin, Ogilvie, Hanley, & Elliott, 2019; De Moor et al., 2018; DeGroff et al.,
2018; Molina-Barceló et al., 2018; Rogers et al., 2017; Zhao, Okoro, Li, & Town, 2017).
Data for this study were obtained from the CDC BRFSS database. In this chapter, I
provide a detailed description of the research design and method, data access and
collection procedures, instrumentation and operationalization, threats to validity, and
ethical procedures for data collection.
Research Design and Rationale
This study utilized a quantitative, cross-sectional, descriptive design to analyze
secondary data collected from the BRFSS database. Quantitative designs are used to
count features and to examine statistically significant relationships between quantifiable
groups (Creswell & Creswell, 2018; Rudestam & Newton, 2015). Cross-sectional designs
are observational in nature and are assumed to have high reliability (McCusker &
Gunaydin, 2015) and higher methodological quality (Yang & Yu, 2018). Cross-sectional
designs are used to describe characteristics in a population, make inferences about
relationship between variables, and to gather preliminary information to support further
research (Creswell, 2014). The independent variables used in this study were age, sex,
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race/ethnicity, education level, household income, health insurance coverage, and access
to healthcare professional. Age, sex, and race/ethnicity were also used as covariates in the
statistical analysis. The outcome variable was CRC Screening Use (CRCSU). These
variables were important for this Maryland-based study because previous studies have
shown statistically significant (p < 0.001) relationships between them and CRC screening
participation and adherence to surveillance CRC screening guidelines (Cardoso et al.,
2019; Macrae, 2019; O’Leary et al., 2019).
A cross-sectional design was appropriate for this study to determine the factors
that predict CRCSU, because the BRFSS stores quantitative data with survey questions
on demographic and socioeconomic variables (Maryland BRFSS, 2018) that are specific
to the research topic and the outcome variable of this study. The overall strategy chosen
to logically integrate the different components of this study and to practically describe the
research problem, included the utilization of two RQs and several analyses that were
necessary to correctly address the RQs. The RQ and hypotheses that drive this study were
as follows:
1. Research Question 1 (RQ1): Is there any association between socioeconomic
status measured by education level, household income, and colorectal cancer
screening use among adults age 50–75 years in Maryland, after adjusting the
effects of age, sex, and race/ethnicity?
Null Hypothesis 1 (H01): There is no statistically significant association between
socioeconomic status measured by education level, household income, and
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colorectal cancer screening use among adults age 50–75 years in Maryland, after
adjusting the effects of age, sex, and race/ethnicity.
Alternative Hypothesis 1 (Ha1): There is a statistically significant association
between socioeconomic status measured by education level, household income,
and colorectal cancer screening use among adults age 50–75 years in Maryland,
after adjusting the effects of age, sex, and race/ethnicity.
The research design for this study provided a streamlined approach to answer
RQ1 with the focus to determine the relationship between the five independent variables
(age, sex, race/ethnicity, education level, household income) and the dependent variable,
CRCSU, and whether the covariates (age, sex, race/ethnicity) have a confounding effect
on the outcome or not. To answer RQ1, the categorical predictor variables were
manipulated by creating subgroups and coding of the variables for simplicity in the
analysis. Since there are more than one independent variable and a single nominal
dichotomous outcome variable, multiple logistic regression analysis was used to assess
associations between the predictor variables and the outcome variable, and to test the
hypothesis whether the odds ratio (OR) is statistically significant at 95% confidence
interval (CI) or not.
2. Research Question (RQ2) – Is there any association between access to preventive
health care service measured by health insurance coverage, access to health care
professional, and colorectal cancer screening use among adults age 50–75 years in
Maryland, after adjusting the effects of age, sex, and race/ethnicity?
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Null Hypothesis 2 (H02): There is no statistically significant association between
access to preventive health care service measured by health insurance coverage,
access to health care professional, and colorectal cancer screening use among
adults age 50–75 years in Maryland, after adjusting the effects of age, sex, and
race/ethnicity.
Alternative Hypothesis 2 (Ha2): There is a statistically significant association
between access to preventive health care service measured by health insurance
coverage, access to health care professional, and colorectal cancer screening use
among adults age 50–75 years in Maryland, after adjusting the effects of age, sex,
and race/ethnicity.
For RQ2, there are two predictor variables (health insurance coverage, access to
health care professional), three covariates (age, sex, and race/ethnicity) and one
dichotomous outcome variable (CRCSU). The research design of this study corresponds
to RQ2 in that, multiple logistic regression was applied to understand the functional
relationship between the identified predictor variables and CRCSU and to determine if
the covariate affect the probability of the outcome to change or not. The research design
also connects to RQ2 in that, analyses were performed to test the hypothesis whether the
OR is statistically significant at 95% CI or not.
The use of accessible secondary data was suitable for this study because it helps
to maximize the output of data collection efforts by eliminating the issue of time and
resource constraints, safeguards anonymity, and reduces cost that are consistent with
primary data collection and qualitative designs (Wickson-Griffiths et al., 2014). The
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design choice for this dissertation is consistent with current epidemiological research
designs as the most popular approach to enhance the overall efficiency of the health
research enterprise (Betge et al., 2017). The cross-sectional design is unique for this study
because the main concern of the dependent variable relates to peoples’ behaviors which
cannot be correctly conducted even in a well-controlled experimental design (McDonald,
2014). The quantitative design choice will also help to advance public health knowledge
in the discipline on CRC screening behaviors by utilizing the large data available in the
BRFSS database; necessary to inform the best strategic approach for designing and
implementing CRC screening programs in Maryland.
Methodology
This study utilized a quantitative methodology using secondary data from the
BRFSS database. Quantitative methodologies are useful to determine differences,
relationships and patterns between groups and to emphasize objective and precise
measurements of data collected from polls, questionnaires, and surveys (Rudestam &
Newton, 2015). The quantitative methodology allowed me to seamlessly perform
manipulations of the data using statistical techniques. Multiple logistic regression is the
best fitting and most relevant approach for this study because it produces a model that
shows how the predictor variables affect the probability of the outcome variable, and
covariates can be tested using the model. The rest of this chapter include details of how I
implemented my design and specific procedures used to upload my data, manage the
dataset and analyze the data to address the research problem.
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Target Population
CRC is rare in children and adults less than 45 years of age, and common among
adults 45 years of age and older (Bibbins-Domingo et al., 2016). Based on the United
States Preventive Service Task Force (USPSTF) guidelines on CRC screening for
average-risk individuals; the target population for this study is males and females aged
50–75 years, resident in Maryland and respondents of the BRFSS survey of 2014, 2016
and 2018, the most recent available CRC screening data of Maryland. This population is
suitable for my research because evidence from the literature shows that the selected
variables are associated to the likelihood to adhere to CRC screening schedule (Liang &
Dominitz, 2019; O’Leary et al., 2019); with minority groups highly disadvantaged to be
compliant with routine CRC screening programs (Cross et al., 2019; Bernardo et al.,
2018). Based on the BRFSS survey questionnaire, the target population included both
males and females, ages 50–75. To compensate for missing data, incomplete
questionnaires, and any potential sampling bias, the target population size for this study
was 6641 respondents of the BRFSS survey of 2014, 2016, and 2018.
Sampling and Sampling Procedures
Sample Size
The sample size for this study was calculated using the design-based input mode
of G*Power statistical power analysis software. The G*Power software is preferred
because it is a flexible stand-alone tool to assess a variety of popular statistical tests used
in social and behavioral research (Faul, Erdfelder, Lang, & Buchner, 2007). G*Power
allowed me to choose the preferred effect size, alpha, and power.
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Effect Size and Power Analysis
The power of a statistical test determines the viability of the null hypothesis (H0)
and is used to calculate the probability of detecting an effect such that by using the test,
the H0 will be rightly rejected if the alternative hypothesis (Ha) is true (Mudge, Baker,
Edge, & Houlahan, 2012). According to Ellis (2010), the effect size can be small,
medium or large depending on what is being investigated. Large effect size with a
significant p-value indicates a strong relationship between the measured variables; while
a small effect size shows that even with a significant p-value the relationship between the
measured variables may not be significant (Ellis, 2010). A medium effect size provides
an average but consistent effect to identify and illustrate any association between
variables in the sample under study (Mudge, Baker, Edge, & Houlahan, 2012).
In epidemiological studies, the level of statistical significance (alpha) is the level
of error allowed for the test to reject a true hypothesis (Frankfort-Nachmias, & Nachmias,
2015). The alpha (α) value (p-value) which ranges from 0 to 1 plays a key role in
determining the point to reject or accept a H0 (Frankfort-Nachmias, & Nachmias, 2015).
Traditionally a p-value >.05 means the H0 is accepted and the result is statistically not
significant; and a p-value <.05 means the H0 is rejected and the result is statistically
significant (Frankfort-Nachmias, & Nachmias, 2015).
High power tests minimize type II errors in the results; but require a larger sample
size (Ellis, 2010). Consistent with the power level used by most researchers, I used 80%
power level to determine sample size in this study, because it reduces the probability of
type II error and gives me enough leverage to attain an appropriate sample size for the
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scope of this study. Using an adequate sample size improves confidence in applying the
result to the general population (Amawi, Ashby, & Tiwari, 2017).
To calculate an adequate sample size for this study, linear multiple regression
with respect to the F test and the A priori power analysis in G*Power was used. The
G*Power inputs were set at medium effect size of 0.15, α err prob of 0.05, and power (1β err prob) of 0.80 with 7 predictors. Using these tests statistics, G*Power calculated a
sample size of 103 needed to achieve 80% power level. A post-hoc power analysis was
conducted and the G*Power output showed that, knowing my effect size, α, and sample
size, I achieved 100% power at 3126 participants. In this study, I used a sample size of
3134 to justify empirical validity of the results from my analysis. This large sample size
is significant because it represents data from all 24 counties in Maryland, and accounts
for any potential bias, or any other limitations in data collection.
Procedures for Data Collection
In this study secondary data from the BRFSS was used for statistical analysis.
Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance
System
The CDC BRFSS was established in 1984 with 15 states as the premier system of
health-related telephone surveys, that collect data from U.S. residents on health-related
risk behaviors, chronic conditions, and use of preventive services (CDC, 2014).
Currently, the BRFSS collects data from more than 400,000 adult interviews each year
from all 50 states, the District of Columbia and three U.S. territories; making it the largest
ongoing health survey system in the world (CDC, 2017). By collecting and storing
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behavioral risk data across state and local levels, the BRFSS has become a robust tool
used by public health professionals to target and build health promotion activities (CDC,
2014). Currently, there is a wide demand and sponsorship of the BRFSS survey for states,
other CDC centers and US federal agencies (CDC, 2017).
Maryland Behavioral Risk Factor Surveillance System
The Maryland BRFSS was established and made available in 1995 with a typical
overall annual sample size of 13,000 non-institutionalized Maryland residents aged 18
years and older (Maryland Department of Health and Mental Hygiene MDH, 2019).
Under the CDC sponsorship and guidance, the MDH conducts statewide BRFSS surveys
each year on many topics including the use of preventive services, and elements that
affect chronic diseases (MDH, 2019). The Maryland BRFSS telephone-based disease
surveillance program is designed to collect annual data, maintain, manage and store
extensive state-specific data to estimate the behaviors, and conditions on many healthrelated risk factors such as nutritional habits, tobacco use, cancer screening behaviors and
survivorship that may have public health consequences in Maryland (MDH, 2019).
Data from the Maryland BRFSS is typically used by the MDH for public health
programs, local health departments, universities, and research organizations to assess
needs, plan and evaluate programs, apply for funding, and to inform state public health
policy (MDH, 2017). All Maryland BRFSS data from 1995 to present are publicly
available on the Maryland BRFSS website and the Maryland IBIS website (MDH, 2019).
Estimates from the Maryland BRFSS are weighted by State population and includes
county level data tables as well as industry and occupation health indicators for the state
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(Smith et al., 2019). Examples of results that have been disseminated using data from the
Maryland BRFSS include findings from the 2016 six nationally-recognized disability
status questions on disability and chronic health conditions among Maryland adults
(Maryland BRFSS, 2018). The results revealed that 21.6% of Maryland adults have one
or more disability ranging from cognitive disability (8.8%), mobility disability (11.4%),
vision disability (3.1%), hearing disability (4.1%), self-care disability (2.6%), and 5.7%
with an independent living disability (Maryland BRFSS, 2018). The 2018 BRFSS briefs
also revealed findings on prediabetes (volume 1); hypertension and cognitive decline
among older adults in the State (volume 2).
A benefit of using the BRFSS database for this study is that the data are readily
available for research use, and the BRFSS analysis tool has options to download data in a
format that is compatible with the IBM Statistical Package for the Social Science (SPSS)
software used for analyses in this study. More also, the BRFSS tool allowed me to
seamlessly generate simple descriptive statistics such as frequencies and cross-tabulation
which are appropriate for my quantitative methodology. The BRFSS is the best source of
data for this study because it is based on large sample sizes of statewide survey that are
representative of the Maryland population (Maryland BRFSS, 2018).
Procedure for Data Access and Collection Process
Data used for this study is publicly available. Permission to access the dataset and
approval to conduct this study was granted by the Walden University’s Institutional
Review Board (IRB) with approval number 02-25-20-0678352. After receiving IRB
approval, data was extracted following Walden IRB guidelines. Since the data were
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readily available, there are no specific collection methods; except that datasets were
uploaded from the database, saved on my computer and reloaded into SPSS for analysis.
An advantage of using secondary data is that it is easily accessible and requires less time
to gather data, thereby expediting the data collection phase and strengthen the research
project (Boyd et al., 2015).
Instrumentation and Operationalization of Constructs
Instrument & Materials
I used the 2014-2018 datasets from the CDC BRFSS database for this study. The
BRFSS survey questions do not distinguish between a diagnostic or a screening test for
CRC. However, the BRFSS surveys questions related to CRC screening use are asked in
ways such as (1) Have you had one or more of the USPSTF recommended CRC tests
within the recommended time interval? (2) If “Yes,” “When was your last test?” (CDC,
2014). BRFSS survey questions about access to a health care professional, are usually
asked like, “Do you have one person you think of as your personal doctor or health care
provider?” If “No”, Is there more than one or is there no person who you think of as your
personal doctor or health care provider? (CDC, 2018). The BRFSS provide invaluable
health information at national, state and local levels that are comparable to those of other
survey instruments (Nelson, Powell-Griner, Town, & Kovar, 2003).
There is evidence that supports BRFSS validity with high survey response rates
compared to estimates from other national health survey instruments such as the National
Health Interview Survey (NHIS) and the National Health and Nutrition Examination
Survey (NHANES) on multiple topics of health risk behavior (Zhang et al., 2014;
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Pierannunzi, Hu, & Balluz 2013). According to Pierannunzi, Hu, & Balluz (2013)
limitations of the BRFSS compared to the NHANES and the NHIS instruments could be
due to differences in the mode of data collection. However, the BRFSS is a reliable and
highly reputable source of data for many health surveys and provides anonymous CRC
screening data by age, sex, race/ethnicity, education level completed, household income,
health insurance coverage, and access to a health care professional (MDH, 2018); which
are necessary to estimate associations in this study. To maximize the output of data
collection and to enhance the overall efficiency of this research, I assessed more variables
than those strictly needed to verify my hypotheses. Considering the reliability of BRFSS
data, and mindful of the fact that an objective of this study is to utilize secondary data, no
new instrument, device, or tool was developed for this study.
Validity and Reliability of Behavioral Risk Factor Surveillance System Data
Researchers have examined the reliability and validity of the instrument used in
BRFSS measurements and the system’s capability to provide valid national estimates and
multiple assessments across states. Consistent across many studies, the validity and
reliability of the BRFSS survey compared to the NHIS and the NHANES reveals high
participation rates and similar estimates for several outcome measures including cancer
screening, coronary heart disease, and stroke (Leung et al., 2015; Towle, Tolliver, Bui,
Warner, & van Dyke, 2015; Silva, 2014; Pierannunzi, Hu, & Balluz, 2013); obesity,
smoking, hypertension, diabetes, and lack of health insurance coverage as barriers to
medical care (Moore et al., 2015; Zhang et al., 2015; Skopec, Musco, & Sommers, 2014;
Pierannunzi, Town, Garvin, Shaw, & Balluz, 2012). For example, the validity and
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reliability of BRFSS survey instrument was tested by using the 2008–2015 data from the
NHIS, NHANES and BRFSS databases, to examine CRC screening measurements on
individuals aged 50–75 years with health insurance coverage, and results showed a higher
(88.4%) survey respond rate for the BRFSS compared to the NHIS and NHANES survey
instruments (De Moor et al., 2018). By using the BRFSS survey instrument to evaluate
the test-retest reliability and validity of stool-based and endoscopic CRC screening tests
over 2-week, 3-month, and 6-month intervals, Vernon et al., (2008) found that at the end
of the validation survey, the test-retest reliability assessment showed high participation
rates across all three survey modes; face-to-face and telephone (99%), and mail (98%).
The CDC’s Division of Cancer Prevention and Control has analyzed BRFSS data
for several publications in the Morbidity and Mortality Weekly Report (MMWR) and
report age-adjusted estimates for specific cancers by age groups (CDC, 2014). Evidencebased findings from epidemiological researches, show that BRFSS data are collected
using new methods of weighting, and multiple modes of data collection that include,
mail, cell and landline telephone, face-to-face survey and by mailing follow-up surveys
(CDC, 2014, Qayad et al., 2013). The validity and reliability of BRFSS survey suggest
that the instrument can classify groups of adults into levels recommended and defined by
Healthy People 2010 (Yore et al., 2007). It is reassuring from the literature that there is
consistency and similarity between the BRFSS, NHANES and the NHIS estimates of key
health indicators, as defined by Healthy People 2020 (CDC, 2014). This study provides
empirical support for the proposition that the reliability and validity of self-reported
survey instrument such as the BRFSS is a reliable source of data (MDH BRFSS, 2018).
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Study Operational Variables
In epidemiological quantitative research design, operationalization is the process
of precisely defining the variables used into measurable factors (Allen, 2017). I used six
independent and one dependent variable for the main analysis in this study, and two of
the predictor variables as potential covariates. All variables were collected from the
BRFSS public data files of 2014, 2016, and 2018. No variable was calculated. The
independent variables and covariates were assessed based on the needs of this study and
their importance as potential predictors of CRCSU in Maryland.
Independent Variables
Education level completed. Corresponds to the highest level of education
completed by the respondent. assessed as an indicator of socioeconomic status, and
measured as a categorical variable and coded as 1 = did not complete high school, 2 =
completed high school, 3 = some college or technical school, 4 = college graduate.
Household income. Corresponds to individuals’ total annual household income
from all sources in dollar amounts. Also assessed as an indicator of socioeconomic status;
measured as a categorical variable and recoded as: 1 = $0–<$35,000 (low-income), 2 =
$35,000–<$75,000 (middle-income), and 3 = $75,000 or more (high-income).
Health insurance coverage. Corresponds to the primary source of a person’s
health care coverage. Assessed as a succor to using preventive health care services;
measured as a categorical variable and coded as: 0 = other health insurance plan, 1 =
private plan, 2 = public plan.
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Access to healthcare professional. Corresponds to the BRFSS survey question
of whether a respondent has one, or more than one person considered of as his personal
doctor or health care provider. Assessed as a source to using preventive health care
service; measured as a categorical variable, recoded as 0 = no health care professional, 1
= one health care professional; 2 = more than one health care professional.
Dependent Variable: Colorectal cancer screening use.
This variable corresponds to the BRFSS survey question of whether respondents
have fully met the USPSTF recommendation by receiving one or more of the CRC
screening test within the recommended time interval or not. This variable was measured
as a dichotomous variable and recoded as coded as: 0 = did not fully meet the USPSTF
recommendation; 1 = fully meet the USPSTF CRC screening recommendation.
Covariates
Age. The categorical age variable corresponds to an individual’s age, with values
ranging from 50–75 years based on the USPSTF CRC guidelines for average-risk
individuals. The age variable was stratified to three subgroups; 50–59, 60–69, and 70–75.
Sex. Sex as a biological variable is based on the BRFSS definition of male and
female; measured as a categorical dichotomous variable; M = male; F = female.
Race/ethnicity. Corresponds to an individual’s race or ethnicity; measured as a
nominal categorical variable and coded as; 1 = white, 2 = black, 3 = Asian, 4 = Hispanic,
5 = other. The race/ethnicity values of multiracial, Native Hawaiian, and American
Indian, were recoded as “Other,” because there was not enough of these race groups to
warrant a regression.
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Data Analysis Plan
Statistical Analysis Plan
The data analysis plan for this study on the relationship between age, sex, race,
education level, income, health insurance coverage, access to health care professional,
and CRC screening use (CRCSU) in Maryland includes, the BRFSS data dictionary
which helped me to understand the data items, variable types, categories, permissible
values and level of measurement used in the analysis to address the research questions
and hypotheses (Statistics Solution, 2019). The dataset, the statistical tests, and the
software used for analysis are also included in this data analysis plan. I did not create the
dataset, all variables that I used to answer my research questions were collected from the
BRFSS database. The data analysis plan for this study identifies with Kamin’s (2010)
five steps procedure for analyzing inferential statistics.
1. The null (H0) and alternative (Ha) hypotheses statements.
2. The test to determine the proper statistical test.
3. The decision rule, degrees of freedom (df) and the region of rejection.
4. The statistical results based on the calculated test statistic.
5. Interpretation of the results using the p-value. Details of steps 4 and 5 are
discussed in chapter 4.
All data manipulation and statistical analyses were conducted using SPSS version
25 software. Data from the BRFSS was uploaded by survey years 2014, 2016, and 2018,
and reloaded into SPSS. The dataset files were merged into one dataset file in SPSS and
used for all analyses to answer my research questions. Researchers have pointed that
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including missing data in the data analysis can reduce the statistical power, produce
biased estimates of parameters, reduce the representativeness of the sample, and may
complicate the analysis, leading to invalid conclusions from the study (DeCrane et al.,
2013; Kang, 2013). Since this study assumed that the causes of missing data are not
controlled by the dependent variable (missing data at random), cases with missing
observations from the dataset file were excluded from my analysis. Descriptive statistics
including frequency distribution of each distinct variable and category were conducted to
show the characteristics of the study population (Marshall, & Jonker, 2010). Results from
the descriptive analysis clearly indicated how missing data were handled.
Graphical representation of the data was examined for normality and skewness;
although emphasis was not placed on the distribution and shape of the data, because the
multiple logistic regression model used is a generalized model that is distribution-free
(McDonald, 2014). Based on the categorical variables used, the research questions and
hypotheses, the nonparametric Pearson chi-square test of independence was used to check
the appropriateness of the model (Kamin, 2010) and to test the assumption that the
multiple logistic regression model fits the data, by comparing the observed cases with the
expected ones. The Pearson chi-square test was conducted with the assumption that all
observed frequencies are equal in proportion; and the “expected” counts were calculated
under the assumption that the null hypothesis (H0) is true. The Pearson chi-square test
generated the chi square value, the degrees of freedom (df), and the statistical
significance measured by the p-value. The alpha (α) level showed how extreme the result
of the test for significance must be to reject or retain the H0 (Taylor, 2017). Hypothesis
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testing was two-sided with an alpha of .05, and a 95% CI for statistical comparisons
across groups.
For inferential statistics, multiple logistic regression analyses were performed to
determine the associations, test statistical significance, and to identify the variables that
predict the likelihood for individuals 50–75 years to fully meet the USPSTF CRC
screening recommendation or not. Multiple logistic regression analysis is appropriate for
this cross-sectional design, because there are multiple predictor variables and a single
dichotomous nominal outcome variable (McDonald, 2014). The SPSS calculated Exp(B)
values in the logistic regression model represents the OR used to determine the likelihood
to fully meet the CRC screening recommendation. The Wald statistics was used to
determine whether the beta (β) for any of the predictor variable in the model is
significantly different from zero or not (Field, 2013).
The decision rule for all analyses was that, where the test statistic was in the
region of rejection, the H0 was rejected; indicating a type I error (Kamin, 2010). The df
was assessed based on k - l, where k is the number of participants (Kamin, 2010).
Hypothesis testing was two-sided and statistical significance determined by α level of
0.05. A 95% CI was used for statistical comparisons across groups. Where the p = .000, I
interpreted as p < .05 and rejected the H0 that there is no statistically significant
association between the independent and the dependent variable. Likewise, where p > .05
indicating non-significance, I accepted the H0, implying that the prediction does not differ
significantly and if any difference exists, it was probably due to chance.
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Analytical Techniques to Answer Research Questions
The research questions (RQ) and hypotheses (H01 and Ha1) used for analysis were:
1. RQ1. Is there any association between socioeconomic status measured by
education level, household income, and colorectal cancer screening use
among adults age 50–75 years in Maryland, after adjusting the effects of age,
sex, and race/ethnicity?
H01. There is no statistically significant association between socioeconomic
status measured by education level, household income, and colorectal cancer
screening use among adults age 50–75 years in Maryland, after adjusting the
effects of age, sex, and race/ethnicity.
Ha1. There is a statistically significant association between socioeconomic
status measured by education level, household income, and colorectal cancer
screening use among adults age 50–75 years in Maryland, after adjusting the
effects of age, sex, and race/ethnicity.
The variables to be analyzed to answer RQ1 are:
Age. Age is a predictor variable collected as a categorical variable measured in
years ranging from 50–75 years. To control for the wide age difference between 50 and
75 years, the age variable was stratified into three subgroups for men and women, and
recoded as: 1 = 50–59 years, 2 = 60–69 years, and 3 = 70–75 years. Frequency
distribution was conducted to see if there was a small or wide dispersion in the
measurement of age groups, and to determine the smallest and largest number and
percentage of cases in each age group to be used for analysis. The Pearson chi-square test
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of independence was conducted to examine if there is a statistically significant
relationship between age and CRCSU. Since the dependent variable is dichotomous,
binary logistic regression analysis was performed to test for association and to determine
the odds of age to predict CRCSU when all the variables are in the model. The Wald
statistics from the logistic regression model was used to determine whether the β for any
of the predictor variables in the model was significantly different from zero or not. The
“Decision Rule” for this analysis was that, if the test statistic is in the region of rejection,
the H0 was rejected. Where p < .05 the null hypothesis (H0) was rejected and the
alternative (Ha) retained. The degrees of freedom (df) was assessed based on k - l, where
k is the number of participants (Kamin, 2010). Hypothesis testing was two-sided and
statistical significance was determined by α of .05. A 95% CI was used for statistical
comparisons across groups.
Sex. Sex is a predictor variable measured as a dichotomous variable
(male/female). The frequency distribution for sex was performed to assess and exclude
missing data, and to determine the number and percentage of samples to be used for
analysis. Sex values such as don’t know/not sure or refused were removed from the
analysis. The Pearson chi-square test of independence was performed to test the statistic
and to check the appropriateness of the model used to examine if there is a statistically
significant relationship between sex and CRCSU under the assumption that the H0 is true.
A binary logistic regression analysis was performed to assess the association between sex
and CRCSU when all the variables are in the model. The OR value in the logistic
regression model was used to determine the change in the odds of CRCSU based on a
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change in sex. For this analysis, where p < .05 the H0 was rejected and the Ha accepted;
where p > .05 the H0 retained and the Ha forgone. The df was assessed based on k - l,
where k is the number of participants (Kamin, 2010). Hypothesis testing was two-sided
and statistical significance was determined by α level of .05, at 95% CI.
Race/ethnicity. Race/ethnicity is a predictor variable measured as a nominal
categorical variable and stratified into five subgroups to account for a discrete
comparison between the groups. I recoded the race/ethnicity variable as: 1 = white, 2 =
black, 3 = Asian, 4 = Hispanic, 5 = other. The frequency distribution was performed to
assess and exclude missing data, and to determine the number and percentage of cases to
be used for analysis. Race/ethnicity values of don’t know/not sure or refused were
removed from the analysis. Values of multiracial, native Hawaiian, and American Indian,
were recoded as “Other,” because there was not enough of each of these race groups to
warrant a regression. Stratified random sampling approach was used to ensure an equal
probability of selecting cases from all race/ethnicity groups.
The Pearson chi-square test of independence was performed to test the statistic
and to check the appropriateness of the model used in the logistic regression. A binary
logistic regression analysis was conducted to test for associations between race/ethnicity
and CRCSU, and to determine the odds of race/ethnicity to predict CRCSU when all the
variables are in the model. The OR values in the logistic regression model was used to
determine the likelihood to fully meet the CRC screening recommendation based on race
group. The Wald statistics was used to determine whether the β of any of the
race/ethnicity subgroup was significantly different from zero or not. The decision rule
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here is that, if the test is in the region of rejection, the H0 was rejected. Where p > .05 the
H0 that there is a statistically significant association between race and CRCSU was
retained and the Ha forgone. Likewise, where p = .000, I interpreted as p < .05 and
rejected the H0 and the Ha retained. The df was assessed based on k - l, where k is the
number of participants (Kamin, 2010). Hypothesis testing was two-sided at 95% CI.
Education level completed. Education level is a predictor variable measured as a
categorical variable and recoded as: 1 = did not complete high school, 2 = completed
high school, 3 = some college or technical school, 4 = college graduate. Frequency
distribution for the education level variable was obtained to get the sum of responses for
each subgroup to be used in the analysis. The Pearson chi-square test of independence
was performed to test the statistic and to check the appropriateness of the model used to
examine association between education level completed and CRCSU under the
assumption that the H0 is true.
A binary logistic regression analysis was conducted to test the association, and to
determine the odds of education level to predict CRCSU. The OR values from the logistic
regression model was used to determine the likelihood to fully meet the CRC screening
recommendation based on the level of education completed. The Wald statistics showed
whether education level made a significant contribution to the model or not. The decision
rule here is that, where p < .05 the H0 that there is no statistically significant association
between education level completed and CRCSU was rejected. Likewise, where p = .000,
I interpreted as p < .05 and rejected the H0 as well. If the test statistic is not in the region
of rejection, the H0 will be accepted. The df will be assessed based on k - l, where k is the
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number of participants (Kamin, 2010). Hypothesis testing will be two-sided and
statistical significance will be determined by α level of 0.05 at 95% CI.
Household income. Household income is a predictor variable measured as a
categorical variable and stratified into three subgroups, coded as: 1 = $0-<$35,000 (lowincome), 2 = $35,000-<$75,000 (middle-income), and 3 = $75,000 or more (highincome). Frequency distribution was performed to determine the number and percentage
of samples for each income group to be used for analysis. The Pearson chi-square test of
independence was performed to test the statistic and to check the appropriateness of the
model under the assumption that the H0 is true. A binary logistic regression analysis was
conducted to test for associations and to determine the odds of income level to predict
CRCSU. Additionally, age group, sex, and race/ethnicity variables were used as
covariates to test for effect modification in this model. The OR values from the logistic
regression model was used to determine the likelihood to fully meet the CRC screening
recommendation based on income level. The Wald statistics was used to determine
whether any income level model made a significant contribution to the model or not. The
decision rule here is that, where p > .05 the H0 was accepted and the Ha forgone.
Likewise, where p = .000, I interpreted as p < .05 and rejected the H0 that there is no
statistically significant association between income level and CRCSU. The df was
assessed based on k - l, where k is the number of participants (Kamin, 2010). Hypothesis
testing was two-sided at 95% CI.
CRC screening use (CRCSU). CRCSU is the outcome variable measured as a
categorical dichotomous variable coded as 0 = did not fully meet the USPSTF CRC
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screening recommendation, and 1 = fully meet the USPSTF CRC screening
recommendation. A single outcome variable was used in this study to answer the RQs.
For all variables, the Pearson chi-square test of independence was used to test the
hypotheses, and to determine the chi-square value, degrees of freedom for both the row
and the column variables, and the p-values at 95% CI. A relationship exists between the
variables when the H0 is rejected and the Ha is accepted (Statistics Solutions, 2019).
Since both the predictor and the outcome variables in this study are categorical, the nonparametric Pearson chi-square test of independence was appropriate to test the statistics,
and the “expected” counts calculated under the assumption that the H0 was true. Findings
from this study can be used for suggestions about which predictor variables have a major
effect on CRC screening rates in Maryland.
2. RQ2. Is there any association between access to preventive health care service
measured by health insurance coverage, access to health care professional, and
colorectal cancer screening use among adults age 50–75 years in Maryland,
after adjusting the effects of age, sex, and race/ethnicity?
H02. There is no statistically significant association between access to
preventive health care service measured by health insurance coverage, access
to health care professional, and colorectal cancer screening use among adults
age 50–75 years in Maryland, after adjusting the effects of age, sex, and
race/ethnicity.
Ha2. There is a statistically significant association between access to
preventive health care service measured by health insurance coverage, access
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to health care professional, and colorectal cancer screening use among adults
age 50–75 years in Maryland, after adjusting the effects of age, sex, and
race/ethnicity.
Health insurance coverage. Health insurance coverage is a predictor variable
collected and measured as a categorical variable, and recoded as: 0 = other health
insurance plan, 1 = private health insurance plan, 2 = public health insurance plan. The
“other health insurance plan” subgroup was used as the reference category for
comparison relative to private purchased plan and public health insurance plan. Health
insurance plans of TRICARE, Tribal Health Services or health insurance from some
other source were grouped as “Other plan” because there was not enough of each of these
groups to warrant a regression. More also, individuals with health insurance plans such as
TRICARE and Tribal Health Services are less likely to participate in surveillance CRC
screening programs (DeMoor et al., 2018). Frequency distribution was performed to
determine the number and percentage of samples to be used for analysis.
The Pearson chi-square test of independence was performed to test the statistic
under the assumption that the H0 is true. A binary logistic regression analysis was
performed to determine if there is a statistically significant relationship between health
insurance coverage and CRCSU. The OR was used to determine the likelihood to fully
meet the CRC screening recommendation based on health insurance plan. The Wald
statistics was used to determine whether the health insurance coverage variable made a
significant contribution to the model by assessing the β value. The decision rule here was
that, where p = .000, I interpreted as p < .05 and rejected the H0 that there is no
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statistically significant association between health insurance coverage and CRCSU.
Likewise, where p > .05 the H0 was accepted and the Ha rejected. The df was assessed
based on k - l, where k is the number of participants (Kamin, 2010). Hypothesis testing
will be two-sided and statistical significance was determined by α level of 0.05. A 95%
CI was used for statistical comparisons across groups.
Access to healthcare professional. Access to healthcare professional is a
predictor variable collected and measured as a categorical variable, and recoded as 0 = no
health care professional, 1 = access to one health care professional; 2 = more than one
health care professional. Frequency distribution was performed to determine the number
and percentage of samples to be used for the analysis. The Pearson chi-square test of
independence was performed to test the statistic and to check the appropriateness of the
model used to examine if there is a statistically significant relationship between access to
healthcare professional and CRCSU under the assumption that the H0 is true.
A binary logistic regression analysis was performed to determine if there is a
statistically significant relationship between access to healthcare professional and
CRCSU. Additionally, age group, sex, and race/ethnicity variables were used as
covariates to test for effect modification in this model. The OR was used to determine the
likelihood to fully meet the CRC screening recommendation based on the number of
healthcare professional that an individual has access to. The Wald statistics was used to
determine whether access to healthcare professional made a significant contribution to
the model. The decision rule here was that, where p = .000, I interpreted as p < .05 and
rejected the H0 that there is no statistically significant association between access to
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healthcare professional and CRCSU. Likewise, where the p > .05 the H0 was retained and
the Ha forgone. The df was assessed based on k - l, where k is the number of participants.
Hypothesis testing was two-sided and statistical significance was determined by α level
of .05 at 95% CI for statistical comparisons across groups.
For both RQs, statistical analysis included a descriptive analysis of the variables,
the chi-square test of independence to test the appropriateness of the models and multiple
logistic regression analyses to determine associations. Additionally, age group, sex,
race/ethnicity variables were used as covariates to test for confounding effects on the OR
between the independent and the dependent variable. Except for sample size calculation
that was done using the G*Power software, all statistical analyses were conducted using
IBM SPSS version 25, following steps outlined by Merlo, Wagner, Austin, Subramanian,
& Leckie, (2018). According to Field (2013), the result of the Wald statistics in logistic
regression indicates whether the predictor variable makes a significant contribution to the
outcome occurring or not.
An OR greater than one indicates that the odds of the outcome occurring increases
as the predictor variable changes; while an OR value less than one signifies that the odds
of the outcome occurring decreases as the predictor increases or changes (Field, 2013).
The results of these analyses are reported as OR for simplicity. Conclusions are based on
the OR because failing to reject the H0 under the constraints of committing a Type I or
Type II error, is a better decision than simply accepting the H0 (Kamin, 2010). Results of
the analyses for this study are presented in chapter 4. Also, an objective assessment, and
cautious interpretation of the results are presented in chapter 5.
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Rationale for Using Specific Statistics
The goal of this study is to assess the predictive relationship between multiple
categorical variables and a dichotomous outcome variable. The five-step data analysis
plan stands as a unified entity that will allow me to follow a procedure for all the
statistical tests to be used in this study. Descriptive statistics helped me to assess if there
are trends within different groups and CRCSU or if perhaps age, or race/ethnicity are
predictors for Marylanders to participate in CRC screening programs. Multiple logistic
regression technique used for the inferential statistics is appropriate because it is used to
assess the relationship between multiple predictors and an outcome variable (Betge et al.,
2017); and to determine if the characteristics of the variables differ by a statistically
significant margin (McDonald, 2014). The model has been used in multiple scientific and
epidemiological research that examined demographic and socioeconomic factors
affecting the use of preventive health behaviors such as CRC screening uptake, across
several small- and large-scale populations (Cardoso et al., 2019; Doubeni et al., 2019).
Also, by using multiple logistic regression analysis, I was able to control for imbalanced
characteristics identified in the descriptive analysis, and identify outliers (Weedmark,
2018). Hence the research problem and findings from these analyses stand as a distinctive
unit of thought and effort.
Threats to Validity
In epidemiological studies validity refers to accuracy and the absence of bias in
the research (Szklo, & Nieto, 2014). A threat to the validity is anything that causes a shift
from an accurate result (Szklo, & Nieto, 2014). The validity of the inferences made from
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a study therefore, depends on the accuracy of the research method and procedures
(Alexander, Lopes, Ricchetti-Masterson, & Yeatts, 2016). To maximize the validity of a
study, threats to external, internal and construct validity must be minimized as much as
possible (Frankfort-Nachmias et al., 2015). If threats to validity are not given proper
consideration, they can either underestimate or overestimate the true effect or association
between variables. The following are potential threats to validity in this study.
Threats to External Validity
External validity is the degree to which the results from a study can be
generalized to other groups not studied (Boyd et al., 2015). A potential threat to external
validity from this study is that of recall bias (Cutts, Izurieta, & Rhoda, 2013; Taylor et al.,
2013). Respondents to the BRFSS survey could have provided answers based on their
ability to recall past events and do not recall if they had ever received CRC screening.
Secondly, respondents are mostly those in CRC surveillance screening programs; hence
those who are not in the surveillance program, and may have received CRC screening for
other reasons may not be accounted for in this study, which limits the generalization of
the results to the entire Maryland population.
However, to minimize potential threats to external validity and improve the
strength of the results, I used a research method that precludes minimal exclusion criteria,
using data from a more natural setting as the original data is from surveys conducted
specifically for the Maryland population. Also, potential threats to external validity where
minimized by using a large sample size, medium effect size, and a 95% CI for the sample
size calculation (Sullivan, & Feinn, 2012). Social desirability bias was minimized by
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using the most recent data from the validated BRFSS database. Hence this is a pragmatic
research with high external validity.
Threats to Internal Validity
Internal validity is the extent to which the study outcome is explained by the
effects of a predictor variable on the outcome variable and not by any manipulation of the
predictor variable or any other factor (Cuncic, 2019; Mcleod, 2013). Threats to internal
validity affect the reliability of the study results, which may include instrumentation bias,
statistical errors and differential selection (Frankfort-Nachmias et al., 2015). According
to Creswell, (2014), an experimental study is the only way to control for threats to
internal validity. Hence a potential threat to internal validity in this study is due to
limitations from the use of secondary data and a non-experimental design. To minimize
potential threats to internal validity I used the most appropriate descriptive statistics
(frequency distribution), and inferential statistics (multiple logistic regression) to estimate
parameters and determine associations.
Threats to construct validity is the ability of a test to measure what it was meant to
measure (Frankfort-Nachmias et al., 2015; McLeod, 2013). In this study, threats to
construct validity were minimized by using the Pearson chi-square test of independence,
which has shown valid and reliable results to a test statistic (Frankfort-Nachmias et al.,
2015). A valid study is one whose results are based on the most appropriate research
design and methodology that produces results that are close to the truth (Knottnerus, &
Tugwell, 2014). This research is considered a valid study because an extensive literature
review was carried out to ensure the degree to which bias was prevented in other studies,
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and the degree to which the most appropriate study design and statistical tests were
implemented (Althubaiti, 2016; Pannuucci & Wilkins, 2010).
Ethical Procedures
Ethical challenges with epidemiological studies include issues of data access,
privacy, confidentiality, informed consent, reporting of research results and findings,
commercialization, benefit-sharing, and the possibility of discrimination (Chanda-Kapata
et al., 2015; van der Heide, Uiters, Schuit, Rademakers, & Fransen (2015). Considering
that the secondary data used for this study is freely available on the BRFSS database, no
concern or issues with privacy is expected because respondents must have signed consent
documents as to the use of their data for future research (Ehrenstein et al., 2017). Hence
permission for further use is implied (Chanda-Kapata et al., 2015). Since no new
instrument or survey question was developed for this study, I expect to have only limited
to no ethical concerns in conducting this research.
Potential Risk to and Protection of Participants
Since this study employed secondary data, there is no risk to participants’
involvement and relatively fewer risks for Institutional Review Board (IRB) concerns
(Walden University, n.d.). However, appropriate ethical procedures and standards were
upheld throughout the conduct of the study. All efforts were made to protect the rights of
respondents by using Walden’s quantitative checklist and strictly following Walden
University’s IRB guidelines. Walden’s IRB approval was obtained before data collection.
It is understood that data from the BRFSS survey are protected and respondents are
guaranteed that their personal information is kept confidential (MDH BRFSS, n.d.).
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However, ethical issues related to participants’ confidentiality and anonymity of data
were upheld by protecting and storing the uploaded data electronically to maintain data
integrity. Only me as the primary researcher and potentially my committee chair has
access to the data. More about data coding is discussed in chapter 4.
Transparency and ethical judgment was followed at all stages of the research
process; from data collection to analysis; and a careful interpretation of the results, being
mindful of any potential contractual obligations between the data owners and myself. The
results of this study may be disclosed to the MDH. For this dissertation, ethical integrity
began with understanding the research process and working closely with Walden IRB for
guidelines on ethical issues surrounding secondary data collection on CRC research.
However, no data were collected, viewed or analyzed without IRB approval for me to do
so. The original data will be destroyed after I successfully defend my research following
guidelines from the Walden’s Center for Research Quality.
Summary
In this chapter, I described the research design (cross-sectional descriptive) and
methodology used to determine predictors of CRC screening use in Maryland. I also
described the procedures used to determine the sample size within a quantitative
methodology, from a secondary dataset file. Reliability and validity of BRFSS survey
instrument was also discussed in this chapter. Self-reporting bias and social desirability
bias was minimized by using the most recent data from the validated BRFSS database
(MDH, 2018). The independent, dependent, covariate variables, and their levels of
measurements were provided. I also provided information on how data were cleaned and
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manipulated for analyses as well as the descriptive and inferential statistics used to
determine the associations between the predictor variables, and the outcome variable. I
explained how the Pearson chi-square test of independence was used as a test statistic,
with medium effect size of .15, alpha (α) 0.05, power (1-β) of 0.80 at 95% CI. The data
analysis plan was described in the methodology section. I also described the potential
threats to external and internal validity, and how they were minimized in this chapter.
Finally, I provided information on the steps that I followed to adhere to ethical concerns,
by ensuring that I received Walden IRB approval before data abstraction and analysis.
Chapter 4 covers a detailed description of the steps taken to perform all statistical
analyses and an outline of the results as relates to my research questions and hypotheses.
I also provide a cautious interpretation of my results and how my findings are
representative of the general population. Chapter 4 also includes information of how my
findings add knowledge and provide insight to public health practice as relates to CRC
screening programs. An explanation of how data was stored throughout the study and
destroyed at the end of the study is provided in Chapter 4.
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Chapter 4: Results
Introduction
The purpose of this study was to improve understanding of colorectal cancer
(CRC) screening by utilizing a quantitative cross-sectional study to examine factors that
predict CRC screening use (CRCSU) among adults, age 50–75 years, in Maryland. To
conduct this study, I used secondary data from the CDC BRFSS database to assess the
association between age, sex, race/ethnicity, education level, household income, health
insurance plan, access to health care professional, and CRC screening use. In this study,
CRCSU represents, fully meeting the USPSTF guidelines, measured as receiving one or
more of the recommended CRC tests within the recommended time interval.
I extracted and merged Maryland BRFSS data of 2014, 2016, and 2018 into one
dataset file to answer two RQs. The Pearson chi-square test of independence was used to
test the statistical association and multiple logistic regression was used to determine
associations between the independent and the dependent variables. In this chapter, I
provide the results obtained from the analyses and display them in tables. I begin this
chapter by repeating the RQs that I explored in this study.
Research Questions and Hypotheses
Research Question 1: Is there any association between socioeconomic status
measured by education level, household income, and colorectal cancer screening use
among adults age 50–75 years in Maryland, after adjusting the effects of age, sex, and
race/ethnicity?
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H01: There is no statistically significant association between socioeconomic status
measured by education level, household income, and colorectal cancer screening use
among adults age 50–75 years in Maryland, after adjusting the effects of age, sex, and
race/ethnicity.
Ha1: There is a statistically significant association between socioeconomic status
measured by education level, household income, and colorectal cancer screening use
among adults age 50–75 years in Maryland, after adjusting the effects of age, sex, and
race/ethnicity.
Research Question 2: Is there any association between access to preventive health
care service measured by health insurance coverage, access to health care professional,
and colorectal cancer screening use among adults age 50–75 years in Maryland, after
adjusting the effects of age, sex, and race/ethnicity?
H02: There is no statistically significant association between access to preventive
health care service measured by health insurance coverage, access to health care
professional, and colorectal cancer screening use among adults age 50–75 years in
Maryland, after adjusting the effects of age, sex, and race/ethnicity.
Ha2: There is a statistically significant association between access to preventive
health care service measured by health insurance coverage, access to health care
professional, and colorectal cancer screening use among adults age 50–75 years in
Maryland, after adjusting the effects of age, sex, and race/ethnicity.

105
Data Collection
Publicly available secondary data of 2014, 2016, and 2018 were used to conduct
this study. I accessed the data repository through the CDC BRFSS website. I followed the
data collection plan as outlined in Chapter 3 with minor deviation; because I pulled the
Maryland data through the CDC BRFSS instead of the Maryland BRFSS website.
Walden University’s Institutional Review Board (IRB) was duly informed about this
discrepancy before data collection. The IRB approval number for this study was 02-2520-0678352. Following the IRB guidelines allowed me to be in compliance with Walden
University’s research requirements. The data repository provided access to a ZIP file that
included 336 different variables with 48,588 cases. I downloaded the files that included
data from all states in the U.S., saved the files on my computer and then uploaded into
SPSS. In SPSS, I split the file to include only Maryland data and then merged all three
data sets (2014, 2016, 2018) into one dataset file.
Discrepancies in Data Collection
Originally, the independent variables to be used were to include health care
professional recommendation for screening, screening test methods—Fecal Occult Blood
Test (FOBT), sigmoidoscopy and colonoscopy. However, after collecting and reviewing
the data, the health care professional recommendation variable was not available, and the
assumptions of collinearity were not met for the screening test methods variable;
therefore, not reported in my analyses. Nonetheless, I replaced these variables with three
new variables; education level, household income, and access to health care professional,
to match the data collection procedure discussed in chapter three. The data were limited

106
to respondents, age 50-75 years, due to lack of CRC screening data of individuals below
50 years of age. The current national guideline is for CRC screening to begin at 50 years
of age for average risk individuals (USPSTF, 2018).
The above discrepancies which were due to lack of available data, led me to
modify my original RQs as presented above. The intent of this study to examine
association between socioeconomic status (SES), access to preventive health care, and
CRC screening use remained the same despite these changes. The new independent
variables for this study are age, sex, race, education level, income level, health insurance
coverage, access to health care professional; and dependent variable is CRCSU. To
support the use of education level and income to determine association between SES and
CRCSU, the literature reveals that there is a statistically significant (p < .05) and positive
relationship between education level, income, and completion of CRC screening (Zhao,
Okoro, Li, & Town, 2017). Likewise, DeGroff et al., (2018) found an association
between access to health care professionals, and increase in CRC screening uptake.
Data Analysis
Data Cleaning
This study assumed that missing data were not due to the outcome variable, but
missing at random. All variables were collected as categorical variables. No variable was
calculated. I excluded variables not needed for my analysis, and utilized data of 6641
respondents with eight different variables. I excluded 2601 cases with values of either,
don’t know/not sure, refused, or missing. Simple random sampling technique was used to
select cases. The application of stratified random sampling to select the data makes the
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sample a good representation of the study population and provided a strong external
validity and credibility to my results. The dataset files included the data dictionary, and
code book, which I used to recode the variables, input the values and labels in SPSS.
Data Coding
I created three new subcategories for “age” based on age grouping from the
BRFSS codebook, and recoded as 1 = 50–59 years, 2 = 60–69 years, and 3 = 70–75
years. Sex was coded as 1 = male, and 2 = female. Race and ethnicity were used as one
entity in this study. Race/ethnicity was recoded as, 1 = white, 2 = black, 3 = Asian, 4 =
Hispanic, 5 = other. The race/ethnicity values of multiracial, native Hawaiian, and
American Indian, were recoded as “other,” because there was not enough of each of these
race groups to warrant a regression. Education was collected as, elementary school, some
high school, high school graduate, some college or technical school, and college
graduate. I recoded education level as: 1 = no or some high school, 2 = high school, 3 =
some college or technical school, 4 = college graduate. Household income was collected
as, <$10,000; $10,000-< $15,000; $15,000-<$20,000; $20,000-<$25,000; $25,000<$35,000; $35,000-<$50,000; $50,000-<$75,000; $75,000 or more. I recoded household
income as: 1 = $0-<$35,000 (low-income), 2 = $35,000-<$75,000 (middle-income), and
3 = $75,000 or more (high-income). Health insurance coverage was collected as, a plan
purchased through an employer or a union; medicare; medicaid; tribal health services;
TRICARE; some other service; and No coverage. I recoded health insurance coverage as:
0 = other health insurance plan, 1 = private plan, 2 = public plan. Access to health care
professional was coded as 0 = no health care professional, 1 = access to one health care
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professional; 2 = more than one health care professional.
Furthermore, the question of whether respondents have fully met the USPSTF
CRC screening test recommendation within the recommended time interval in the code
book, represents the dependent variable (CRCSU). CRCSU was collected as a
dichotomous variable and coded as: 0 = did not receive one or more of the CRC test
within recommended time interval, and 1 = received one or more of the CRC test within
the recommended time interval. I limited the covariates to age, sex and race/ethnicity,
because other variables like history of CRC, and marital status were not captured in the
datasets and hence not considered in the analysis. After IRB approval, the timeframe to
begin and complete the data collection process was approximately three weeks.
Descriptive and Demographic Characteristics of the Sample
The demographic characteristics of this study includes a sample size of 3134
cases of males and females age 50–75 years from five race/ethnicity groups, who
responded to the 2014, 2016, and 2018, BRFSS survey. The frequency distribution for
the set of categorical variables (age, sex, race, education, income, health insurance
coverage, health care professional, CRCSU) showed 100% (n = 3134) valid cases and no
missing data. There were slightly more cases in the 60–69 years’ group (n = 1347,
43.0%) compared to the 50–59 years’ group (n = 1148, 36.6%), and the 70–75 years’
group (n = 639, 20.4%). There were slightly more females (n = 1,966, 62.7%) than males
(n = 1,168, 37.3%). The frequency distribution of race variable, showed that there were
more whites (n = 2328, 74.3%) than any other race group; blacks (n = 612, 19.5%),
Asians (n = 58, 1.9%), Hispanics (n = 43, 1.4%), other (n = 93, 3.0%).
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The frequency distribution for the four education levels shows that most
respondents were college graduates (n = 1388, 44.3%), followed by high school (n = 861,
27.5%), then some college (n = 745, 23.8%), and no high school group (n = 140, 4.5%).
Results of the income variable showed that most respondents were in the high-income
group (n = 1,318, 42.1%), followed by middle-income (n = 915, 29.2%), and the least
number of cases was from the low-income group (n = 901, 28.7%). Descriptive of the
health insurance coverage variable showed that all respondents in the sample had at least
one type of health insurance plan. There was none without health insurance coverage.
Those with private plan had the highest number of cases (n = 2196, 70.1%), followed by
public plan (n = 811, 25.9%), and other health insurance plan (n = 127, 4.1%). For the
health care professional variable, those with access to only one health care professional
were seven times (n = 2608, 83.2%), those with access to more than one health care
professional (n = 358, 11.4%), and the smallest number of cases was the no health care
professional group (n = 168, 5.4%). The descriptive statistics of the dependent variable
(CRCSU) further showed that out of the 3134 cases, most of the respondents have
received one or more of the recommended CRC test (n = 2387, 76.2%), and those who
have not (n = 747, 23.8%). Result of the frequency distribution of all variables is
displayed in Table 1.
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Table 1
Frequency Distribution of Demographic and Sample Characteristics
Variable
Age Group
50 - 59 years
60 - 69 years
70 -75 years
Sex
Male
Female
Race/Ethnicity
White, Non-Hispanic
Black, Non-Hispanic
Asian, Non-Hispanic
Hispanic
Other
Education Level
No or Some High School
High School Graduate
Some College
College Graduate
Household Income
Low-Income
Middle-Income
High-Income
Health Insurance Coverage
Private plan
Public plan
Other plan
Health Care Professional
One health care professional
More than one health care professional
No health care professional
CRC Screening Use
Yes
No

Frequency

Percent

1148
1347
639

36.6
43.0
20.4

1168
1966

37.3
62.7

2328
612
58
43
93

74.3
19.5
1.9
1.4
3.0

140
861
745
1388

4.5
27.5
23.8
44.3

901
915
1318

28.7
29.2
42.1

2196
811
127

70.1
25.9
4.1

2608
358
168

83.2
11.4
5.4

2387
747

76.2
23.8
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Results of Statistical Analysis
Through this study I examined the association between seven independent
variables: age, sex, race, education, income, health insurance coverage, health care
professional, and one dichotomous dependent variable: CRCSU. I performed the nonparametric Pearson chi-square test of independence to test the statistics, and multiple
logistic regression inferential statistics to determine association between the predictors
and the outcome variable. I also employed the Hosmer-Lemeshow (H-L) goodness of fit
test to compare the observed cases to the number predicted by the regression model. The
SPSS calculated Exp(B) which is the odds ratio (OR) was used to describe the probability
of associations and to reflect the effect size. The beta (β) value which represents the
change in odds of an outcome as a result of a unit change in the predictor variable; and
the Wald statistics which indicates whether the β for a predictor variable is significantly
different from zero or not (Field, 2013), were essential in reporting the results.
Prior to conducting the inferential statistics, the assumptions of multiple logistic
regression analysis (large sample size, multicollinearity and outliers) were tested and met.
To test for threat of multicollinearity, a Pearson correlation and linear regression analyses
were conducted for all predictor variables. Results of the correlation analysis showed that
none of the variables had tolerance value <.1; or Variance Inflation Factor (VIF) >10.
Therefore, this assumption was met. For all analyses, a 95% confidence interval (CI) was
used for statistical comparison. Hypothesis testing was two-sided at an alpha level of .05.
Table 2 shows results of the cross-tabulation and Pearson chi-square test; and tables 3-9
show results of the binary logistic regression analysis by RQs.
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Table 2
Cross tabulation: Chi-Square Test between the Independent and the Dependent Variables
Number of Cases, N = 3134
Fully meet CRC screening
P–
recommendation (CRCSU)
Value
Yes
No
Age Group
50 - 59 years
60 - 69 years
70 -75 years
Sex
Male
Female
Race-Ethnicity
White, Non-Hispanic
Black, Non-Hispanic
Asian, Non-Hispanic
Hispanic
Other Race/Ethnicity
Education Level
No or some High School
High School Graduate
Some College
College Graduate
Household Income Level
Low-Income
Middle-Income
High-Income
Health Insurance Coverage
Private Plan
Public Plan
Other Plan
No Health Insurance
Health Care Professional
One Health care professional
More than one health care
professional
No health care professional

.000
762 (66.4%)
1083 (80.4%)
542 (84.8%)

386 (33.6%)
264 (19.6%)
97 (15.2%)
.640

895 (76.6%)
1492 (75.9%)

273 (23.4%)
474 (24.1%)
.015

1754 (75.3%)
492 (80.4%)
42 (72.4%)
36 (83.7%)
63 (67.7%)

574 (24.7%)
120 (19.6%)
16 (13.8%)
7 (16.3%)
30 (32.3)
.000

87 (62.1%)
606 (70.4%)
577 (77.4%)
1117 (80.5%)

53 (37.9%)
255 (29.6%)
168 (22.6%)
271 (19.5%)
.006

655 (72.7%)
696 (76.1%)
1036 (78.6%)

246 (27.3%)
219 (23.9%)
282 (21.4%)
.000

1635 (74.5%)
648 (79.9%)
104 (81.9%)
0 (0.0%)

561 (25.5%)
163 (20.1%)
23 (18.1%)
0 (0.0%)
.002

2019 (77.4%)
281 (78.5%)

589 (22.6%)
77 (21.5%)

87 (51.8%)

81 (48.2%)
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Research Question 1: Socioeconomic Status and Colorectal Cancer Screening Use
To answer RQ1, I conducted the Pearson chi-square test of independence to test
the null hypothesis and determine model fitness; and a binary logistic regression to assess
whether SES measured by education level and household income is associated with
CRCSU, after adjusting the effects of age, sex, and race/ethnicity. For the binary logistic
regression, the omnibus test of model coefficients was significant (chi-square = 44.627,
df = 5, p = .000); the model summary showed the Nagelkerke R2 = .021. The H-L test
(chi-square = 3.704, df = 7, p = .813) showed that the prediction did not differ
significantly from the observed cases in the contingency table, implying that at the
model’s estimates fit the data are well fitted at an acceptable level. The classification
table showed that the specificity of the model with respect to those who responded “Yes”
to CRCSU was 100% with an overall classification accuracy of 76.2%.
Education level. Results of the cross-tabulation and the Pearson Chi-square
between education and CRCSU (Table 2) showed that most respondents who have fully
met the CRC screening test recommendation are college graduate 1117 (80.5%), and the
least are No high school graduate 87 (62.1%); high school graduate 606 (70.2%) and
some college 577 (77.4%). Among those who did not fully meet the CRC screening
recommendation, college graduate 271 (19.5%) had the least percentage and No high
school 53 (37.9%) had the largest percentage. The chi-square = 45.900, df = 3, p = .000,
showed a significant association between education level and CRCSU. Based on the
preliminary results, I reject the null hypothesis that there is no statistically significant
association between education level and CRCSU.
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For the binary logistic regression (Table 3), the OR for No high school graduate
was used as the reference category for comparing groups relative to the high school
through college graduate groups, because it is expected that those with no high school are
less likely to fully meet the CRC screening test recommendation (Rodriguez, & Smith,
2016). The Wald statistics (34.755) and significance (p = .000), showed that education
level makes a significant contribution to the model. The results showed that compared to
the no high school graduate group, high school graduate were 1.4 times more likely (OR
= 1.424; 95% CI: .978, 2.074); some college were 2 times more likely (OR = 2.040; 95%
CI: 1.379, 3.017), and college graduate were 2.4 times more likely (OR = 2.420; 95% CI:
1.644, 3.562) to CRCSU; showing increase in odds from the high school graduate level.
Nevertheless, the difference across groups was, non-significant for high school
graduate (β = .354, S.E. = .192, Wald = 3.403, p = .065); and significant for some college
(β = .713, S.E. = .200, Wald = 12.753, p = .000) and college graduate groups (β = .884,
S.E. = .197, Wald = 20.070, p = .000). The OR for all education levels were >1, and the β
were positive, indicating that increasing education level is associated with increasing
odds of CRCSU. Therefore, I reject the null hypothesis that there is no statistically
significant association between education level and CRCSU, and conclude that education
level completed is significantly associated to CRCSU in Maryland.
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Table 3
Binary Logistic Regression for Education, Income, and Colorectal Cancer Screening Use
Variables

Education Level
No High Sch. Grad (BL)
High School Grad.
Some College
College Graduate
Income Level
Low Income (Baseline)
Middle Income
High Income

B

S. E. Wald

df Sig.

34.755 3
.354 .192
.713 .200
.884 .197

3.403
12.753
20.070
.360

1
1
1
2

.051 .111
.064 .111

.212
.327

1
1

Exp(B) 95% CI. for
EXP(B)
Lower Upper

.000
1.00
.065 1.42
.000 2.040
.000 2.420
.835
1.00
.645 1.052
.568 1.066

.978
1.379
1.644

2.074
3.017
3.562

.847
.857

1.308
1.326

a. Variable(s) entered on Step 1: Education Level, Income Level.

Household income level. Results of the cross-tabulation between income and
CRCSU showed that among respondents who answered “Yes” to fully meeting the CRC
screening recommendation, high-income 1036 (78.6%), middle-income 696 (76.1%) and
low-income 655 (72.7%) had the smallest number of cases. Among those who responded
“No”, low-income 246 (27.3%) had the most percentage of cases followed by middleincome 219 (23.9%) and high-income 282 (21.4%). The Pearson chi-square test (chisquare = 10.293, df = 2, p = .006), showed a statistically significant association between
income and CRCSU. Therefore, I reject the null hypothesis in favor of the alternative.
For the binary logistic regression, the OR for low-income was used as the
reference category for comparing groups relative to middle and high income, because low
income has been associated with lowest CRC screening rates (Simkin, Ogilvie, Hanley,
& Elliott, 2019). Results showed that compared to the low income group, middle income
was 1 time as likely (OR = 1.052; 95% CI: .847, 1.308) to fully meet the CRC screening
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test recommendation. Similarly, the high income was 1 time as likely (OR = 1.066; 95%
CI: .857, 1.326) to fully meet the CRC screening test recommendation compared to the
low income group. Nonetheless, the difference is positive and non-significant; middle
income (β = .051, S.E. = .111, Wald = .212, p = .645), and high income (β = .064, S.E. =
.111, Wald = .327, p = .568). Since, the OR is slightly greater than the null hypothesis
OR of 1.0, and the β for all income levels were positive, this indicated that there is a
slightly increasing probability that increase in income level is associated with increasing
odds of CRCSU. Based on these results, I retain the null hypothesis; and conclude that
the association between income level and CRCSU is statistically non-significant.
Age. In the next analysis, the age variable was added to the multiple logistic
regression (Table 4); and the results showed that age made a significant contribution to
the model (Wald = 113.289, p = .000). The model summary (chi-square = 161.843, df =
7, p = .000); the Nagelkerke R2 (.076) and the H-L test (chi-square = 15.160, df = 8, p =
.056) indicated a well fitted model. Using the 50–59 years’ age group as a reference
category, those in the 60–69 years’ group were 2.2 times more likely (OR: 2.202; 95%
CI: 1.827, 2.653); and those in the 70–75 years’ group were 3.3 times more likely
(OR=3.332; 95% CI: 2.576, 4.309) to fully meet the CRC screening recommendation.
Nevertheless, the difference in both age groups are positive and significant; 60–69 years’
(β = .789, S.E. = .095, Wald = 68.837, p = .000), and 70–75 years’ (β = 1.203, S.E. =
.131, Wald = 84.094, p = .000). Based on these results, I reject the null hypothesis that
there is no statistically significant association between age and CRCSU, and conclude
that age is a positive and significant predictor of CRCSU in Maryland.
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Furthermore, by adding age to the model, the OR for high school increased from
(OR: 1.424; 95% CI: .978, 2.074; p = .065) to (OR: 1.503, 95% CI: 1.020, 2.214, p =
.039); some college from (OR: 2.040; 95% CI: 1.379, 3.017, p = .000) to (OR: 2.179,
95% CI: 1.456, 3.262; p = .000); and college graduate increased from (OR: 2.420; 95%
CI: 1.644, 3.562; p = .000) to (OR: 2.558, 95% CI: 1.716, 3.812, p = .000). Similarly, the
OR for middle income level increased from (OR: 1.052; 95% CI: .847, 1.308, p = .645)
to (OR: 1.105, 95% CI: .885, 1.380, p = .379); high income increased from (OR: 1.066;
95% CI: .857, 1.326, p = .568) to (OR: 1.326, 95% CI: 1.057, 1.665, p = .015). Based on
these results, I reject the null hypothesis and conclude that age is a statistically significant
(p < .05) and confounding factor on the association between education level, household
income level, and CRCSU in Maryland.
Table 4
Binary Regression for Education, Income, Age, and Colorectal Cancer Screening Use
Variables

Education Level
No HS. Grad. (BL)
High School Grad.
Some College
College Graduate
Income Level
Low Income (BL)
Middle Income
High Income
Age Group
50-59 years (BL)
60-69 years
70-75 years

B

.407
.779
.939

.100
.282

.789
1.203

S. E.

.198
.206
.204

.113
.116

.095
.131

Wald

df

Sig.

35.106

3

.000

4.246
14.323
21.281
6.184

1
1
1
2

.039
.000
.000
.045

.773
5.928
113.289
68.837
84.094

1
1
2
1
1

.379
.015
.000
.000
.000

Exp(
B)

95% CI. for
EXP(B)
Lower Upper

1.00
1.503
2.179
2.558

1.020
1.456
1.716

2.214
3.262
3.812

1.00
1.105
1.326

.885
1.057

1.380
1.665

1.00
2.202
3.332

1.827
2.576

2.653
4.309

a. Variable(s) entered on Step 1: Education Level, Income Level, Age.

118
Sex. When sex variable was added to the model (Table 5), the Wald statistics
(.000), and significance (p = .999) showed that sex made a non-significant contribution to
the model. The model summary (chi-square = 44.627. df = 6, p = .000), the Nagelkerke
R2 (.021); and the H-L test (chi-square = 5.276, df = 8, p = .728) indicated a well fitted
model. Using male as the reference category, females were no more nor less likely (OR:
1.000; 95% CI: .841, 1.190) to fully meet the CRC screening test recommendation
compared to males. Since the OR = 1, this indicates no difference in the probability of
CRCSU from female to male. Based on this result, I accept the null hypothesis that there
is no statistically significant association between sex and CRCSU, and conclude that sex
is not a predictor to CRCSU in Maryland.
Furthermore, by adding sex to the model, the OR for all education levels (high
school graduate, some college, college graduate) and income categories (middle-income,
high-income) as well as values for the β, the Wald statistics and the levels of significance
across all categories remained the same. Sex had no confounding effect on the OR.
Therefore, sex is not a confounder on the association between education level, household
income, and CRCSU.
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Table 5
Binary Regression for Education, Income, Sex, and Colorectal Cancer Screening Use
Variables

Education Level
No HSch. Grad. (BL)
High School Grad.
Some College
College Graduate
Income Level
Low Income (BL)
Middle Income
High Income
Females

B

S.
E.

Wald

df Sig.

34.753 3

.000

.354 .192 3.401 1
.713 .200 12.735 1
.884 .197 20.070 1
.356
2

.065
.000
.000
.837

.051 .111 .211
.064 .112 .323
.000 .089 .000

1
1
1

.646
.570
.999

Exp(B) 95% CI. for
EXP(B)
Lower Upper
1.00
1.424
2.040
2.420

.978
1.379
1.644

2.074
3.017
3.562

1.00
1.052
1.066
1.000

.847
.856
.841

1.308
1.327
1.190

a. Variable(s) entered on Step 1: Education Level, Income Level, Sex.

Race/ethnicity. When the race/ethnicity was added to the model (Table 6), the
results showed that race/ethnicity made a significant contribution to the model (Wald
=15.504, p = .004). The model summary (chi-square = 60.575. df = 9, p = .000); the
Nagelkerke R2 (.029); and the H-L test (chi-square = 7.113, df = 6, p =.310) indicated a
well fitted model. In this model, White was used as the reference category for comparing
groups relative to all other race groups, because White is the largest racial group in the
sample. Compared to whites, blacks were 1.4 times as likely (OR: 1.430; 95% CI: 1.143,
1.789), Asians were 25% less likely (OR: .754; 95% CI: .418, 1.359); Hispanics were 1.7
times as likely (OR=1.681; 95% CI: 737, 3.834); and “other” race was 29% less likely
(OR: .709; 95% CI: .452, 1.111) to fully meet the CRC screening test recommendation.
Nonetheless, the difference is positive, blacks (β = .358, S.E. = .114, Wald = 9.802, p =
.002); Asians (β = .283, S.E. = .301, Wald = .883, p = .347); Hispanics (β = .519, S.E. =
.421, Wald = 1.522, p = .217); and “other” (β = .344, S.E. = .229, Wald = 2.249, p =
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.134). Based on these results, I accept the null hypothesis that there is no statistically
significant association between race/ethnicity and CRCSU; and conclude that the
likelihood to CRCSU depends on the race/ethnic group.
Moreover, by adding race/ethnicity to the model, high school graduate increased
from (OR: 1.424; 95% CI: .978, 2.074, p = .065) to (OR: 1.462, 95% CI: 1.002, 2.133, p
= .049); some college from (OR: 2.040; 95% CI: 1.379, 3.017, p = .000) to (OR: 2.068,
95% CI: 1.396, 3.064, p = .000); and college graduate from (OR: 2.420; 95% CI: 1.644,
3.562; p = .000) to (OR: 2.530, 95% CI: 1.716, 3.732, p = .000). Similarly, by adding
race/ethnicity to the model, the OR for middle income increased from (OR: 1.052; 95%
CI: .847, 1.308, p = .645) to (OR: 1.070, 95% CI: .860, 1.331, p = .546); and high income
increased from (OR: 1.066; 95% CI: .857, 1.326, p = .568) to (OR: 1.086, 95% CI: .872,
1.352, p = .462). Race/ethnicity is a confounder on the association between education
level, income level and CRCSU in Maryland.
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Table 6
Binary Regression for Education, Income, Race, and Colorectal Cancer Screening Use
Variables

Education Level
No High Sch. Grad. (BL)
High School Grad.
Some College
College Graduate
Income Level
Low Income (Baseline)
Middle Income
High Income
Race-Ethnicity
White, Non-Hispanic
(BL)
Black, Non-Hispanic
Asian, Non-Hispanic
Hispanic
Other Race/Ethnicity

B

S. E.

Wald

df

Sig.

36.782

3

.000

.380
.727
.928

.193
.201
.198

3.880
13.132
21.924
.601

1
1
1
2

.049
.000
.000
.740

.067
.082

.111
.112

.365
.541
15.504

1
1
4

.546
.462
.004

Exp(B)

95% CI. for
EXP(B)
Lower Upper

1.00
1.462
2.068
2.530

1.002
1.396
1.716

2.133
3.064
3.732

1.00
1.070
1.086

.860
.872

1.331
1.352

1.143
.418
.737
.452

1.789
1.359
3.834
1.111

1.00
.358
.283
.519
.344

.114
.301
.421
.229

9.802
.883
1.522
2.249

1
1
1
1

.002
.347
.217
.134

1.430
.754
1.681
.709

a. Variable(s) entered on Step 1: Education Level, Income Level, Race-Ethnicity.

Research Question 2: Preventive Health Care Service and CRC Screening Use
To answer RQ2, I conducted the Pearson chi-square test to determine model
fitness; and binary logistic regression to assess whether access to preventive healthcare
service measured by health insurance coverage and access to health care professional is
associated to CRCSU, after adjusting for the effects of age, sex, and race/ethnicity.
Results of the binary logistic regression (Table 7), showed that the prediction did not
differ significantly from the observed cases in the contingency table. The omnibus test of
model coefficients (chi-square =31.253, df = 4, p = .000); the Nagelkerke R2 (.015); and
the H-L test (chi-square =3.805, df = 2, p = .149) indicated a good fit model. The
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classification table shows that the specificity of the model with respect to those who
responded “Yes” to CRCSU was 100% with an overall classification accuracy of 76.2%.
Health insurance coverage. Results of the cross-tabulation between health
insurance coverage and CRCSU showed that most respondents who answered “Yes” to
CRCSU had private plans 1635 (74.5%), followed by public plan 648 (79.9%) and
“other” health insurance plan 104 (81.9%). Among those who answered “No,” private
plan 561 (25.5%), public plan 163 (20.1%) and “other” plan 23 (18.1%) had the smallest
percentage. Results of Pearson chi-square (chi-square = 12.072, df = 2, p = .002), showed
a statistically significant association between health insurance coverage and CRCSU.
Based on this result, I reject the null hypothesis that there is no statistically significant
association between health insurance coverage and CRCSU.
For the binary logistic regression, the OR for “other” health insurance plan was
used as the reference category for comparing groups relative to private and public plans,
because individuals with health insurance plans such as TRICARE are less likely to
participate in surveillance CRC screening programs (DeMoor et al., 2018). The result
showed that health insurance coverage made a significant contribution to the model
(Wald =19.905, p = .000). Compared to “other” plan, those with private plan were 1.3
times as likely (OR: 1.309; 95% CI: .872, 1.967) to CRCSU. Similarly, those with public
plan were 14% less likely (OR: .868; 95% CI:.569, 1.324) to CRCSU. Nonetheless the
difference for both plans is positive and non-significant, private plan (β = .269, S.E. =
.208, Wald = 1.685, p = .194), and public plan (β =.142, S.E. = .215, Wald = .433, p =
.511). Based on these results I accept the null hypothesis that there is no statistically
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significant association between health insurance coverage and CRCSU; and conclude
that, the likelihood to fully meet the CRC screening test recommendation in Maryland
depends on the health insurance plan.
Table 7
Binary Logistic Regression of Health Insurance Coverage, Access to Health Care
Professional, and Colorectal Cancer Screening Use
Variables

B

S. E. Wald

d
f

Sig.

Exp(B) 95% CI. for
EXP(B)
Lower Upper

Health Insurance Cov.
19.905 2 .000
Other Plan (Baseline)
1.00
Private Plan
.269 .208 1.685 1 .194 1.309
.872
1.967
Public Plan
.142 .215 .433
1 .511 .868
.569
1.324
Health Care Professional
12.375 2 .002
No Health Care Prof. (BL)
1.00
One Health Care Prof.
.590 .169 12.189 1 .000 1.803
1.295 2.511
More than One Hlth C.
.488 .204 5.708 1 .017 1.628
1.092 2.429
Prof.
a. Variable(s) entered on step 1: Health Insurance Coverage, Health Care Professional.
Access to health care professional. Results of the cross-tabulation between
health care professional and CRCSU showed that among those who answered “Yes” to
CRCSU, most respondents had access to only one health care professional (n = 2019,
77.4%); more than one health care professional (n = 281, 78.5%), and no health care
professional (n = 87, 51.8%). The highest percentage for those who answered “No” to
CRCSU was the no health care professional group (n = 81, 48.2%), followed by one
health care professional (n = 589, 22.6%) and more than one health care professional (n =
77, 21.5%). The Pearson chi-square test (chi-square = 58.316, df = 2, p = .000), indicated
a statistically significant association between access to health care professional and
CRCSU. Based on these results, I reject the null hypothesis that there is no statistically
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significant association between access to health care professional and CRCSU.
For the binary logistic regression, the OR for no health care professional was used
as the reference category for comparing groups relative to only one health care
professional and more than one health care professional, because those without access to
a health care professional are less likely to screen for CRC (DeGroff et al., 2018). The
results showed that access to health care professional made a significant contribution to
the model (Wald =12.375, p = .002). Those with access to only one health care
professional were 1.8 times as likely (OR: 1.808; 95% CI: 1.295, 2.511) to CRCSU
compared to those without access to a health care professional. Similarly, those with
access to More than one health care professional were 1.6 times as likely (OR: 1.628;
95% CI: 1.092, 2.429) to CRCSU. Nevertheless, the difference across all groups is
positive and significant; Only one health care professional (β = .590, S.E. = .169, Wald =
12.189, p = .000), and More than one health care professional (β = .488, S.E. = .204,
Wald = 5.708, p = .017). Based on these results, I reject the null hypothesis that there is
no statistically significant association between access to health care professional and
CRCSU; and conclude that access to health care professional is significantly (p < .05)
associated to CRCSU in Maryland.
After adding the age variable to the model (Table 8), the OR for private health
insurance plan increased from (OR: 1.309; 95% CI: .872, 1.967, p = .194) to (OR: 1.467,
95% CI: .967, 2.225, p = .072); and public plan from (OR = .868; 95% CI: .569, 1.324, p
= .511) to (OR: .971, 95% CI: .630, 1.496, p = .895). This result indicated that age had a
non-significant, effect on the association between health insurance coverage and CRCSU.

125
Similarly, the OR for those with access to Only one health care professional changed
from (OR: 1.808; 95% CI: 1.295, 2.511, p = .000) to (OR: 2.031, 95% CI: 1.445, 2.855, p
= .000); and More than one health care professional changed from (OR: 1.628; 95% CI:
1.092, 2.429, p = .017) to (OR: 2.123, 95% CI: 1.406, 3.207, p = .000). Age mediated the
effect on the association between access to health care professional and CRCSU by
increasing the OR. Age is a confounder on the association between health insurance
coverage, access to health care professional, and CRCSU in Maryland.
Table 8
Binary Logistic Regression of Health Insurance Coverage, Health Care Professional,
Age, and Colorectal Cancer Screening Use
Variable

Health Insurance
Coverage
Other Plan (Baseline)
Private Plan
Public Plan
Health Care Professional
No Hlth Care Prof. (BL)
Only One Hlth Care Prof.
More than One HC. Prof.
Age Group
50-59 years (Baseline)
60-69 years
70-75 years

B

S.
E.

Wald

df Sig.

20.254

2

.383
.029

.213 3.248
.221 .018
17.137

.709
.753

.174 16.652 1
.210 12.818 1
101.477 2

.737 .094 61.346
1.112 .129 74.204

1
1
2

1
1

Exp(B) 95% CI. for
EXP(B)
Lower Upper

.000
1.00
.072 1.467
.895 .971
.000
1.00
.000 2.031
.000 2.123
.000
1.00
.000 2.089
.000 3.040

.967
.630

2.225
1.496

1.445
1.406

2.855
3.207

1.737
2.360

2.511
3.915

a. Variable(s) entered on Step 1: Health Insurance Coverage, Health Care Prof., Age Group.

Furthermore, when race/ethnicity variable was added to the model, (Table 9) the
results showed that, race/ethnicity had a confounding effect on the association between
health insurance coverage and CRCSU. The OR for private plan changed from (OR:
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1.309; 95% CI: .872, 1.967, p = .194) to (OR: .625, 95% CI: .391, .999, p = .049);
indicating that people with private plans are less likely to have CRCSU. Moreover, public
plan changed from (OR: .868; 95% CI:.569, 1.324, p = .511) to (OR: .873, 95% CI: .535,
1.426, p = .589). Similarly, the OR for access to Only one health care professional
changed from (OR: 1.808; 95% CI: 1.295, 2.511, p = .000) to (OR: 1.460, 95% CI: 1.036,
2.057, p = .031); and access to More than one health care professional changed from
(OR: 1.628; 95% CI: 1.092, 2.429, p = .017) to (OR: .473, 95% CI: .253, .888, p = .020).
Based on these results, race/ethnicity is a confounder on the association between health
insurance coverage, access to health care professional and CRCSU in Maryland.
Table 9
Binary Logistic Regression of Health Insurance Coverage, Health Care Professional,
Race, and Colorectal Cancer Screening Use
Variable

Health Insurance Cov.
Other Plan (Baseline)
Private Plan
Public Plan
Health Care Professional
No Hlth Care Prof. (BL)
Only One Hlth Care Prof.
More than One HC Prof.
Race-Ethnicity
White, Non-Hisp. (BL)
Black, Non-Hispanic
Asian, Non-Hispanic
Hispanics
Other Race/Ethnicity

B

S. E.

Wald

d Sig.
f

13.519

2 .001

.470
.135

.239
.250

3.863
.292
54.913

1.186
1.269

.163
.202

53.155
39.247
12.999

.304
.171
.530
.404

.114
.300
.421
.230

7.100
.325
1.585
3.074

Exp(B)

1.00
1 .049 .625
1 .589 .873
2 .000
1.00
1 .000 3.273
1 .000 3.556
4 .011
1.00
1 .008 1.355
1 .568 .843
1 .208 1.699
1 .080 .668

95% CI. for
EXP(B)
Lower Upper

.391
.535

.999
1.426

2.380
2.391

4.502
5.288

1.084
.468
.745
.425

1.694
1.517
3.876
1.049

a. Variable(s) entered on Step 1: Health Insurance Coverage, Health Care Prof., Race-Ethnicity.
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Summary
In this chapter, I reported the results of the statistical analyses used to assess the
association between age, sex, race, education level, household income level, health
insurance coverage, access to health care professional, and CRC screening use. I further
explained the effect of covariates age, sex, race/ethnicity on the association between SES,
access to preventive health care service, and CRC screening use. The results of the
Pearson Chi-square test of independence and multiple logistic regression analyses
showed that age, race/ethnicity, education level, income level, health insurance coverage,
and access to health care professional, were associated with whether an individual 50–75
years of age in Maryland would fully meet the USPSTF CRC screening test
recommendation at the recommended time interval or not. No association was observed
between sex and CRC screening use.
Furthermore, when the covariate variables were added to the regression models,
the results showed that age, and race/ethnicity had a confounding effect on the
association between SES, access to preventive healthcare service, and CRC screening
use, and sex did not. These results support the hypotheses that age, race, education level,
and access to healthcare professional are significantly (p < .05) associated to CRSU. In
chapter 5, I provided an interpretation of the results and the study findings in lieu of
existing literature. I also provided information on the significance of the findings,
recommendations for future research, implications for positive social change and
conclusion of the study.

128
Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
This quantitative, cross-sectional study was conducted to examine the association
between the independent variables (age, sex, race, education, income, health insurance
coverage, access to health care professional), and the dependent variable (CRCSU) in
Maryland, using secondary data of 2014-2018, extracted from the CDC BRFSS data
repository. I merged and analyzed data of 3134 respondents, 50–75 years of age. I then
used the Pearson chi-square test of independence to test the statistic and multiple logistic
regression to determine the associations and explain the relationships between the
predictors and the outcome variable.
This study was justified because, despite evidence from the literature on the role
of screening in reducing CRC incidence and mortality (Sauer, Siegel, Jemal, & Fedewa,
2019), CRC screening rates remain low in Maryland (MDH, 2016-2020 cancer report)
and even? lower in some age, race and socioeconomic groups that have limited resources
to participate in CRC screening programs (Platz, 2018). Key findings revealed
statistically significant associations (p < .05) between socioeconomic status (SES), access
to preventive health care service, and CRCSU; age and race/ethnicity were confounders
on the associations. However, non-significant association was observed with some
measured variables (sex, income level, health insurance coverage). This chapter includes
a detailed interpretation of the findings, limitations of the study, recommendations for
future research, positive social change implications, and my conclusion.
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Interpretation of the Findings
This study fills a gap in research on factors that predict whether an individual will
fully meet the USPSTF CRC screening test recommendation within the recommended
time interval (CRCSU) in the state of Maryland. Findings from this research were based
on the following research questions:
Research Question 1: Socioeconomic Status and Colorectal Cancer Screening Use
My first finding is that SES, as measured by education level and household
income, is significantly (p < .05) associated with CRCSU among adults 50–75 years of
age in Maryland; hence, it is a predictor for fully meeting the CRC screening test
recommendation. For the education category, those in the high school graduate group
were 1.4 times more likely to fully meet the CRC screening test recommendation (p
=.065) compared to those who did not graduate from high school; some college group
was 2 times more likely (p =.000) and college graduate group was 2.4 times more likely
(p =.000). As education level increases so is the likelihood of fully meeting the CRC
screening test recommendation in Maryland. This finding is consistent with the literature,
which shows that a person living in a county in the U.S. where many residents have lower
education level is less likely to get tested for CRC (Weir, Li, Henley, & Joseph, 2017).
Furthermore, Siegel, Desantis, & Jemal, (2014) found that the rate of appropriate
CRC screening for people with less than 11 years of education (43.9%) was lower than
the rate for individuals with college education (69.2%). Other researchers have found that
education level is a strong predictor (p <.05) to the utilization of CRC screening services
in the U.S. (DeMoor et al., 2018; Miranda et al., 2017; Wools, Dapper, & de Leeuw,
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2016). However, contradictory to these findings, Almadi et al., (2015) found that neither
gender, education level, nor marital status, were associated with the willingness to
undergo CRC screening in a large-scale population-based cross-sectional study. The
inability of education level to predict CRCSU in some population suggest the need to
explore other factors that may be barriers to CRC screening uptake among those at lower
education level. Similarly, results from this study revealed that income level is a positive
but non-significant (p > .05) predictor of CRCSU among adults 50–70 years of age in
Maryland. Relative to the low-income category, the odds of CRCSU among the middleincome group (OR: 1.052; 95% CI: .847, 1.308, p = .645) and high-income (OR: 1.066;
95% CI: .857, 1.326, p = .568). This finding suggest that some segments of the Maryland
population may be experiencing barriers that limits their ability to participate in the free,
and low-cost CRC screening programs provided by the state (Maryland Cancer Report,
2017; Palmer, Chhabra & Mckinney, 2011). Therefore, the effect of income level on
CRC screening should be examined relative to other variables that may have a substantial
influence on CRC screening use.
Findings from these analyses are consistent with other research findings that
lowest CRC screening rates are seen among those with lower levels of education or lower
income (Miranda et al., 2017; Honein-AbouHaidar et al., 2016). Some researchers have
also found that those from minority populations and those of low SES have lower rates of
CRC screening (Doubeni, 2019; Doubeni et al., 2012; Fiscella et al., 2011). Since factors
related to socioeconomic disadvantage tend to occur in the same persons (Miranda et al.,
2017), improvement in strategies to promote screening uptake, and to enhance existing
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screening programs can help the state of Maryland achieve, sustain and surpass its ≥80%
CRC screening goal for all screen eligible individuals regardless of SES. There is a need
to adopt strategies that account for all education and income levels to increase CRC
screening in every segment of the Maryland population.
A second model of the regression analysis was performed to ascertain the effects
of age, sex and race/ethnicity on the likelihood to fully meet the CRC screening test
recommendation. The results from this analysis revealed that there is a statistically
significant (p < .05) association between age, race/ethnicity, and CRSCU. Also, age and
race had statistically significant (p < .05) confounding effects on the association between
education level, income level, and CRCSU by increasing the OR at each level. For
example, before adjusting for age, the OR for the high school graduate group, compared
to lowest educated group was (OR: 1.424, p = .065), and after adding age to the model,
the OR (OR: 1.503, p = .039) increased slightly. Similarly, before adjusting for age,
people with some college education (OR: 2.040, p = .000); and after adjusting for age, the
OR increased (OR: 2.179, p = .000). For college graduate, the OR increased from (OR:
2.420, p = .000) to (OR:2.558, p = .000) after adjusting for age.
However, sex was not associated and did not mediate the effect on the OR
between education, income, and CRCSU. This is contrary to findings from previous
research that 65.5% of women and 62.4% of men adhered to CRC screening in a large
community-based research (Kang & Son, 2017). In the same vein, Sava, Dolan, May, &
Vargas (2018) found that CRC screening participation rate was higher in women (44.0%)
aged 50-59 years than in men (25.91 %) of same age group. Statistically (p < .001) higher
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CRC detection rate and advanced adenoma in men have been attributed to lower CRC
screening rates in men compared to women (Arana-Arri et al., 2017). Another study
revealed higher odds of CRC screening participation in males (OR = 1.63, 95% CI: 1.36,
1.96), compared to females (Molina-Barceló et al., 2018). Some researchers have
suggested that, reasons for the sex differences in CRC screening participation is because
women have greater self-care and a higher perception of vulnerability to disease
compared to men (Mehta et al., 2016; Symonds et al., 2016). Differences between studies
on the association between sex and CRC screening signify the need to better understand
the effect of sex on CRC screening participation within groups. According to the MDH
(2019), it is essential for public health professionals to know the behavioral risk factors
within groups to inform the design and implementation of CRC screening programs.
Similarly, this study demonstrated that race/ethnicity is a significant (p < .05)
contributor to the likelihood to fully meet the screening recommendation; and a
confounder on the association between education level, household income, and CRCSU
by increasing the OR. Compared to Whites, the probability for CRCSU was significantly
lowest among Asians (OR = .754; 95% CI: .418, 1.359), relative to Blacks (OR: 1.430;
95% CI: 1.143, 1.789), and Hispanics (OR = 1.681; 95% CI: 737, 3.834). This is
consistent with previous finding that, Asians in Maryland have the lowest (53.6%) CRC
screening rate compared to any other race groups (Platz, 2018). Furthermore, evidence
from previous research revealed that self-reported CRC screening rates are highest
among whites (62.0%), relative to blacks (59.0%), Hispanics (52.5%), and Asians
(47.2%), and remain high even after adjusting for SES and access to health care (Liss &
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Baker, 2014). More also, Whites are more likely to participate and complete CRC
screening programs compared to any other race group (Mehta et al., 2016).
However, finding from this analysis is contradictory to previous research that
participation, adherence, and completion of CRC screening programs is increasingly
driven by age, sex, race (Wilder & Wilson, 2016; Hurtado et al., 2015). Based on these
findings, there is a need to pay more attention to improve CRC screening among Asians
in Maryland. Therefore, multi-component and culturally tailored CRC screening
programs are important strategies for addressing CRC screening differences among at
risk age, sex and race groups.
Research Question 2: Preventive Health Care Service and Colorectal Cancer
Screening Use
My second relevant finding from this research is that access to preventive health
care service measured by health insurance plan and access to health care professional can
predict whether an individual 50–75 years of age in Maryland will fully meet the
USPSTF CRC screening recommendation or not. Results from this analysis further reveal
that, age and race are confounders on the association between health insurance coverage,
access to a health care professional and CRCSU. Compared to those with “other” health
insurance plan, those with private plan were 1.3 times more likely to have CRCSU (OR:
1.309; 95% CI: .872, 1.967); and those with public plan were 14% less likely (OR: .868;
95% CI:.569, 1.324) to fully meet the CRC screening test recommendation. The
frequency distribution for the health insurance variable showed that out of the 3134 cases
analyzed, all (100%) had at least one form of health insurance plan either through, an
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employer or family based purchased private plan, Medicare or Medicaid public plan, or
some other health insurance plan (TRICARE, Alaska Native, Indian Health or Tribal
Health Services). Since every subject in this study had some type of health insurance, I
do not know the effect of having no health insurance on CRCSU in Maryland. When
comparing the differences in CRCSU among people with different types of health
insurance, there was no significant difference across groups (p > .05). I therefore judge
that there is no association between health insurance type and CRCSU in Maryland.
This finding is consistent with findings that individuals with traditional employersponsored insurance were 62.2% more likely, and those with traditional private purchase
plans were 50.9% more likely to be screened for CRC compared to those with other
health plans like TRICARE (De Moor et al., 2018). Moreover, it had been suggested that
type of health insurance coverage is associated with receipt of preventive health services
in the US (Sabatino, White, & Thompson, 2015). Although changes to health insurance
laws like the Affordable Care Act, have expanded access to health insurance options for
many people in the US (Blumenthal & Collins, 2014), cost-sharing for adults with
Medicaid continues to vary by state. Notably, the absence of cost-sharing for most health
insurance plans, was suggested as the reason why many eligible adults are not screening
according to USPSTF recommendations (White et al., 2017). Findings from this analysis
demonstrate that segments of the Maryland population are screening within the
recommended time intervals. However, CRC screening use remain lower for some
groups that experience persistent barriers to healthcare access, such as those without
access to a health care professional (Richardson, King, Dwyer, Parekh, & Lewis, 2015).
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Another finding from this analysis is that access to health care professional is a
significant (p < .05) predictor to CRCSU. The frequency distribution for the health care
professional variable showed that out of the 3134 cases, 2608 (83.2%) had access to one
health care professional, 358 (11.4%) had access to more than one health care
professional and 168 (5.4%) were without access to a health care professional. Result
from the Pearson chi-square test showed that among those with access to only one health
care professional, there was a statistically significant (p = .000) difference between those
who respondent “Yes” 2019 (77.4%) versus those said “No” 589 (22.6%) to CRCSU. Of
the 168 without access to a health care professional, 87 (51.8%) responded “Yes” to
CRCSU and 81 (48.2%) responded “No.” Also, when compared to those who do not have
access to a health care professional, those with access to only one health care professional
were 1.8 times more likely (OR=1.808; 95% CI: 1.295, 2.511, p = .000); and those with
access to more than one health care professional were 1.6 times more likely (OR: 1.628;
95% CI: 1.092, 2.429, p = .017) to CRCSU. This result supports findings from Yang &
Hwang, (2016) that access to a health care professional as a health care resource is a
predictor to utilization of preventive health services. Sabatino, White, & Thompson,
(2015) found that there is limited cancer screenings among adults who lack access to
preventive health care services; implying that there is relatively high CRCSU among
those who visit at least one health care professional compared to not having access to any
health care professional.
Furthermore, findings from these analyses persisted even after controlling for
some demographic variables. Age, and race/ethnicity confounded the relationship
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between the predictors and the outcome variable (CRCSU); but the odds ratios for
CRCSU remained the same even after adjusting for sex. This finding is consistent to
previous research finding that age (DeMoor et al, 2018; Symonds et al., 2016) and race
(Burnett-Hartman, Mehta, & Zheng, 2016; Mehta et al., 2016) are confounding factors to
CRC screening participation. However, it is contrary to previous research that
sociodemographic factors such as sex is a confounder to the association between
preventive health care services and adherence to CRC screening program (Sava, Dolan,
May, & Vargas, 2018; Kang & Son 2017). Factors such as age, sex, and race/ethnicity are
essential measures to assess CRC screening behaviors in large scale populations (Brenner
& Chen, 2018; Molina-Barceló et al., 2018).
Other studies have revealed that respondents in the low-income groups tend to
have low-paying jobs, which may have an effect on their use of preventive health care
services regardless of their sex (Meester et al., 2018; Yang & Hwang, 2016; Almadi et
al., 2015). The influence of health insurance coverage, and access to health care
professional on CRCSU should be explained relative to other factors that may affect CRC
screening use. For example, physician recommendation for screening and other social
determinants of health have been associated to CRC screening use in community-based
populations (Bernardo et al., 2018; Jih et al., 2018; Lin, McKinley, Sripipatana, &
Makaroff, 2017; Mehta et al., 2016; Palmer et al., 2011; Gilbert & Kanarek, 2005). These
findings suggest that more efforts to reduce lapses in insurance coverage and encourage
individuals to visit a doctor for preventive purposes are needed to encourage compliance
with national guidelines for CRC screening.
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The latest initiative from the 2019 National Colorectal Cancer Roundtable
(NCCRT) was to enhance strategies to achieve ≥80% CRC screening rates in every
community (NCCRT, 2019). Findings from this study add knowledge to the public health
discipline in that both health insurance coverage and access to a healthcare professional
are linked to preventive health care use. Therefore, to increase CRC screening adherence
in communities, public health officials need to promote initiatives necessary to increase
access to health care resources in minority communities (Wilder & Wilson, 2016).
According to Liang & Dominitz, (2019) the availability of multiple CRC screening test
options offers opportunities to both patients and physicians to choose the best screening
test for each patient.
Findings from this study, are consistent to findings from systematic reviews and
trend analysis that, there is a wide gap in CRC screening utilization between individuals
at different education levels, income levels, and access to a health care professional
(Cardoso et al., 2019; Doubeni et al., 2019; Sauer, Siegel, Jemal, & Fedewa, 2019; Jih et
al., 2018; Levin et al., 2018). Considering that my data was a random sample from a large
population, the multiple logistic regression technique provided some clues as to the
direction of the relationship between the independent and the dependent variables. Based
on the decision rule for my research questions, the null hypothesis was rejected for some
measures and accepted on others. Since I cannot draw an absolute conclusion from this
study alone, I can only state that there is insufficient evidence to reject the null hypothesis
that there is no statistically significant difference in the association between SES, access
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to preventive healthcare service, and CRCSU even after controlling for age, sex and
race/ethnicity.
This research makes a unique contribution to two theoretical and conceptual
frameworks, Health Belief Model (HBM) and Fundamental Cause Theory (FCT), that I
selected to guide this study. The HBM is structured to develop an understanding of
people’s willingness to engage in prevention programs to control disease (Glanz, Rimer,
& Viswanath, 2015); while the FCT is structured around the effect of socioeconomic
resources such as money, knowledge, and power to individuals taking actions towards
preventive behaviors to improve health and reduce disease mortality (Link & Phelan,
1995). By applying the concept of cues to action, results obtained from this study support
the HBM model, by effectively incorporating education level and access to healthcare
professional as avenues for taking action towards CRC screening.
The FCT is supported in this study by effectively incorporating the types of health
insurance plan, and income level as resources necessary to take action towards preventive
health behaviors such as CRC screening. Through this study, I expanded the use of the
HBM and the FCT to CRC screening use, and advanced the application of these
frameworks to different age, sex and race/ethnicity groups. One could argue that as long
as the HBM concept of cues to action is concerned, both the HBM and the FCT
compensate for the gaps in each other and therefore cannot be used without each other.
This study further contributes to the application of the HBM and the FCT in CRC
screening by providing insights into the complexity involved in CRC screening behaviors
in other geographic areas with similar demographic distribution like Maryland. At the
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least, given the lack of sufficient research on the predictors of CRC screening use in
Maryland, this study provides a crucial background upon which future studies on this
topic can be based on.
Limitations of the Study
Despite its contribution stated above, there are limitations to this study that need
to be discussed. Firstly, using secondary data from self-reported survey may be
susceptible to recall bias. Most of the BRFSS survey questions depended on the ability of
respondents to recall when a CRC screening was done and what test was used. Although
there is evidence of high reliability and validity of BRFSS data, there is the possibility
that some respondents might under-report or over-report responses. Inaccurate responses
to survey questions, may be a significant limitation to accurate data analysis (Ponto,
2015). There is a potential for selection and information bias as, more information may
have been pulled from some counties in Maryland than others.
Secondly, the original dataset included many cases with missing data which I
basically removed from the analysis; hence limiting the results from generalization to the
entire Maryland population of over 6 million people (U.S. Census, 2018). However,
using stratified random sampling technique in selecting cases was helpful to minimize the
problem of missing data in the analytic stage of this research. Hence the reliability of the
results was similar to that of the full version of the BRFSS dataset. Also, there was a
limitation in the balance of the samples in some categories. For example, the frequency
distribution shows that there are almost twice as many respondents in the college
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graduate subgroup compared to some college group; and respondents in the White
race/ethnicity group were over three times those in the black and other race groups.
Thirdly, although the use of a cross-sectional design was appropriate for this
study; it is limited in its ability to conclude causal inferences for the study variables.
Moreover, all six concepts of the HBM were not incorporated in this study, which could
limit its ability to describe the impact of knowledge, susceptibility, severity and barriers
of CRC screening. Lastly, it was difficult to ascertain whether observed differences in
results were confounded by other variables such as marital status that were not measured
in the analysis.
Recommendations
The strength of this cross-sectional study is grounded in the use of multiple
logistic regression technique which is an excellent model to estimate associations
simultaneously with the effects of group-level predictors on the outcome (Merlo et al.,
2018). Multiple logistic regression analyses used in this study corrected for the effects of
data collection at different age, sex, and race/ethnicity categories. This study is beneficial
because it reveals the relationship between demographic, SES, access to preventive
health care service and CRC screening use; and exposes the need to develop targeted
CRC screening programs for specific subgroups.
A power of this study is that it uses secondary data from a reliable and recognized
database, that stores CRC data from all states in the US. By using datasets from the
BRFSS, there is a high probability that my results are reliable and valid. More also data
from the CDC BRFSS are freely available hence eliminates time and cost constrains
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usually associated with primary data collection (Althubaiti, 2016). Another strength is
that most of the literature was pulled from recent articles published less than five years.
The studies reviewed included research findings of both primary and secondary datasets
from a wide geographic area. Although findings from this study showed statistically
significant associations between the predictors and the outcome variable, this study was
limited to the state of Maryland.
A recommendation for future research is that another quantitative study can be
conducted to examine the barriers implicated in low CRC screening use among specific
subgroups in Maryland. This study pointed to the role of demographic characteristics to
fully meet the CRC screening test recommendation. Future research could include a focus
on balancing the frequency distribution of all demographic variables. A randomized study
will allow for a more generalized result that could be applied to a larger population in the
United States. It is essential for future researchers to conduct prospective studies with
larger sample sizes to examine the intra-relation within specific predictor variables across
all SES levels. For example, future researchers can examine if there is a difference in
CRC screening use restricted to race/ethnic groups at the same education level. A
prospective study could focus on evaluating CRC screening programs in specific groups,
and estimate the effect of low CRC screening rates in minority populations.
There is a chance that low CRC screening rates in minority population may have a
negative health and economic impact in a community; however, more studies are needed
to ascertain that theory. Given existing literature and findings from this study, there are
other potential predictors of CRC screening use that are not applicable to Maryland in
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particular. Future studies could, therefore, include longitudinal investigations that provide
more than a snapshot of predictors of CRC screening use in Maryland. Such longitudinal
studies, could include a cluster of predictor variables and tracking of survey respondents
from 50 years to when they are 75 years or older to see if their CRC screening behaviors
change with age and time.
Social Change Implications
Findings from this study revealed that the predictors of CRC screening use among
adults aged 50–75 years are multifactorial. This information is of interest to public health
professionals, governmental and non-governmental organizations, physicians, individuals
and volunteers who work to reduce the cancer burden of the communities in which they
serve. In their 2019 annual conference, the NCCRT pointed out that despite efforts to
promote and increase CRC screening rates across groups “not everyone is benefiting
equally as some racial/ethnic groups, many rural and low income communities still
experience lower CRC screening rates” (NCCRT, 2019). To increase CRC screening
rates to 80% and higher, the NCCRT can use findings from this study to understand
which predictors have a significant effect on CRC screening adherence.
This study helps to narrow the gap in knowledge by improving understanding of
the effects of age, sex, and race/ethnicity on CRC screening use and the complex nature
of factors that predict CRC screening across groups. This study could be excellent in
advancing epidemiological knowledge as it provides a useful framework for problems
that have a multifactorial structure. Public health practitioners in Maryland, can design
programs that target specific groups as an effort to help increase CRC screening use and
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reduce CRC incidence in the State. CRC causes over $15 billion of the US health care
costs per year, with the potential to increase if CRC prevalence is not controlled
(Bibbins-Domingo et al., 2016). The policy implications from this study are that, there is
an urgent need for public health administrators and policymakers who lead the
development and approve the implementation of programs at state and federal levels to
prioritize initiatives that focus on eliminating inequity in CRC screening across all
communities.
Key stakeholders for CRC screening initiatives may include public health
professionals who will design CRC screening programs; public health agencies at all
levels that will fund the programs; community leaders who will help health care workers
to advocate for screening by encouraging dynamic behavioral and lifestyle changes that
correspond to CRC screening guidelines; physicians who will educate and recommend
screening when patients visit the clinics; individuals who must adhere to screening
guidelines; and health insurance companies that will advocate for CRC screening to
reduce cost of treatment if the disease if diagnosed. The NCCRT ≥80% screening goal
can be met if all stakeholders collaborate to the success of various public health
initiatives towards CRC screening use. For example, public health professionals can work
with volunteer organizations to donate free CRC screening kits, and educational materials
to low SES communities.
Conclusion
Colorectal cancer is one of the most common cancer diagnosed in both men and
women, and a good candidate for screening programs (Levin et al., 2018). Given the
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multiple benefits of CRC screening and better prognosis associated with early diagnosis,
more efforts to increase screening rates are essential strategy to improve Maryland
population health. Findings from this study suggest that predictors of CRC screening may
not be homogeneous in all populations. The results showed that CRC screening use
among minority groups that experience persistent barriers to preventive healthcare
services, remain lower than expected. Higher odds ratios of CRCSU was observed among
those with higher education and income levels compared to those at the lower levels of
education and income, or no access to healthcare professionals.
Although race and SES are associated factors, they both reflect distinct processes
of stratification where either race or SES is likely to be a proxy for exposures that affect
health outcomes (Williams, Priest, & Anderson, 2016). Hence, SES cannot fully explain
the reasons for CRC screening differences across age and race groups (Siegel, Desantis &
Jemal, 2014). Maryland is a state with significant health care resources, hence a targeted
program that can ensure access to health care resources such as specific health insurance
coverage for minority groups can potentially help to increase CRC screening uptake in
the state. As of 2019, Maryland is yet to meet its ≥80% CRC screening goal. Based on
the resolution from the 2019 NCCRT conference, members agreed to continue on their
mission to achieve at least 80% screening rates in every community, by defining the
target population for screening, surveillance intervals, and potential risk strategies.
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Appendix A: USPSTF CRC Screening Guideline for Average-risk Individuals
Screening
method

Main issues for informed
decisions
Most sensitive. Can detect
Reduction in
precancerous lesions.
Every 10
mortality in a
Colonoscopy
Requires full bowel
years
prospective cohort
preparation and possibly
study
sedation.
Only distal colon is
examined. Can detect
Reduction in
Sigmoidoscopy Every 5 years
precancerous lesions.
mortality in RCTs
Requires limited bowel
preparation.
Performed at home but
should be repeated annually.
Reduction in
Limited ability in detecting
FOBT
Every year
mortality in RCTs
precancerous lesions. Followup colonoscopy is needed if
result is positive.
Performed at home but
Higher sensitivity
should be repeated annually.
and specificity in
Limited ability in detecting
FIT
Every year
detecting CRC than
precancerous lesions. FollowFOBT, but RCTs is
up colonoscopy is needed if
lacking
result is positive.
Note. From “Recent advances in colorectal cancer screening”, by Li D., 2018, Journal of
Chronic Diseases and Translational Medicine, 4(3), 139–147. Published online 2018 Sep
17. doi: 10.1016/j.cdtm.2018.08.004
Frequency

Efficacy
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Appendix B: Maryland Department of Health, Medical Advisory Committee Guidelines
for Colorectal Cancer Screening Revised Version May 2018

